A New Generation of Polymer/Ceramic Composite Biomaterials for Bone Regeneration by Salarian, Mehrnaz
Western University 
Scholarship@Western 
Electronic Thesis and Dissertation Repository 
12-10-2014 12:00 AM 
A New Generation of Polymer/Ceramic Composite Biomaterials 
for Bone Regeneration 
Mehrnaz Salarian 
The University of Western Ontario 
Supervisor 
Prof. Paul A. Charpentier 
The University of Western Ontario 
Graduate Program in Biomedical Engineering 
A thesis submitted in partial fulfillment of the requirements for the degree in Doctor of 
Philosophy 
© Mehrnaz Salarian 2014 
Follow this and additional works at: https://ir.lib.uwo.ca/etd 
 Part of the Biomaterials Commons 
Recommended Citation 
Salarian, Mehrnaz, "A New Generation of Polymer/Ceramic Composite Biomaterials for Bone 
Regeneration" (2014). Electronic Thesis and Dissertation Repository. 2562. 
https://ir.lib.uwo.ca/etd/2562 
This Dissertation/Thesis is brought to you for free and open access by Scholarship@Western. It has been accepted 
for inclusion in Electronic Thesis and Dissertation Repository by an authorized administrator of 
Scholarship@Western. For more information, please contact wlswadmin@uwo.ca. 
A NEW GENERATION OF POLYMER/CERAMIC COMPOSITE 
BIOMATERIALS FOR BONE REGENERATION   
(Thesis format: Integrated Article)  
 
 
 
by 
 
 
 
Mehrnaz Salarian 
 
 
 
 
Graduate Program in Biomedical Engineering 
 
 
 
 
A thesis submitted in partial fulfillment 
of the requirements for the degree of  
Doctor of Philosophy 
 
 
 
 
The School of Graduate and Postdoctoral Studies 
The University of Western Ontario 
London, Ontario, Canada 
 
 
 
 
© Mehrnaz Salarian 2014 
 ii 
 
Abstract 
There is a substantial emerging interest for fundamental and applied research on the 
reinforcement of polymeric materials using nanotechnology. In the biomedical industry, 
development of novel bone cement composite materials with enhanced mechanical 
properties is of tremendous potential importance. The most universally used injectable 
bone cement is made of poly(methyl methacrylate) (PMMA); however, the major 
disadvantage of PMMA is its non-biodegradability. Polymers such as poly(propylene 
fumarate) (PPF) and polycaprolactone (PCL) are biodegradable, but suffer from a lack of 
mechanical properties. The aim of this research was to test the efficacy of these 
biodegradable polymers integrating nanotechnology for the development of composite 
biomaterials with improved mechanical properties sufficient for bone cements.  
This goal was investigated through a range of different studies. Focusing on 
nanostructured titania (n-TiO2) initially, titania nanofibers (n-TiO2 fibers) and nanowires 
(n-TiO2 wires) were introduced into a PPF matrix for potential use as an orthopaedic 
biomaterial to treat skeletal bone defects and diseases such as osteonecrosis. PPF was 
modified with maleic anhydride to provide functionality for the coordination of PPF to 
the surface of TiO2 nanofibers through a ring-opening reaction. The synthesis and 
modification of PPF were confirmed by NMR (
1
H and 
13
C) and XPS. The reaction 
chemistry of the functionalized PPF and nano-TiO2 was also investigated by XPS and 
FTIR analyses. The PPF-grafted nano-TiO2 was further employed in the development of 
bone cement composites by crosslinking/polymerization in the presence of N-vinyl 
pyrrolidone. Mechanical testing of the resulting bone cement composites demonstrated a 
significant enhancement of the tensile and flexural properties attributed to the chemical 
bonding between the PPF matrix and TiO2 nanofibers. On the basis of the determined  
mechanical properties, an optimum composition was found at 5 wt% loading of n-TiO2 
fiber (0.5% in the starting composition) which provided a significant increase in Young’s 
modulus (153%), tensile strength (113%), flexural modulus (196%), and flexural strength 
(126%) when compared with the unfilled PPF. These improvements were attributed to 
the chemical linkage of the filler to the polymer matrix which enhances the transfer of a 
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mechanical load to the n-TiO2 fiber, leading to an increase in the mechanical properties 
of the bone cement composite. 
Secondly, bone formation is an angiogenesis-dependent process, and the need for 
treatment modalities that enhance neovascularization is especially important for bone 
regeneration in necrotic bone. A bone cement system capable of delivering an angiogenic 
modulator in a controlled manner may have the ability to boost the angiogenic response 
when injected to an osteonecrotic lesion. Therefore, an angiogenic agent, ginsenoside 
Rg1, was incorporated into an orthopedic PPF-based  cement. Additionally, Sr-doped 
TiO2 nanofibers synthesized in supercritical CO2 were added to the cement formulation 
as an alternative radiopacifier to enable visualization of the bone cement composites and 
potential monitoring of the healing and loosening processes. XPS analysis showed that 
Sr
2+
 was doped in the crystalline matrix of anatase with the formation of SrTiO3. The 
strong interfacial adhesion between PPF and nanofibers were characterized by SEM, 
FTIR, XPS, and thermal analyses and mechanical testing. The Sr-doped n-TiO2 fibers 
were shown to provide reasonably higher radiopacity to the PPF matrix, which is 0.32 ± 
0.03 mm Al, than the unmodified fibers at the same loading level (0.20 ± 0.01 mm Al). In 
addition, bone cement composites loaded with ginsenoside Rg1 were found to provide a 
high drug release without sacrificing the mechanical properties of the bone cement. 
Furthermore, tube formation bioassays suggested that human umbilical vein endothelial 
cell lines would rearrange and align into a tubular structure in the presence of ginsenoside 
Rg1. Consequently, the proposed cement combines the immediate mechanical support 
given by the chemical bonding between the filler/polymer and optimum radiopacity (0.30 
± 0.12 mm Al) due to the incorporation of the Sr-doped TiO2 nanofibers to PPF matrix. 
Thirdly, because of the unique biological activities of ginsenoside Rg1, upregulating in 
vitro proliferation, migration, chemo-invasion, and tube formation in human umbilical 
vein endothelial cells (HUVECs), Rg1 can be incorporated into scaffold materials for 
bone tissue engineering applications. This incorporation could be achieved by 
encapsulation of ginsenoside Rg1 in biodegradable microspheres of PPF. Rg1-loaded PPF 
microspheres were prepared by both a double emulsion and a microfluidic technique for 
the first time in this research. The size and morphology of the Rg1-loaded PPF 
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microspheres were characterized by SEM, showing unimodal 50-65 µm size diameters 
using the microfluidic technique, ideal for easy flowing powders required in commercial 
formulations. The PPF microspheres produced from the microfluidic technique gave high 
encapsulation efficiencies of up to 95.35 ± 0.82%, while those obtained from a 
conventional double emulsion method gave a much broader size distribution in the range 
of 2-45 µm with lower encapsulation efficiencies of 78.48 ± 1.68%. Release profiles 
were studied and quantified by UV-Vis spectrophotometry, with the results showing a 
lower initial burst in the release of Rg1 from the unimodal microspheres prepared by the 
microfluidic technique than from the double emulsion method. The burst effect was 
followed by a slow release profile which can be used for long term drug delivery 
applications to maintain the ginsenoside Rg1 concentration for an extended time period. 
Moreover, the released Rg1 showed a significant stimulatory effect on angiogenesis 
behavior and tube formation in human umbilical vein endothelial cells (HUVECs). 
Therefore, PPF microspheres developed in this study have potential for next-generation 
biomedical agents in drug-release devices for bone tissue engineering. 
Finally, the use of hydroxyapatite HAp is rather limited for heavy load-bearing 
applications due to low mechanical reliability and poor processability. Therefore, 
immobilization of a biocompatible metal/metal oxide on the surface of HAp has been 
receiving increased attention for applications involving the enhancement of mechanical 
properties of biocompatible prostheses. A novel nanostructured HAp and a composite of 
HAp and TiO2 with ultrafine structure and significantly improved mechanical properties 
were prepared using combined co-precipitation and sol-gel method in the green solvent, 
scCO2, and incorporated into poly(ε-caprolactone) (PCL) matrix to develop scaffolds 
with enhanced physical and mechanical properties for bone regeneration. SEM and TEM 
analyses were employed to examine the morphology of the HAp nanoplates and HAp-
TiO2 nanocomposites. The presence of Ti, O, Ca, and P in the HAp-TiO2 nanocomposites 
was detected by EDX. In addition, the effect of metal alkoxide concentration, reaction 
temperature, and pressure on the morphology, crystallinity, and surface area of the 
resulting nanostructured composites was examined using SEM, XRD, and  the BET 
method. Chemical composition of the products were characterized using FTIR, XPS, and 
XANES analyses. TGA analysis was performed to investigate thermal behavior of the 
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synthesized nanomaterials. Mechanical testing revealed a significant increase in the 
Young’s modulus (88.6%), tensile strength (122%), flexural modulus (47%), and flexural 
strength (59.6%) of PCL/HAp-TiO2 composites containing 20 wt % HAp-TiO2 compared 
to PCL/HAp composites.  
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Chapter 1  
 
1 General Introduction and Literature Review 
 
1.1 Vascular necrosis of femoral head 
Blood circulation is a key factor to have healthy bone tissue, since it transports oxygen, 
nutrition, carbon dioxide, waste, and other materials to and from bone cells.[1] However, 
there are many risk factors which can cause the temporary or permanent loss of blood 
supply to bone. Reduced blood flow to bones will result in osteonecrosis, which mainly 
occurs in the weight-bearing parts of the body, for example the anterosuperior aspect of 
the femoral head, as shown in Figure 1.1.[2] Osteonecrosis is a disease with a wide 
ranging etiology and poorly understood pathogenesis,[3] being most common in adults 
between the ages of 20 and 50 years.[4] Regardless of what causes the death of the bone 
cell, the cellular events and therefore the tissue responses constituting the repair are the 
same whether the cells are killed by interfering with their blood supply, by freezing them, 
or killing them with cytotoxic chemical agents.[5] Because of this common path for 
repair and the fact that the actual cause of cell death is unknown in most cases, the term 
“osteonecrosis” is used rather than “avascular necrosis”, which indicates a distinct 
etiology for cell death.[5] 
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Figure 1.1. The lack of normal blood supply to the femoral head causes the bone to die. 
Etiology is the study of the factors that cause a disease. Trauma-induced avascular 
necrosis of the femoral head represents the most common type of aseptic 
osteonecrosis.[6] With the stress of weight-bearing, the necrotic segment of bone is likely 
to collapse leading to painful degenerative arthritis of the hip.[7] Therefore, the term 
“avascular necrosis” is exclusively used for this post-traumatic group, as they originate in 
ischemia resulting from blood flow interruption.[6] When the mechanism of necrosis is 
not clearly understood, the etiology is often presumed on the basis of an association with 
a particular risk factor.[2] For example, obesity and gout are considered to be frequent as 
noted by R. Merle d'Aubigne, but their role is uncertain.[8] Moreover, alcoholism is 
implicated as a risk factor for avascular necrosis as Ono and Sugioka identified an 
increased risk for avascular necrosis in people who drank as little as 400 milliliters of 
alcohol per week.[9] In addition, steroid therapy in which corticosteroids were  
dministered before pain appeared in the hip accounts for a rising incidence of necrosis of 
the femoral head.[10, 11] Exposure to corticosteroids and alcohol consumption are 
responsible for approximately 90% of all reported causes of avascular necrosis.[2] Age is 
also considered to be a modulating factor having an influence on the development of 
avascular necrosis, although the reported data are contradictory.[12] According to Brown 
there is a strong relationship between older age and higher incidence of avascular 
necrosis;[13] however, Barnes et al. reported a decrease in the avascular necrosis 
incidence beyond the age of 75.[14] Furthermore, women have shown a higher tendency 
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towards avascular necrosis than men.[12] Besides, there is a higher number of avascular 
necrosis incidence among patients with a higher level of activity before fracture.[6] 
Pathogenesis deals with the cellular events, reactions, and other pathological mechanisms 
happening in the progression and development of a disease.[2] Multiple theories about 
the mechanism of interruption of the blood supply to the femoral head have been 
formulated.[2, 8] Some of these theories comprise thromboemboli in the blood supply to 
bone resulting from circulating fat or nitrogen bubbles,[15] abnormally shaped red blood 
cells causing sickle-cell anaemia,[16] infection and vasculitis leading to vessel wall 
injury,[2] and radiation damage or release of vasoactive factors as in Gaucher 
disease.[17]  
Osteonecrosis of the femoral head leads to end-stage degenerative arthritis, which is 
responsible for approximately 10% of the primary total hip arthroplasties performed in 
the United States.[18] If no treatment is applied, more than 70% of osteonecrotic femoral 
heads will collapse and require prosthetic replacement within three to four years of 
diagnosis.[19] In early stages of osteonecrosis, the goal is to avoid collapse.[20] Present 
surgical treatments such as core decompression and bone grafting have been the most 
effective treatments for necrosis of the femoral head at an early stage.[4] However, these 
methods consume time for biologic incorporation of bone graft, revascularization, or 
replacement of dead bone by creeping substitution, and are less efficacious in Stages III 
and IV.[20] When lesions are large and collapse has already occurred, the goal is to halt 
additional collapse and to restore femoral head sphericity.[21] Bone grafting techniques 
are less successful at joint restoration once collapse occurs (Stage III osteonecrosis), so 
the open reduction and cement fixation (cementation) can be more efficacious;[4, 20] 
total hip arthroplasty is the most successful treatment for Stage IV.[22] 
The Association Research Circulation Osseous (ARCO) international classification 
system classifies osteonecrosis into five stages (0-IV) using computer tomography (CT) 
scanning, magnetic resonance imaging (MRI), and bone scanning findings summarized in 
Table 1.1.[23] Stage 0 includes at-risk patients, who have shown no positive 
radiographic, MRI, or scintigraphic findings. Patients with Stage I osteonecrosis have 
4 
 
normal radiographs and CT scans with positive MRI or scintigraphic findings or both, 
and they are treated by core decompression. In Stage II osteonecrosis, a mottled and 
sclerotic rim around the area of necrosis is evident in radiographs and CT scans in 
addition to the MRI changes diagnostic for osteonecrosis. These patients are treated with 
vascularized free fibular grafts. Based on the location and extent of infarct size, Stages I 
and II are subcategorized into three types (A, B, and C). Patients with Stage III 
osteonecrosis show a crescent sign, flattening, or both in radiographs and CT scan, and 
they are treated by open reduction and cementation. Stage III is also subdivided (A, B, 
and C) using the quantification of collapse.[20] In Stage IV osteonecrosis, arthritic 
findings become evident, and total hip arthroplasty is the most successful treatment for 
Stage IV.[20] 
Table 1.1. ARCO international classification of osteonecrosis.[24] 
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1.2 Cementation 
Cement fixation is a recently introduced method for treating stage III osteonecrosis of 
femoral heads. Bone cementation involves the injection of fluid material, which instantly 
hardens in the defect, and provides mechanical support to prevent collapse.[20] Bone 
cement is considered to make the treatment of irregular defects easier. It is also easier to 
use for clinical practice, providing immediate symptomatic relief and faster recovery of 
the patient, while allowing improvement in mobility.[23, 25] Cement augmentation has 
the potential to maintain reduction and restore femoral head sphericity and prevent 
further collapse before progression to stage IV disease.[21, 25] However, the long term 
results in regard to progression of disease and secondary arthritis is unknown. The 
possible indication for this procedure is a young patient with stage III osteonecrosis who 
has active, unresolved disease.[4, 20] 
The procedure is performed with the patient in the lateral decubitus position. A 20-cm 
incision is made centered over the greater trochanter, and a T-shaped capsulotomy is 
made at the base of the femoral neck. Using a skeletal traction device, subluxation and 
distraction of the femoral head and observation of the pathologic area of articular 
cartilage is performed. Then, a 6-mm hole is drilled in the neck (Figure 1.2(A)), which 
allows access for debridement of dead bone and insertion of cement. A joker is used to 
elevate the necrotic bone and reduce the collapse. Next, the high or low viscosity cement 
is pressurized by injection with a cement gun into the femoral head, and the injection is 
completed when the shape of the femoral head is restored. Reduction of the collapsed 
segment is performed under direct observation, and the cement is allowed to harden with 
contouring and molding of the femoral head by the acetabulum. A small bone dowel graft 
from the greater trochanter is used to plug the hole (Figure 1.2(B)). After the operation, 
the patient is encouraged to mobilize the hip, while weight-bearing is only permitted after 
3 weeks with the assistance of crutches for as many as 6 months.[4, 20] 
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Figure 1.2. The operative procedure of cementation for osteonecrosis 
of femoral head.  
A small burr hole is created at the base of the cartilage allowing for debridement of 
necrotic bone and access for the cement (small arrow). Cartilage deformity is shown 
(large arrow) (A). A small bone dowel taken from the greater trochanter is placed in the  
entry hole (small arrow). The cartilage deformity has been reduced (large arrow) 
(B).[20] 
1.2.1 PMMA-based bone cements 
The history of bone cements goes back more than 100 years ago. Gluck et al. reported the 
use of ivory ball-and-socket joints in the treatment of hip joint diseases.[26] They used a 
cement composed of colophony, pumice powder, and plaster to stabilize these joints in 
the bone.[27] The most universally used injectable bone cement is made of poly(methyl 
methacrylate) (PMMA).[28] Haboush presented a self-curing acrylic dental cement to 
secure a total hip replacement.[26, 29] At this time, PMMA cements were mostly used in 
dentistry to produce partial dentures, artificial teeth, orthodontic retainers, denture repair 
resins, and so forth. However, Charnley pioneered the use of PMMA in total hip 
replacement (THR) in 1964 to secure fixation of the acetabular and femoral components 
and to transfer loads to bone.[30, 31] Nowadays, several million joint replacements are 
performed worldwide each year with more than half of them using bone cements, with an 
increasing trend.[32] In 1982 Ewald et al. performed hip arthroplasties that preserved a 
normal articular surface, whereby the trabecular bone of the femoral head was replaced 
with PMMA in experimental animals.[33] In addition, Wood et al. first practiced the use 
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of PMMA in cement augmentation for the treatment of stage III vascular necrosis of the 
femoral head in 2000, and found that the use of this procedure should be restricted to 
symptomatic, young patients (less than 40 years), preferably with mild to moderate Stage 
III osteonecrosis.[4] 
1.2.1.1 Drawbacks associated with PMMA 
PMMA is reportedly bioinert and shows good biocompatibility over long-term follow-
up.[34] Several inherent advantages to PMMA include familiarity for operating 
physicians, ease of handling, good biomechanical strength and stiffness, and cost-
effectiveness.[35] However, there are several disadvantages associated with PMMA bone 
cements.[26] Firstly, PMMA is nonbiodegradabile; thus, it cannot be replaced with new 
bone formation.[36, 37] Secondly, the high exothermic reaction during polymerization, 
ranging between 67 and 124 C at the center of the cement mantle in vivo results in 
impaired local blood circulation and thermal necrosis of the surrounding bone at the 
cement-bone interface.[38] Thirdly, the release or leakage of unreacted monomer liquid 
before polymerization of the cement in the bone bed may cause chemical necrosis of the 
bone.[38] Forthly, the foreign body reaction at the cement-bone interface indicates that 
PMMA cement is not bioinert and biocompatible. The cellular responses or tissue 
reactions might be associated with the chemical effects from unreacted MMA monomer 
produced during the setting process, and may be involved as the possible cause of 
junctional tissue damage and cement loosening.[36] According to Herman et al., PMMA 
cement particles evoke inflammatory periprosthetic tissue responses directly affecting the 
bone resorption at the cement-bone interface.[39] Fifthly, PMMA bone cements suffer 
from shrinkage during polymerization.[38] In addition, toxic substances or unreacted 
monomers released during the setting process may jeopardize the repairing process such 
as cell proliferation, neovascularization, and the dead bone resorption by osteoclasts or 
new woven bone formation by osteoblasts.[36, 37] Therefore, it is of great necessity to 
develop a bioactive bone cement which is nontoxic, isothermic curing, mechanically 
capable, and has osteoconductive and osteoinductive properties. 
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1.2.2 Poly(propylene fumarate)-based bone cements and properties 
Recently, poly(propylene fumarate) (PPF) has attracted considerable interest as a 
promising degradable material for treating skeletal defects.[40] PPF is a linear and 
unsaturated polyester made of repeating units, which contain one unsaturated carbon-
carbon double bond allowing for cross-linking of the polymer into a covalent polymer 
network and two ester linkages for hydrolysis of the polymer into biocompatible products 
fumaric acid and propylene glycol, both of which can be absorbed by the body.[41, 42] 
Cross-linked PPF is often incorporated with calcium phosphates found to provide 
comparable mechanical properties to those of human trabecular bone.[43] Although the 
double bonds of PPF can cross-link with itself to form cross-linked polymer 
networks,[44] a variety of cross-linking agents such as N-vinyl pyrrolidinone (N-VP), 
poly(propylene fumarate)-diacrylate (PPF-DA), poly(ethylene glycol)-dimethacrylate 
(PEG-DMA), diethyl fumarate, and methylmethacrylate (MMA) have been explored in 
combination with PPF.[45] When combined with an appropriate initiator system, it may 
be cross-linked in situ during surgery to form a solid biodegradable bone cement via an 
addition polymerization reaction between PPF and cross-linking reagents.[46] The 
chemical structure of PPF and PPF-DA and cross-linking reaction of PPF and PPF-DA 
are shown in Figure 1.3. As the cross-linking reaction proceeds, the viscous polymer is 
transformed to a putty-like state before solidifying. During this transition, the material 
may be injected or molded into a bone defect. It is particularly interesting for orthopaedic 
applications in filling irregularly shaped bone defects, which are relatively inaccessible, 
with minimal surgical intervention.[41] Addition polymerization reactions are generally 
exothermic as in the case of PMMA bone cements, which may cause some local tissue 
necrosis. In the case of PPF with N-VP used as a cross-linker, the generated heat by the 
addition polymerization reaction between PPF and N-VP is milder with no local tissue 
necrosis noted in vivo after implantation compared to the curing temperature measured 
for PMMA bone cement.[47] For example, the maximum cross-linking temperature 
reported for a range of formulations based on PPF, N-VP, benzoyl peroxide, and 
tricalcium phosphate (TCP) varied from 38 to about 48 C.[48, 49] Besides, the curing 
times varied between 1 and 121 min allowing the composites to be tailored to specific 
applications.[49] 
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The properties of cross-linked PPF networks, including mechanical strength, degradation 
kinetics, and handling of the polymer are dependent on the molecular characteristics of 
the constituent polymer, including the molecular weight and polydispersity of PPF.[46] It 
has been reported that achieving high molecular weight PPF is difficult. Typically PPF 
molecular weights vary from 500 to 4,000 Da, and polydispersities are generally below 
1.4.[46] The major disadvantage of PPF is that it is a viscous liquid at room temperature, 
which makes handling of the polymer somewhat cumbersome.[50] As PPF molecular 
weight increases, its viscosity also increases, which often impacts the handling of the 
polymer and the intended applications.[46] Furthermore, a higher molecular weight PPF 
and a more viscous polymer solution may cause greater autoacceleration of the 
polymerization, leading to rapid release of heat.[48] However, the total heat released 
upon crosslinking decreased by an increase in PPF molecular weight.[51]  
 
Figure 1.3. Cross-linking reaction of PPF and PPF-DA to synthesize PPF/PPF-DA 
polymer networks.[45] 
PPF-based materials undergo only bulk degradation by hydrolysis of the ester linkages 
within its chemical structure.[52] PPF degrades to fumaric acid, a naturally occurring 
substance, found in the tri-carboxylic acid cycle (Krebs cycle), and propylene glycol, 
which is a commonly used diluent in drug formulations.[53, 54] Degradation time is 
dependent upon polymer structure as well as other factors.[54, 55] According to Timmer 
et al., PPF/PPF-DA systems represent a fairly slow in vitro degradation over 52 weeks in 
buffered saline solution at 37 C.[56] They also demonstrated that low quantities of 
acrylic acid and poly(acrylic acid-co-fumaric acid) along with fumaric acid and 
propylene glycol were obtained upon degradation of PPF/PPF-DA via ester hydrolysis as 
illustrated in Figure 1.4.[45] According to Peter et al. PPF-based materials do not exhibit 
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a deleterious long-term inflammatory response when implanted subcutaneously in rats 
and rabbits.[54] In addition, in vitro cytotoxicity studies by Timmer et al. demonstrated 
favorable cell viability in the presence of the water-soluble extracts of PPF/PPF-DA.[45] 
Consequently, PPF-based polymers have been widely explored for a number of 
biomedical applications, such as the fabrication of orthopedic implants, scaffolds for 
tissue engineering, controlled bioactive factor delivery systems, and cell transplantation 
vehicles owing to their injectability, biocompatibility, and biodegradability. 
 
Figure 1.4. Degradation scheme of PPF/PPF-DA networks.[57] 
1.2.2.1 Mechanical properties  
The mechanical properties of PPF networks differ greatly depending on the synthesis 
method and the cross-linking agent.[58] Mechanical properties of PPF polymeric 
networks can be tailored by varying the molecular weight of PPF, the molecular weight 
of the cross-linking agent used for the formation of PPF-based network, and the ratio of 
the cross-linking agent to PPF.[56] Yaszemski et al. showed that PPF-based scaffolds 
have a greater degradation from the surface region compared to the interior of the 
scaffold specimen. When this material was used as a temporary replacement, it was able 
to provide the reconstructed skeletal region with adequate mechanical strength from the 
time of surgery, through the time that the material degraded and the region reconstituted 
itself with new bone, until the new bone provided the required mechanical properties.[59] 
As the PPF-based scaffold degrades from its surface and has new bone continually 
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advance against that surface, it may allow the remaining bulk of nondegraded material 
farther from the surface to retain its mechanical properties and provide strength to the 
reconstructed region.[59] He et al. prepared PPF-based polymer networks by radical 
polymerization using PPF and PPF-DA macromers, and demonstrated a dramatic 
increase in the compressive strength of PPF/PPF-DA polymer networks as the double 
bond ratio of PPF/PPF-DA decreased.[60] Additionally, incorporation of ceramic filler 
materials such as hydroxyapatite (HAp),[42] tricalcium phosphate (TCP),[51] dicalcium 
phosphate dehydrate,[61] calcium carbonate,[54, 62] calcium sulfate,[54] or bioactive 
glasses[63] could be used to enhance the mechanical strength. Particularly β-TCP has 
been shown to be useful for reinforcement, and compositions without TCP reinforcement 
disintegrated very early in the implant.[54, 64] However, the development of composite 
materials combining PPF and inorganic particles has not been investigated to a large 
extent, in comparison with the extensive research efforts dedicated to PMMA-based 
composites. 
Shi et al. investigated the effects of the dispersion of single-walled carbon nanotubes 
(SWNTs) and functionalized SWNTs (F-SWNTs) in unsaturated PPF, and examined the 
rheological properties of un-cross-linked nanocomposite formulations as well as the 
electrical and mechanical properties of cross-linked nanocomposites.[65, 66] F-SWNTs 
were produced from individual SWNTs by a diazonium-based method, and showed better 
dispersion than unmodified SWNTs in both un-cross-linked and cross-linked PPF 
matrixes. Mechanical testing demonstrated a 3-fold increase in both compressive 
modulus and flexural modulus and a 2-fold increase in both compressive offset yield 
strength and flexural strength of crosslinked nanocomposites compared to the pure PPF 
networks. Low SWNT concentrations of the order of 0.05 wt% gave the best 
properties.[65] In another attempt, Sitharaman et al. studied the effects of size and surface 
area of the carbon nanostructures on the rheological properties of un-cross-linked PPF 
nanocomposites and the mechanical properties of cross-linked nanocomposites as a 
function of the nanostructure loading. It was found that the rheological properties of un-
cross-linked nanocomposites depend mainly on the carbon nanostructure size, while the 
mechanical properties of the cross-linked nanocomposites are dependent on the carbon 
nanostructure surface area.[67] However, there is a sustained debate regarding the 
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biocompatibility of carbon nanotubes, and bone cement reinforced with carbon nanotubes 
may have adverse effects on the surrounding living cells.[68] Horch et al. studied the 
mechanical enhancement of cross-linked PPF using surface-modified carboxylate 
alumoxane nanoparticles.[69] They investigated various surface-modified nanoparticles, 
including a surfactant alumoxane, an activated alumoxane, a mixed alumoxane 
containing both activated and surfactant groups, and a hybrid alumoxane containing both 
groups within the same substituent. They found that hybrid alumoxane nanoparticles 
dispersed in PPF/PPF-DA exhibited over a 3-fold increase in flexural modulus at 1 wt % 
loading compared to the polymer resin alone. This dramatic improvement in flexural 
properties is attributed to the fine dispersion of nanoparticles into the polymer and the 
increased covalent interaction between the polymer chains and the surface-modified 
nanoparticles.[69] 
1.2.2.2 Radiopacity  
Radiopacity refers to the relative inability of electromagnetic radiation, specifically X- 
rays, to pass through a particular material. Radiopaque substances do not allow X-rays or 
similar radiation to pass through, and exhibit a white appearance in radiographic imaging 
using X-rays.[70, 71] Radiopacity is a desirable property in bone cements allowing post-
operative assessment using X-radiography.[72] It is important that the orthopaedic 
surgeon can easily monitor healing and loosening processes to differentiate between 
bone, bone cement, and osteolysis after a joint replacement surgery.[73] 
PMMA itself is a radiolucent material, and PMMA cement did not contain any 
radiopaque materials until 1972; therefore, it was impossible to directly determine the 
boundaries of bone cement of pure PMMA matrix during the surgery by ordinary X-ray 
imaging techniques.[73] For this reason, 8-15 wt% X-ray radiopaque media, barium 
sulphate (BaSO4) or zirconium dioxide (ZrO2), have been added to all commercially 
available PMMA bone cements.[74] Poor wetting and weak interfacial interactions 
between the inorganic particulates and the non-polar polymer matrix often result in 
detrimental effects on the mechanical properties of the cement.[72] According to Lewis 
et al. incorporation of strontium oxide (SrO) particles as an alternative radiopacifier in an 
acrylic cement matrix provided a radiopacity as high as that exhibited by a cement 
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containing BaSO4. It also gave improved biocompatibility while inhibiting bacterial 
growth. However, SrO fillers did not provide a significant increase in fracture toughness 
and fatigue properties compared to a BaSO4-containing cement.[75] Hernandez et al. 
used radiopaque strontium hydroxyapatite (SrHA) treated with MMA as filler particles in 
a PMMA based cement to enhance the compressive properties of the composites by 
improving the integration between the filler particles and the acrylic matrix.[76] Abboud 
et al. incorporated alumina (Al2O3) particles treated with the coupling agent 3-
(trimethoxysilyl)propyl methacrylate (c-MPS) into a PMMA matrix in an attempt to 
produce reinforced radiopaque cements. This coupling agent enhanced the reinforcement 
effect, while the formulations required high processability because of poor wetting of the 
filler surface with liquid monomer.[77] Gomoll et al. achieved a significant enhancement 
in tensile strength of an acrylic bone cement by incorporating nanosized radiopaque 
BaSO4 particles.[78] Ricker et al. investigated the effect of nano MgO and nano BaSO4 
on the PMMA matrix in an attempt to improve the cytocompatibility and radiopacity of 
the PMMA based bone cements. They found that poor osteoblast function of PMMA 
could be improved by incorporation of MgO or BaSO4 nanoparticles.[79] In another 
attempt, Goto et al. incorporated silanized n-TiO2 particles (60 wt%, average diameter 
200 nm) into a cement matrix, but did not obtained a composite with improved flexural 
modulus.[80] Khaled et al. added functionalized n-SrO-TiO2 tubes to a PMMA matrix 
presenting significantly enhanced mechanical properties, radiopacity, and 
biocompatibility.[72] 
On the contrary, a very limited number of studies have been performed to improve the 
radiopacity of PPF-based bone cements. Kim et al. introduced PPF biopolymer 
containing 30% barium sulfate as a suitable alternative for kyphoplasty.[81] However, a 
major drawback associated with the presence of barium sulphate is poor dispersion of 
these radiopacifiers through the polymer resin, which can affect both crack initiation and 
crack propagation in the hardened cement.[75, 82] In another study, Wu et al. attempted 
to improve radiopacity and visual control of PPF cement using a newly developed bone 
filler, a-TCP/HAp, and sought to quantify the radiopacity by CT scan.[83] Therefore, 
there is a sustained interest and need for innovative development of PPF-based bone 
cements exhibiting sufficient mechanical properties, radiopacity, improved 
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biocompatibility, and reasonable handling properties in order to overcome the prevailing 
limitations of the current commercial bone cements. 
1.2.2.3 Angiogenesity  
It is also believed that delivery of bioactive molecules from the PPF-based composite or 
delivery of osteoblasts and osteoid cultured on the material may promote bone growth in 
a surgical site where it would otherwise not occur.[84] However, without a sufficient 
vascular support, these approaches are not considered to be effective in a necrotic 
environment. The need for treatment modalities that enhance neovascularization in 
necrotic femoral head is especially important for bone regeneration, because bone 
formation is an angiogenesis-dependent process.[85, 86] Therefore, a system capable of 
delivering an angiogenic growth factor in a controlled and localized manner may have the 
ability to boost the angiogenic response when implanted subcutaneously. 
Angiogenesis is a complex multi-step process which consists of activation, chemotactic 
invasion and migration, morphological alteration, proliferation, and capillary tube 
formation of endothelial cells (ECs) from preexisting vasculature (shown in Figure 
1.5.);[87]. Angiogenesis is a key step in many physiological and pathological situations 
including development, wound healing, and tumor growth. There is a dynamic balance 
between inhibitors and stimulators of angiogenesis in the mature organism. Stimulators 
include an adequate matrix such as fibrin or collagen, and angiogenic growth factors.[86] 
A variety of growth factors that direct angiogenesis have been identified. The most 
important angiogenesis inducer is vascular endothelial growth factor (VEGF) owing to its 
potency, selectivity for endothelial cells, and ability to regulate key steps in angiogenesis, 
including proliferation and migration of endothelial cells.[88] Nitric oxide (NO) is also 
considered to be a critical angiogenesis stimulator. Kaigler et al. showed that by 
delivering VEGF from a biodegradable polymeric scaffold made of PLGA, blood vessel 
formation and vascular perfusion could be sufficiently enhanced in osseous defects where 
the blood supply had been compromised by radiation therapy.[89] It is believed that 
localized VEGF delivery may be acting not only on the vasculature, but also directly on 
osteoprogenitor cells, osteoblasts, osteoclasts, and conjunctively with osteoinductive 
factors resident in the osseous defects. Other studies have investigated the use of large 
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quantities of osteoinductive protein, BMPs, in the repair of irradiated osseous defects. 
Leach et al. hypothesized that the addition of an osteoconductive surface to VEGF-
releasing scaffolds would enhance bone regeneration through improved vascularization 
and integration with native tissues. They incorporated VEGF into three-dimensional, 
porous scaffolds made from PLGA for localized protein delivery, then coated the surface 
with bioactive glass to enhance the osteoconductivity and potentially the osteoinductivity 
of the construct.[90] Similarly, Murphy et al. synthesized a biomineral coating on the 
surface of three-dimensional, porous PLGA scaffold via a biomimetic approach to serve 
as an osteogenic substrate, and VEGF was incorporated into the scaffolds for localized 
delivery to direct simultaneous regeneration of bone and vascular tissue.[91] 
It is important to note that promoting bone regeneration via induced angiogenesis could 
be particularly important in larger-sized defects, in which the presence of a vascular 
supply is perhaps more vital.[91] In addition, it is noteworthy that the clinical delivery of 
VEGF in patients undergoing reconstruction can potentially be harmful, particularly if the 
defect area was originally created by resection of a malignancy as it is well documented 
that VEGF contributes to the growth of tumors.[89] 
 
Figure 1.5. Multi-step process of blood vessels formation. 
(i) reception of angiogenic signals (yellow spot) from the surrounding  by endothelial 
cells (EC); (ii) retraction of pericytes from the abluminal surface of capillary and 
secretion of protease from activated endothelial cells (aEC) and proteolytic degradation 
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of extracellular membrane (green dash-line); (iii) chemotactic migration of EC under the 
induction of angiogenic stimulators; (iv) proliferation of EC and formation of 
lumen/canalisation by fusion of formed vessels with formation of tight junctions; (v)  
recruitment of pericytes and deposition of new basement membrane and initiation of 
blood flow.[87] 
1.3 Angiostimulating activity of ginsenoside Rg1  
Ginsenoside Rg1, the most prevalent active constituent of ginseng, has been demonstrated 
to be a highly stable proangiogenic compound by upregulating in vitro proliferation, 
migration, chemo-invasion, and tube formation in human umbilical vein endothelial cells 
(HUVECs) as well as ex vivo aortic sprouting and in vivo neovascularization.[92] Rg1 is 
a functional ligand of the glucocorticoid receptor. Leung et al. suggested that Rg1 can 
activate the glucocorticoid receptor triggering non-transcriptional pathways to produce 
NO production.[92] Basically, Rg1 increases the phosphorylation of GR and endothelial 
nitric oxide synthase (eNOS) leading to an increase in NO production in human umbilical 
vein endothelial cell.[92] NO is an important transcellular signaling molecule 
contributing to anti-tumor, anti-microbial, anti-inflammatory, anti-oxidative, and 
immunosuppressive activity of macrophages. Thus, NO-related endothelial proliferation 
and angiogenesis has been shown to be part of the activities of Rg1.[92] In addition, 
Cheung reported that Rg1 increases interaction between the glucocorticoid receptor and 
the fibroblast growth factor receptor-1 (FGFR-1) and mediates its ligand-independent 
transactivation, resulting in eNOS phosphorylation, ultimately enhancing 
angiogenesis.[93] Leung et al. showed for the first time that Rg1 is a potent stimulator of 
vascular endothelial growth factor (VEGF) expression in human umbilical vein 
endothelial cells.[94] VEGF can upregulate the expression of endothelial NO synthase 
(eNOS), thereby inducing the release of NO and subsequent activation of endothelial 
cells and smooth muscle cells in vessels, keratinocytes and macrophages in wounds, and 
tumor cells.[87] Furthermore, NO can increase VEGF synthesis in a positive feedback 
manner. In other words, VEGF and nitric oxide (NO) are critical angiogenic stimulators, 
closely related to ginsenoside-mediated angiomodulation.[87] VEGF and NO work 
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closely with one another in the modulation of angiogenesis. The schematic overview of 
ginsenoside Rg1-mediated angiogenic action in HUVEC is shown in Figure 1.6. 
 
Figure 1.6. The schematic overview of ginsenoside Rg1-mediated 
angiogenic action in HUVEC. 
Ginsenoside Rg1 acts as a functional ligand of glucocorticoid receptor (GR). It increases 
nitric oxide (NO) production via the PI3K-Akt pathway: GR → phosphatidylinositol-3 
kinase (PI3K)/Akt pathway → endothelial nitric oxide synthase (eNOS) pathway. Rg1 
also increases vascular endothelial growth factor (VEGF) production through the GR →  
PI3K/Akt → GSK3β → β-catenin/TCF pathway. Gene expression profiling data 
indicated that Rg1 could increase the expression of a group of genes, which are related to 
cell-cell adhesion, migration and cytoskeletal remodeling.[87] 
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1.4 Inorganic reinforcing agents 
1.4.1 Hydroxyapatite 
Calcium phosphates [95], in particular hydroxyapatite (HAp), has attracted a great deal of 
attention for dental and orthopedic applications owing to its excellent biocompatibility, 
remarkable ability to bond directly to bone (bioactivity), high osteoconductivity, and 
close chemical and crystallographic structure with the mineral phase of human hard 
tissues, bone and teeth.[96, 97] Stoichiometric HAp, with the chemical formula 
Ca10(PO4)6(OH)2, has a hexagonal crystal structure (Figure 1.7).[98] The mineral 
constituent of bone, enamel, and dentin consists of one phase known as B-type HAp 
having phosphate groups in the HAp crystal lattice substituted with a carbonate ion. HAp 
crystals grow along the c-axis when nucleated on collagen fibers in mineralized tissue 
(Figure 1.7).[99, 100] 
HAp can be synthesized by many chemical processing routes such as solid state 
reaction,[101] co-precipitation,[102] sol-gel method,[103] pyrolysis of aerosols,[104] 
microemulsion,[105] hydrothermal, sol-gel hydrothermal,[106] and surfactant-assisted 
hydrothermal techniques.[107, 108] Solid state reactions usually give stoichiometric and 
well-crystallized products but they require relatively high temperatures and long heat-
treatment times.[107] Wet precipitation represents a common commercial route for the 
preparation of nanometer size HAp. Here, the drop-wise addition of phosphoric acid to a 
suspension of calcium hydroxide, or reactions between calcium nitrate and ammonium 
phosphate results in a calcium-deficient apatite precipitate.[102] Sol-gel chemistry 
involves the hydrolysis of phosphorous containing alkoxides and calcium salt and 
subsequent polycondensation providing molecular level mixing leading to excellent 
control over the composition and chemical homogeneity of the product. However, to 
produce crystalline HAp powders using this method, calcination at elevated temperature 
is required, which may cause the formation of secondary phases such as β-TCP and 
granular particle shapes.[109] Hydrolysis methods are also used to prepare HAp using 
acid calcium phosphates such as dicalcium phosphate dihydrate (DCPD), octacalcium 
phosphate (OCP), or anhydrous dicalcium phosphate.[110] The hydrothermal technique 
usually results in HAp powders with a high degree of crystallinity and the Ca/P ratio 
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close to the stoichiometric value, 1.67. However, the obtained powders have typical 
agglomeration with very poor control on morphology, and their size distribution is 
relatively wide.[111] Surfactant-assisted hydrothermal method has been used to 
synthesize HAp nanopowders, nanorods, and nanoneedles.[112] This method inhibits the 
excess agglomeration of the particles, since the surfactants can adsorb onto the surface of 
the particles. In addition, the surfactants can serve as a versatile “soft” template for the 
synthesis of 1 D nanostructured materials.[107, 113] Furthermore, the hydrothermal 
treatment can effectively improve the crystallinity of the HAp product.[113] 
The principal limitation of HAp in its clinical use as load bearing implants, such as 
artificial bones or teeth, is its poor mechanical properties, especially in a wet 
environment. Therefore, regardless of its favorable biological properties, the poor 
mechanical properties of HAp can lead to instability and unsatisfactory performance of 
the implant or scaffold in the presence of body fluids and under local loading.[114, 115] 
The diameter and aspect ratio of the HAp powders are important characteristics for 
biomedical applications. Studies have shown that diameters in the nano-scale are 
desirable for optimal biological and mechanical performances. Mechanical properties, 
such as fracture strength and fracture toughness, of the ceramic materials could be 
improved remarkably by making one dimensional (1-D) nanoscale building blocks such 
as nanorods, nanofibers, nanowires, and nanotubes.[113, 116] Nanomaterials have also 
shown superior osteoconductive and bioactive properties as compared to their micron-
sized counterparts.[117, 118] In addition, according to Chung et al. the nano-sized HAp 
provided nanocomposites with superior stiffness and strength, and induced greater 
trabecular bone formation at the tissue-implant interface.[119] 
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Figure 1.7. Crystal structure of stoichiometric hydroxyapatite. 
In mineralized tissues, apatite develops primarily along the c-axis of the hexagonal 
structure, and is oriented along the extended collagen microfibril (A).[99] Hexagonal 
crystal structure of hydroxyapatite projected onto the 001 plane (as visualized down the 
c-axis) (B).[100] 
1.4.2 Hydroxyapatite/titania nanocomposites 
The artificial HAp suffers from its intrinsic low mechanical reliability; thus, the use of 
HAp is still rather limited for heavy load-bearing applications.[114] Immobilization of a 
biocompatible metal/metal oxide on the surface of HAp will enhance the mechanical 
properties of HAp along with improved cellular responses and biocompatibility.[120] Li 
et al. studied the reinforcement effect of alumina in Al2O3-HAp composites showing that 
the mechanical strength of HAp ceramics increased with increasing the alumina content, 
with 30 wt% alumina (70Al2O3-HAp) exhibiting a 2-fold increase in strength compared 
with pure HAp.[121] In another attempt, Sung et al. successfully synthesized 
homogeneous mixtures of hydroxyapatite (HAp) and yttria-stabilized zirconia (YSZ) 
nanoparticles using chemical co-precipitation and subsequent calcination. The prepared 
nanocomposites showed improved mechanical properties, such as flexural strength of 
∼155 MPa and fracture toughness of ∼2.1 MPa m1/2 owing to the YSZ contribution to 
the HAp matrix.[122] Furthermore, Santos et al. reported the preparation of  bioglass-
hydroxyapatite composite samples by a liquid phase sintering process, using a 2.5 wt % 
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addition of Bioglass to HAp. The addition of Bioglass to hydroxyapatite helped the rapid 
formation of the Ca, P-layer, as the time required for nucleation to start was much shorter 
for the composite than for HAp alone. This behavior is attributed to the presence of a 
highly soluble tricalcium phosphate phase formed from the reaction between Bioglass 
and the HAp matrix during the liquid phase sintering process.[123] 
Among the different HAp-based composites, HAp-TiO2 composites have attracted 
considerable attention, due to the combined advantages of both materials, namely HAp 
providing  bioactivity and TiO2 overcoming the poor adhesion to the implant.[124] Such 
composites are expected to have improved mechanical properties, better structural 
integrity, and flexibility than pure HAp ceramics.[125, 126] In addition, HAp-TiO2 
composites have the ability to adsorb and decompose bacteria and organic materials, and 
it is beneficial in antibacterial applications, environmental purifications, and also for 
photocatalytic decomposition of biomaterials, such as proteins and lipids.[127] 
Various processing techniques such as sol-gel,[128] hydrolysis of Ti-bearing dicalcium 
phosphate powders,[129] hydrothermal method,[130] combined high gravity and 
hydrothermal process,[115] electropinning method,[126] and microwave-assisted co-
precipitation process[131] have been utilized to synthesize HAp-TiO2 nanocomposites. 
Even though all the aforementioned techniques involve simplified preparation 
procedures, obtaining a crystalline powder in most of these cases requires costly heat 
treatments at a high temperature or for a long reaction period. Besides, they are not 
environmentally friendly, and suffer scale-up problems.[125] Therefore, it is necessary to 
develop more efficient methodology of synthesis to prepare HAp-TiO2 composites.  
1.4.3 Titania  
Titanium is a common clinically used biomaterial exhibiting corrosion resistance, 
biocompatibility, and excellent mechanical performance.[132] A TiO2 coating on the 
surface of titanium provides a passive surface layer to the implant increasing its corrosion 
resistance and impeding the passage of metal ions (Ti
4+
) into the body.[133] Furthermore, 
the TiO2 coating displays high external hardness. Therefore, titanium alloy implants 
coated with TiO2 exhibit excellent biocompatibility as well as high mechanical 
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strength.[132] The high biocompatibility of titanium is beneficial in load-bearing 
implants, implants intended to stimulate metabolic responses, and also cell-culture 
substrate for in vitro culture and tissue engineering.[134] 
TiO2 particles (>100 nm) have been shown to be biologically inert in both humans and 
animals.[135] With the development of nanotechnology, it has been considered that 
nanoparticles might be more toxic than larger particles of the same substance because of 
their larger surface area, enhanced chemical reactivity, and easier penetration into 
cells.[136] However, several studies have shown that the cytotoxicity of nano-sized 
titania was negligible as compared to other nanoparticles.[74] Besides, without UV 
irradiation, titania nanoparticles have shown no inflammatory effect or genotoxicity in 
rats, and induced no DNA damage in human cells. Moreover, high photocatalytic 
efficiency of nanophase titania results in potential phototoxic effects on bacteria, cancer 
cells, and tumors. This is because of the reactions between the oxidizing agents produced 
from the redox reaction of the photogenerated holes and electrons and the biomolecules 
leading to the damage of the biomolecular structure. Therefore, due to the low 
cytotoxicity and fair biocompatibility, this material is overwhelmingly used as a 
replacement for teeth and bones. Moreover, titania nanotubes/fibers have high aspect 
ratios and high surface area to volume ratios, which may lead to significantly enhanced 
physical and mechanical properties. In addition, biocompatible and radiopaque SrO or 
ZrO2 components can be incorporated into the titania nanotube/fibers to provide higher 
radiopacity compared to the nonmodified nanoparticles. 
1.4.4 Synthesis of nanostructured materials in supercritical CO2 
Supercritical fluids exhibit a range of unusual properties that can be exploited for new 
reactions and new routes to process materials beneficial for the fine chemical and 
pharmaceutical industries.[137, 138] 
In the past decade, it has been shown that a sol-gel process in scCO2 is a promising 
technique for synthesizing metal oxide nanomaterials. However, due to the low solubility 
of precursors in CO2, various surfactants have been examined in the sol-gel process in 
CO2 affecting the morphology of the nanomaterials. For example, Tadros et al. studied 
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the synthesis if TiO2 nanoparticles in scCO2 by hydrolysis and condensation of titanium 
alkoxides using the anionic fluorinated surfactant, [F(CF2CF2)zCH2CH2O]xP(O)(ONH4)y 
(where x=1 or 2, y=2 or 1, z=1–7).[139] In another attempt, Tatsuda et al. prepared TiO2-
coated activated carbon by the penetration of titanium (IV) isopropoxide (TIP) dissolved 
in supercritical CO2 into the nano-spaces of activated carbon.[140] In the past decade, it 
has been shown that sol-gel processes using a green solvent such as supercritical carbon 
dioxide (scCO2) are attractive to synthesize metal oxide nanomaterials. Reverchon et al. 
synthesized amorphous TiO2 nanoparticles on the pilot scale in scCO2 without the 
assistance of surfactant.[95] Also, Sun et al. prepared titania-silica binary oxides using 
the inorganic precursors, tetraethyl orthosilicate (TEOS) and TIP, simultaneously or 
sequentially impregnated into a polypropylene (PP) matrix using scCO2 as a swelling 
agent and carrier.[141] Recently, Sui et al. synthesized TiO2 nanofibers with a typical 
diameter ranged from 9 to 100 nm by esterification and condensation of titanium 
alkoxides using acetic acid as the polymerization agent in scCO2.[142] The Charpentier 
lab also synthesized porous ZrO2 aerogels,[143] ZrO2-modified TiO2 nanotubes,[144] 
and N-doped ZrO2/TiO2 bimetallic materials,[145] nano TiO2/graphene composites,[146] 
and Fe-doped TiO2 nanowires grown on the surface of graphene sheets[147] using a 
similar approach in supercritical CO2.  
1.5 Microencapsulation of bioactive molecules into a polymer 
matrix 
Controlled-release drug-delivery systems are becoming increasingly important in 
biomedicine, showing several advantages compared to the conventional approaches. One 
of the most important limitations of conventional dosage forms is that partial degradation 
of the drug happens before it reaches the intended target in the body. However, controlled 
drug delivery systems preserve the active agent from spoilage caused by enzyme attack. 
A drug delivery system increases the penetration of the drug into the diseased tissue, so 
bioavailability of the drug is enhanced along with an increase in the efficacy and toxicity 
reduction.[148] The delivery system acts as a reservoir of the drug, with specific time-
release profiles of the drug, and it leads to a partial control of the pharmacokinetics.[149] 
Also, a better compliance and convenience for the patient is provided.[149]  
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Microencapsulation of bioactive molecules into a polymer matrix has been developed as 
a method for local delivery of the active pharmaceutical ingredient (API) in a controlled 
manner, over a prolonged period of time.[149] The polymer protects the API, thus 
reducing the need for multiple doses during a prolonged therapy.[150] A variety of 
systems based on natural or synthetic polymers have been examined to deliver API's in a 
sustained manner.[151] Haesslein et al. designed an intraocular drug delivery systems 
based on biodegradable polymer, PPF, which could be effectively utilized for the 
treatment of chronic diseases of the posterior segment of the eye. Based on the hypothesis 
that crosslinked PPF matrices are suitable long-term delivery devices for the sustained 
release of the anti-inflammatory drug fluocinolone acetonide (FA), they fabricated FA-
loaded rods of 10 mm length and 0.6 mm diameter by photocrosslinking PPF with N-
vinyl pyrrolidone (NVP), and studied the release behavior of FA over a period of almost 
400 days.[152] Hacker et al., also designed a preliminary rabbit implantation study to 
investigate the function of a photocrosslinked PPF/poly(N-vinyl pyrrolidone) (PVP) 
matrix for the sustained release of three ophthalmic model drugs, acetazolamide (AZ), 
dichlorphenamide [7], and timolol maleate (TM). They suggested that monolithic 
implants (i.e. discs, rods, plugs, pellets or sheets) are relatively easy to fabricate, sterilize, 
and provide very good control of drug release rate indicating the potential of 
photocrosslinked PPF-based matrices as polymeric carriers for long-term ophthalmic 
drug delivery.[153] In another attempt, Ueda et al. developed an injectable formulation 
for long-term ocular delivery of the FA by dissolving the API and PPF in the 
biocompatible, water-miscible organic solvent, N-methyl-2-pyrrolidone (NMP).[154] 
Their strategy aimed at combining the advantages of a monolithic polymeric implant with 
the benefits of injectable drug delivery systems involving the formulation of injectable in 
situ forming implants.[154] In another study, Kempen et al. investigated the effect of the 
incorporation of PLGA microspheres encapsulating growth factor, BMP-2, in PPF 
scaffolds in a goat ectopic implantation model. Some of the scaffolds were combined 
with autologous BMSCs before implantation to test the influence of progenitor cells on 
the bone regeneration capacity of the composite.[155] Kempen et al., also tried to 
examine the release kinetics of TRD from PPF/PLGA blend microspheres as well as the 
degradation of these microspheres.[150] In another attempt, the same group developed 
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PPF microspheres to enhance the bonding between the particulate and the continuous 
phases of the composite scaffold. The resulting PPF microspheres were expected to 
covalently bind to the PPF matrix through the carbon-carbon double bonds along the 
polymer backbone on the microsphere surface resulting in increased mechanical 
properties.[156] This suggests that the pro-angiogenic mediator, ginsenoside Rg1, can 
potentially be incorporated into the cement formulation or designed scaffolds after 
encapsulation in biodegradable PPF microspheres. 
1.5.1 Techniques for bioactive molecules-loaded microspheres 
preparation 
Microstructured systems encapsulating therapeutic agents can be prepared using several 
techniques, including emulsion-solvent evaporation/extraction methods, polymer solution 
separation method, spray drying, microfluidics, with each method has its own pros and 
cons. The choice of a particular method depends on drug and polymer features, site of 
action, and therapy regimes.[157] In an optimized preparation process, the chemical 
stability and biological activity of the incorporated drug should be guaranteed.[149] An 
ideal microparticle preparation process should have reasonably high encapsulation 
efficiency, loading capacity, and sustained release of the loaded drug with retained 
bioactivity.[158] In addition, the prepared microspheres should display a homogeneous 
size distribution. Besides, preparation and purification processes must result in 
reproducible products, and the release-profile of the drug should meet the specific final 
application requirements.[149] High drug loading and encapsulation efficiencies are 
critical factors due to the extremely high price of API's such as Rg1, which is of interest 
for this thesis.[158] 
1.6 Scope of the research 
The main objective of this project was to investigate our hypothesis that biocompatible 
TiO2 and Sr-doped TiO2 nanoparticles could be used as a reinforcement and 
radiopacifying agent to significantly enhance the mechanical properties and radiopacity 
of PPF bone cement matrix. These novel PPF-TiO2 bone cement nanocomposites are 
proposed for treatment of stage III osteonecrosis. Towards this goal, the use of 
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supercritical carbon dioxide (scCO2) for the synthesis of TiO2 and Sr-doped 
nantubes/fibers was investigated. In order to enhance the reinforcing effect of TiO2, PPF 
was functionalized with maleic anhydride (MA) using a ring opening reaction producing 
carboxyl groups at each end point of the polymer for coordination to the n-TiO2. 
Moreover, a PPF-based bone cement capable of delivering an angiogenic agent, 
ginsenoside Rg1, in a localized and sustained manner would direct regeneration of bone 
and vascular tissue. In addition, inorganic fillers including hydroxyapatite and 
hydroxyapatite/titania nanocomposites were synthesized in scCO2 and also using a 
hydrothermal technique to strengthen the mechanical and physical properties of poly(ε-
caprolactone) (PCL) for tissue engineering applications. 
The following were identified as specific objectives of this project: 
I. Functionalization of PPF with maleic anhydride (MA) and preparation of 
TiO2-PPF nanocomposites followed by mechanical properties analysis of the 
crosslinked bone cement nanocomposites. 
 
II. Synthesis of Sr-dopped TiO2, preparation of Sr-dopped TiO2-PPF 
nanocomposites, and radiopacity measurement of the cross-linked bone cement 
nanocomposites. 
 
III. Synthesis of hydroxyapatite and hydroxyapatite-TiO2 in supercritical CO2 and 
hydrothermal method to prepare polymer nanocomposites. 
 
IV. Encapsulation of ginsenoside Rg1 within PPF microspheres prepared using 
double emulsion and microfluidic technique, examining the release kinetics of 
Rg1 from these microspheres. 
 
V. Incorporation of ginsenoside Rg1 within Sr-dopped TiO2-PPF based bone 
cement nanocomposites and release kinetic study of the ginsenoside Rg1 from 
these bone cement formulation. 
 
VI. Tube formation (angiogenesis behavior) analysis of ginsenoside Rg1 in vitro 
before encapsulation and after release from the PPF microspheres and PPF-
based bone cement nanocomposites. 
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Chapter 2  
 
2 Synthesis and Characterization of Novel TiO2-
Poly(propylene fumarate) Nanocomposites for 
Bone Cementation 
 
Abstract 
This work reports on a new methodology for synthesizing poly(propylene fumarate) 
(PPF)/titania nanowire composites which would be beneficial in tissue engineering for 
orthopaedic bone cements. The synthetic procedure reacted PPF with maleic anhydride to 
create HOOC-PPF-COOH species in a ring-opening reaction at room temperature. These 
species were then coordinated to titania nanowires by metal carboxylate bonding through 
the end -COOH groups. These PPF-grafted nano-TiO2 assemblies were then further 
polymerized and crosslinked in the presence of N-vinylpyrrolidone to produce the bone 
cements. The synthesis and modification of PPF was confirmed by NMR (
1
H and 
13
C) 
and XPS, while the reaction chemistry of the functionalized PPF and nano-TiO2 was also 
investigated by XPS and FTIR. Mechanical testing of the resulting composites 
demonstrated a significant reinforcement of the tensile and flexural properties, showing 
the utility of this synthetic approach for bone tissue engineering. 
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2.1 Introduction 
Developing new materials for bone cementation and bone tissue engineering is of 
emerging scientific interest,[1] requiring new synthetic approaches that provide both 
mechanical strength and biocompatibility.[2] Driving forces include our longer life spans 
and the potential to treat skeletal bone defects and diseases such as osteonecrosis, which 
is caused by the temporary or permanent loss of blood supply to bone.[3] Cementation 
involves the injection of a liquid polymeric material, which hardens in the defect, 
providing mechanical support to the bone.[4] The most universally used injectable bone 
cement is made of poly(methyl methacrylate) (PMMA).[5-7] However, there are several 
drawbacks associated with PMMA bone cements including: (1) exothermic 
polymerization that can lead to impaired local blood circulation and thermal necrosis of 
the surrounding bone, (2) release of unreacted MMA monomer leading to chemical 
necrosis of the bone, (3) non-biodegradability, so PMMA cannot be replaced with new 
bone formation, and (4) non-bioinertness.[8] Recently, poly(propylene fumarate) (PPF) 
has attracted considerable interest as a promising biodegradable material for treating 
skeletal defects.[9-11] PPF is a linear and unsaturated polyester containing one 
unsaturated C=C double bond per repeating unit. The double bonds of PPF can crosslink 
with itself or a variety of crosslinking agents such as 1-vinyl-2-pyrrolidinone (N-VP) to 
form crosslinked polymer networks.[12, 13] In addition, the ester linkage allows for 
hydrolysis of the polymer into biocompatible and excretable degradation products of 
fumaric acid and propylene glycol, shown in Figure 2.1.[14, 15]  
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Figure 2.1. Crosslinking and degradation scheme of PPF-PPF-PVP networks. 
Even though crosslinked PPF can be considered as a material for trabecular bone tissue 
regeneration, significant mechanical reinforcement is needed for the use of this material 
under load bearing conditions.[16, 17] Nanoparticles such as calcium phosphates 
including tetracalcium phosphate (TTCP), dicalcium phosphate (DCPA), and 
hydroxyapatite (HAp) have been investigated for PPF-based cements, enhancing the 
mechanical strength of the composite and osteoconductivity.[18-20] Shi et al. and 
Sitharaman et al. used single-walled carbon nanotubes (SWNTs) as reinforcing fillers in 
PPF because of their excellent mechanical properties and high aspect ratios; however, the 
addition of carbon nanotubes may impose negative effects on the aesthetic requirements 
and biocompatibility of the bone cement.[16, 21] It is believed that one-dimensional 
oxides, such as nanowires or nanotubes of SiO2, ZrO2, Al2O3, and TiO2 would be 
promising for the reinforcement of bone cement compositions due to their unique 
properties and low cost compared to carbon nanotubes.[22, 23] Horch et al. and Mistry et 
al. designed a composite material utilizing surface-modified carboxylate alumoxane 
nanoparticles and PPF network, which showed a significant improvement in flexural 
properties.[17, 24] However, alumina-based implants have rarely shown to initiate apatite 
formation and cannot directly attach to bone.[25, 26] Essentially no studies have 
examined the incorporation of 1D nano-structured oxides into PPF bone cement matrix to 
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enhance its mechanical properties. To the best of our knowledge, this is the first study to 
incorporate 1D nano-structured titania into a PPF matrix, which requires a new synthetic 
methodology. TiO2 nanofibers or wires are expected to be superior to alumina 
nanoparticles owing to their excellent biocompatibility and unique oseointegration. 
Titania nanofibers or wires can directly bond to bone through the formation of a 
biologically active bone-like apatite layer on the surfaces of implants within the body 
(oseointegration).[26, 27] In addition, titania nanofibers or wires have high aspect ratios 
which enhances their interfacial interaction with the resin matrix leading to dramatically 
enhanced mechanical properties.[23, 28]  
In this work we present a new method for the synthesis of functionalized PPF containing 
a carboxyl group at each end of the PPF chains using a ring opening reaction at room 
temperature in the presence of a highly nucleophilic tertiary amine catalyst, 4-
dimethylaminopyridine.[29, 30] The carboxyl group allowed for coordination of PPF to 
nano-TiO2, and the subsequent crosslinking reaction with 1-vinyl-2-pyrrolidinone to form 
crosslinked TiO2-PPF nanocomposites. The mechanical properties of the synthesized 
crosslinked TiO2-PPF nanocomposites were measured, showing potential applications in 
bone cementation.  
  
2.2 Experimental details  
2.2.1 Materials 
Titanium isopropoxide (99.999%), glacial acetic acid (>99.7%), diethyl fumarate (98%), 
propylene glycol (1,2-propanediol) (≥99.5%), anhydrous zinc chloride (ZnCl2, 
≥99.995%), hydroquinone (99%), maleic anhydride (95%), 4-dimethylaminopyridine 
(DMAP), hydrochloric acid (37%), anhydrous magnesium sulfate (99.0%), anhydrous 
diethyl ether (≥99.0%), anhydrous dichloromethane (DC , ≥99.8%), anhydrous 
tetrahydrofuran (THF, ≥99.9%), 1-vinyl-2-pyrrolidinone (N-VP), benzoyl peroxide 
(BPO), and N-dimethyl-p-toluidine (DMT) were purchased from Sigma-Aldrich Canada 
and used as received. Instrument grade carbon dioxide (99.99%) was purchased from 
BOC Canada. 
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2.2.2 Characterization 
Scanning electron microscopy images were collected using a Leo(Zeiss) 1540XB SEM. 
Imaging was performed at either low voltage (1 kV) for morphology or at 10 kV for 
backscatter imaging. Samples were coated with 5nm of osmium metal in a Filgen 
OPC80T. For studying the fracture surface, samples were broken by submersing in liquid 
nitrogen in a stainless steel mortar and broken with a stainless steel pestle. The particle 
diameter and aspect ratio frequency distribution of TiO2 nanoparticles were obtained by 
measuring over 100 TiO2 nanoparticles using Image J software (NIH, version 1.37). 
Transmission electron microscopy images were recorded using a Philips CM10 
transmission electron microscope with an AMT digital camera (Eindhoven, Netherlands) 
operated at 100 kV. 
Attenuated total reflection-Fourier transform infrared (ATR-FTIR) spectra were 
measured using a Nicolet 6700 FTIR spectrometer (Thermo Scientific) equipped with a 
smart iTR (diamond ATR). The spectra were recorded in the range of 600-4000 cm
−1
 
with a resolution of 4 cm
−1
 over 32 scans. X-ray photoelectron spectroscopy (XPS) 
analyses were carried out with a Kratos AXIS Ultra spectrometer using a monochromatic 
Al K(α) source (15mA, 14kV). Samples were placed on a carbon-based double-sided 
adhesive tape for analysis. The Kratos charge neutralizer system was used on all 
specimens. Survey scan analyses were carried out with an analysis area of 300 µm × 700 
µm and a pass energy of 160 eV. High resolution analyses were carried out with an 
analysis area of 300 µm × 700 µm and a pass energy of 20 eV. Spectra were charge 
corrected to the main line of the carbon 1s spectrum set to 284.8 eV. Spectra were 
analyzed using CasaXPS software (version 2.3.14). 
1
H and 
13
C NMR spectra were 
measured using either a Varian INOVA 600 or a Varian INOVA 400 spectrometer at 25 
o
C. CDCl3 was used as the solvent and chemical shifts were referenced to 
tetramethylsilane (TMS; 0.0 ppm). Thermogravimetric analysis (TGA) was performed 
using a TA Q500 TGA at a heating rate of 10 ºC/min under an inert (nitrogen) 
atmosphere.  
Mechanical tensile properties were measured using an Instron 5943 universal testing 
machine (Instron, Canton, MA) equipped with a 500 N (tension) load cell. Tensile testing 
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was conducted in accordance with ASTM D638-91a. Dogbone specimens with overall 
length of 60 mm and width of grip section of 10 mm were used for tensile testing. Stress-
strain relationship was obtained from the load and displacement data. Young’s modulus 
was determined by calculating the slope of the linear portion of the stress-strain curve, 
and tensile strength was defined as the maximum applied stress prior to failure. For each 
group, 5 independent specimens (n=5) were tested in tension at a crosshead speed of 10 
mm/min. Flexural strength and flexural modulus of the nanocomposites were determined 
in accordance with ASTM D790M-92 using a dynamic mechanical analyzer, DMA Q800 
(TA instruments). Flexural testing samples, rectangular bar specimens (n=5) (50 mm  25 
mm  2 mm), were placed on a three-point bending apparatus with two supports spanning 
40 mm from each other and loaded at the cross-head speed of 10 mm/min to the center of 
each specimen until failure. In an approach similar to that of tensile testing, flexural 
modulus was calculated as the slope of the initial linear region of the stress-strain curve, 
while flexural fracture strength was determined as the maximum applied stress prior to 
failure.  
2.2.3 Preparation of materials 
2.2.3.1 Synthesis of poly(propylene fumarate) (PPF) 
PPF was synthesized using a two-step transesterification method described in the 
literature.[31] In a typical experiment, diethyl fumarate (31.56 g, 183 mmol) and 
propylene glycol (41.38 g, 549 mmol) were reacted in an inert atmosphere under stirring, 
with ZnCl2 (0.250 g, 1.83 mmol) and hydroquinone (0.0403 g, 0.366 mmol) being added 
as a catalyst and a crosslinking inhibitor, respectively. After the reaction temperature had 
been increased to 110 ºC, the temperature was further increased from 110 ºC to 150 ºC in 
an increment of 10 ºC every 15 min. Bis(hydroxypropyl) fumarate (1) was formed with 
the continuous removal of the byproduct ethanol, as a distillate. This step was terminated 
by cooling down to 100 
o
C when ~ 90% of the theoretical yield of ethanol was collected. 
The second step of the reaction, transesterification of the intermediate bis(hydroxypropyl) 
fumarate to form PPF (2), was conducted under reduced pressure (<1 mm Hg), producing 
propylene glycol as a byproduct. The temperature was raised gradually from 100 ºC to 
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150 ºC in an increment of 10 ºC every 30 min, and the reaction proceeded until the 
desired molecular weight of PPF was obtained. The polymer product was then dissolved 
in dichloromethane followed by several acid washes with a 5% v/v solution of 1 N HCl, 
two washes with distilled water, and two washes with brine. After drying with 
magnesium sulfate, the organic phase was concentrated by rotary evaporation and then 
precipitated in diethyl ether to remove the hydroquinone inhibitor. The precipitated 
polymer was washed with diethyl ether and dried under vacuum. Yield: 73% (21 g). 
FTIR (cm
-1): 1713 (νC=O), 1645 (νC=C), 1251 (νC-O-C(as)), 1148 (νC-O-C(s)). 
1
H NMR (CDCl3, 
600 H ) δ (ppm): 6.85 (O=C-CH=CH-C=O), 5.29 (O-CH(CH3)-CH2), 4.33 & 4.25 (O-
CH(CH3)-CH2), 1.34 (O-CH(CH3)-CH2), 5.10, 4.22, 4.09, 3.70, 1.29, and 1.23 (end 
groups of the PPF polymer chain). 
13C N R (CDCl3, 100  H ) δ (ppm): 164.0-
164.3(O=C-CH=CH-C=O), 133.3-134.0 (O=C-CH=CH-C=O), 69.2 (O-CH(CH3)-CH2), 
66.6 (O-CH(CH3)-CH2), 16.3 (O-CH(CH3)-CH2), 73.1, 70.3, 65.8, 65.5, 19.2, and 16.0 
(end groups of the PPF polymer chain).  
2.2.3.2 Functionalization of PPF 
In order to functionalize the PPF chain with maleic anhydride, to a solution of PPF (1g, 
0.91 mmol of -OH group) in 10 mL of anhydrous dichloromethane were added DMAP 
(0.11 g, 0.91 mmol) and maleic anhydride (0.36 g, 3.64 mmol). The reaction mixture was 
stirred under argon at room temperature for 24 h. After completion of the reaction, 5 mL 
of dichloromethane was added to the flask followed by washing with 10 mL of 1 N HCl 
solution and distilled water. The organic phase was subsequently dried over anhydrous 
magnesium sulfate. After  that, the organic phase was filtered and the solvent was 
removed by rotary evaporation to afford maleic anhydride-functionalized PPF (MA-PPF) 
(3). Yield: 59% (0.64g). 
1
H NMR (CDCl3, 600  H ) δ (ppm): 8.19 (-COOH). 6.85 
(O=C-CH=CH-C=O), 5.29 (O-CH(CH3)-CH2), 4.33 & 4.25 (O-CH(CH3)-CH2), 1.34 (O-
CH(CH3)-CH2). 
13
C NMR (CDCl3, 100  H ) δ (ppm): 164.0-164.3(O=C-CH=CH-
C=O), 133.3-134.0 (O=C-CH=CH-C=O), 69.2 (O-CH(CH3)-CH2), 66.6 (O-CH(CH3)-
CH2), 16.3 (O-CH(CH3)-CH2). 
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2.2.3.3 Synthesis of TiO2 nanofibers via sol-gel reaction in supercritical 
CO2 
High surface area TiO2 nanofibers were synthesized using supercritical CO2 (scCO2) as 
reported by Sui et al.[32] Briefly, in a typical experiment, titanium isopropoxide (1 g) 
was quickly placed in a 10-mL stainless steel view cell, followed by addition of acetic 
acid (4 g). CO2 was then added to the view cell using a syringe pump (Isco 260D) to the 
desired pressure (6000 psig) while increasing the temperature to 60 °C. A magnetic stirrer 
was used for mixing the reaction mixture. Stirring was stopped after 24 h, and normally 
several days of aging were required for a complete reaction. After aging, the formed gel 
was washed continuously using 80 mL of CO2 at a rate of approximately 0.5 mL/min, 
followed by controlled venting at 0.5 mL/min to prevent collapse of the solid network. 
The as-prepared powder was calcined at 450 °C in air for 2 h with a heating rate of 10 
°C/min and a cooling rate of 0.5 °C/min to room temperature. The calcined powder was 
kept in a vacuum oven at 80 °C. 
2.2.3.4 Synthesis of TiO2-PPF nanocomposites 
To prepare TiO2-PPF nanocomposites (4), 0.5, 1.25, or 2.5 wt% of the synthesized TiO2 
nanofibers (0.005, 0.0125, or 0.0250 g) was dispersed in 20 mL of THF with the aid of 
ultrasonic agitation for 1 h, followed by reacting with the above synthesized MA-PPF (1 
g) at 70 °C under argon with constant stirring for 24 h. After filtering off the solvent and 
the unreacted MA-PPF, the product was further purified by dispersion in THF, 
centrifugation, and removal of the supernatant. This purification process was repeated 
several times until the supernatant became clear. Finally, the resulting solid product was 
dried at 55 ºC under vacuum overnight. The composition of the synthesized 
nanocomposites and the nano-TiO2 concentration in each nanocomposite formulation 
reviewed by TGA analysis are presented which are listed in Table 2.1.  
FTIR (cm
-1
): 1713 (νC=O), 1645 (νC=C), 1570 & 1377 (νCO2
-
(as)), 1251 (νC-O-C(as)), 1165 (ν 
CO2
-
(s)), 1148 (νC-O-C(s)). 
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Table 2.1. Formulation of the TiO2-PPF nanocomposites. 
MA-PPF 
(g) 
nano-TiO2 
(g) 
*nano-TiO2 wt% in the 
synthesized nanocomposite Sample Name 
1 g 0.005 g 5 wt% TiO2-PPF 
nanocomposite-1 
1 g 0.0125 g 10 wt% TiO2-PPF 
nanocomposite-2 
1 g 0.0250 g  22 wt% TiO2-PPF 
nanocomposite-3 
Note: * the weight percentage of nano-TiO2 in each TiO2-PPF nanocomposite formulation is 
obtained from the TGA analysis.For comparison of XPS study, a mechanically mixed PPF-
TiO2 nanocomposite was fabricated by mechanical mixing of the PPF (1 g) and TiO2 
nanoparticles (0.10 g). 
2.2.3.5 Synthesis of bone cement composites 
The bone cement composites (5) were prepared by crosslinking the synthesized TiO2-PPF 
nanocomposites (details are provided in Table 2.1) using N-VP. In a typical experiment, 
the above synthesized TiO2-PPF nanocomposite (1 g) was mixed with N-VP (0.4 g) for 2 
h. Initiator, BPO (0.05 g), was dissolved in 250 μL of N-VP. The 50 μL of BPO solution 
was then combined and mixed with the TiO2-PPF nanocomposite solution. Subsequently, 
40 μL of accelerator solution (20 μL of D T in 980 μL of dichloromethane) was added 
with rapid mixing to accelerate the crosslinking reaction.[4, 19] The resulting paste was 
placed in a Teflon mold, then loaded in an oven at 60 °C for 1 h to facilitate crosslinking. 
After that, the mold was cooled down to room temperature, and the formed bone cement 
composite was removed before being subject to mechanical testing. Three different bone 
cement composites were prepared using the TiO2-PPF nanocomposites synthesized with 
different amounts of TiO2, which are listed in Table 2.2.  
For comparison of mechanical testing, bone cement composites were prepared by 
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crosslinking the mechanically mixed 1 g of PPF and 0.05 g of nano-TiO2 (corresponding 
to the actual TiO2 concentration in the TiO2-PPF nanocomposite-1 reviewed by TGA 
analysis represented in Table 2.1) following the above procedure. The composition of the 
prepared mechanically mixed bone cement composite is also listed in Table 2.2.  
Table 2.2. Formulation of the bone cement composites. 
Entry 
No. TiO2-PPF nano-TiO2 
PPF 
Formed Product 
1   1 g Crosslinked PPF 
2 1 g of TiO2-PPF synthesized 
using 0.005 g of TiO2 
  Bone cement 
composite-1 
3 1 g of TiO2-PPF synthesized 
using 0.0125 g of TiO2 
  Bone cement 
composite-2 
4 1 g of TiO2-PPF synthesized 
using 0.0250 g of TiO2 
  Bone cement 
composite-3 
5  0.05 g 1 g Mechanically mixed 
bone cement 
Note: Additionally, 0.4 g of N-VP, 50 μL of BPO solution, and 40 μL of D T solution 
were added in the preparation of these materials.  
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2.3 Results and Discussion 
2.3.1 Synthesis of poly(propylene fumarate) (PPF) 
The synthesis of PPF involves firstly a transesterification reaction of diethyl fumarate 
with propylene glycol (Step a in Figure 2.2) to produce bis(hydroxypropyl) fumarate (1). 
In step b, poly(propylene fumarate) (PPF) (2) is produced by the 
transesterification/polymerization of 1 with ZnCl2/hydroquinone. In this step, the alkoxy 
group of the intermediate, bis(hydroxypropyl) fumarate), is replaced with an alcohol from 
a second bis(hydroxypropyl) fumarate intermediate, propagating PPF polymerization and 
producing propylene glycol as a byproduct. The synthesized PPF was then reacted with 
maleic anhydride to form maleic anhydride-functionalized PPF (MA-PPF) (3 of Figure 
2.2). A small amount of ZnCl2 was added in the transesterification reaction as a catalyst, 
while a small amount of hydroquinone was added as an inhibitor to prevent the C=C 
double bond from being polymerized at high temperatures up to 150 °C. Continuous 
removal of the byproducts ethanol in the first transesterification reaction and propylene 
glycol in the second transesterification reaction as the condensates is necessary to drive 
the step-growth condensation polymerization reactions. The esterification reaction of 
maleic anhydride and PPF provided PPF with a functional carboxyl group at both ends of 
the polymer chains (3), in order to provide potential coordination of the functionalized 
PPF to the surface of TiO2 nanofibers. 
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Figure 2.2. Synthetic Scheme for the Preparation and Functionalization of PPF. 
Reagents and conditions: (a) propylene glycol, ZnCl2, hydroquinone; (b) ZnCl2, 
hydroquinone; (c) maleic anhydride, DMAP, DCM. 
The synthesis and functionalization of PPF was confirmed by NMR (
1
H, 
13
C). The 
1
H 
NMR spectra of propylene glycol and the synthesized PPF and MA-PPF are compared in 
Figure 2.3. There are four distinct peaks present in the spectrum of propylene glycol 
(Figure 2.3a), with the peaks at 1.16, 3.39 & 3.62, and 3.90 ppm attributed to the methyl 
(CH3), methylene (CH2), and methine (CH) protons, respectively. In the spectrum of PPF 
(Figure 2.3b), major peaks appeared at 6.85, 5.29, 4.33 & 4.25, and 1.34 ppm, 
attributable to the olefinic (O=C-CH=CH-C=O), methine, methylene, and methyl protons 
in the repeating unit, respectively. Some minor peaks are also present in the spectrum at 
5.10, 4.22, 4.09, 3.70, 1.29, and 1.23 ppm, which are attributed to the end group of the 
PPF polymer chain (see Figure 2.3b). By integrating these major and minor peaks (Figure 
2.3), the number average molecular weight (      ) of the synthesized PPF (2) was 
estimated as ~ 2200 Da, which is within the reported range between 500 and 4,000 
Da.[31] When PPF was converted to MA-PPF (3), these major peaks were still present in 
the spectrum, but the minor peaks disappeared (Figure 2.3c). In addition, a minor broad 
peak appeared at 8.19 ppm in the 
1
H NMR spectrum of MA-PPF, attributable to the 
carboxyl proton (-COOH) located at both ends of the polymer chains. Together with the 
disappearance of the minor peaks present in the spectrum of PPF, this minor carboxyl 
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peak in the 
1
H NMR spectrum of MA-PPF suggested successful conversion of PPF to 
MA-PPF. 
 
Figure 2.3. A comparison of 
1
H NMR spectra of (a) propylene glycol, (b) the synthesized 
PPF, and (c) MA-PPF in CDCl3. 
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Figure 2.4.
 1
H NMR spectrum of the synthesized PPF in CDCl3 showing integrals of the 
peaks. 
 
The successful conversion of PPF to MA-PPF was also evidenced by 
13
C NMR results. A 
comparison of the 
13
C spectra of propylene glycol, PPF, and MA-PPF is shown in Figure 
2.5. In the spectrum of propylene glycol (Figure 2.5a), three carbon peaks appear at 68.2, 
67.8, and 18.6 ppm, which are attributed to the methyl (CH3), methylene (CH2), and 
methine (CH) carbons, respectively. In the spectrum of PPF (Figure 2.5b), there are five 
major peaks appearing at 164.0-164.3, 133.3-134.0, 69.2, 66.6, and 16.3 ppm, attributable 
to the carbonyl (O=C-CH=CH-C=O), olefinic (O=C-CH=CH-C=O), methine, methylene, 
and methyl carbons in the repeating unit, respectively. Some minor peaks are also present 
in the spectrum at 73.1, 70.3, 65.8, 65.5, 19.2, and 16.0 ppm, which are attributed to the 
end group of the PPF polymer chains (Figure 2.5b). When PPF was converted to MA-
PPF, these major peaks were still present but the minor peaks disappeared (Figure 2.5c). 
Although the peak of the carboxyl carbon at the end of the PPF-g-MA polymer chains 
was not observed due to its low concentration, the absence of the minor peaks in the 
spectrum of MA-PPF confirmed successful conversion of PPF to MA-PPF. 
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Figure 2.5. A comparison of 
13
C NMR spectra of (a) propylene glycol, (b) the 
synthesized PPF, and (c) MA-PPF in CDCl3 
 
2.3.2 Preparation of TiO2-PPF nanocomposites and bone cement 
composites 
To prepare TiO2-PPF nanocomposites, TiO2 nanowires/fibers were synthesized prior to 
reaction with 3. The morphology and size of the nano-TiO2 synthesized in scCO2 and 
calcined at 450 °C were characterized by SEM and TEM, as shown in Figure 2.6a-b and 
Figure 2.6c-d, respectively. The mean diameter and aspect ratio of the synthesized fiber-
like nanostructures of TiO2 were determined to be 50±10 nm and 30±5, respectively 
(Figure 2.6c-d). These results are in good agreement with those reported in the 
literature.[32, 33] The advantage of this synthetic approach in scCO2 is that high aspect 
ratio nanowires with high porosity and high surface area are produced.  
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Figure 2.6. (a) SEM and (b) TEM images and the distribution of (c) diameter and (d) 
aspect ratio of the synthesized TiO2 nanofibers. 
 
With TiO2 nanofibers being synthesized, TiO2-PPF nanocomposites were prepared by 
coordination reaction of MA-PPF (3) to the surface of TiO2 nanofibers, as shown in 
Figure 2.7. The synthesized TiO2-PPF nanocomposites (4) were further crosslinked to 
form the desired bone cement composites (5).  
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Figure 2.7. Synthetic Scheme for the preparation of (4) TiO2-PPF nanocomposites and 
(5) bone cement composites.  
Reagents and conditions: (a) TiO2 nanofibers, THF; (b) N-VP, BPO, DMT.  
The synthesized TiO2-PPF nanocomposites (4) and cross-linked bone cement composites 
(5) were characterized with FTIR, XPS, and TGA to examine the reaction chemistry. The 
FTIR spectra of TiO2, PPF, TiO2-PPF nanocomposite (4), and bone cement composite (5) 
are compared in Figure 2.8. Several major characteristic peaks appeared at 1713, 1645, 
1251, and 1148 cm
-1 
in the spectrum of PPF (Figure 2.8b), attributed to the C=O 
stretching, C=C stretching, asymmetric C-O-C stretching, and symmetric C-O-C 
stretching bands, respectively.[4, 34] The peak at 1645 cm
-1
 in the FTIR spectrum of both 
PPF and TiO2-PPF nanocomposite shows the C=C double bond was unaffected in the 
polymer chains after the reaction of MA-PPF and nano-TiO2. Additional peaks appearing 
at 1570, 1377 and 1165 cm
-1
 in the FTIR spectrum of the TiO2-PPF nanocomposite 
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(Figure 2.8c) are attributed to the asymmetric and symmetric CO2
-
 stretching bands, 
respectively, indicating successful coordination of PPF to the TiO2 nanofibers. Rotzinger 
et al. described three possible coordination structures of carboxylate to the surface of 
TiO2, i.e., chelating bidentate, monodentate, and bridging bidentate (Figure 2.9).[34] 
These structures can be distinguished in infrared spectra by the separations between the 
carboxylate stretching bands (Δυ). The band separation (Δυ=405 cm-1) between 1570 and 
1165 cm
-1
 falls into the monodentate range (350-500 cm
-1
) while another band separation 
(Δυ=193 cm-1) between 1570 and 1377 cm-1 might be indicative of a structure of bridging 
bidentate (150-180 cm
-1
).[35] These coordination peaks remained evident in the spectrum 
of the crosslinked bone cement composite, although the peak at 1645 cm
-1
 (C=C 
stretching band) disappeared (Figure 5d). The disappearance of the C=C stretching band 
confirmed the crosslink reaction which consumed the C=C double bond (Figure 2.7).[36]  
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Figure 2.8. ATR-FTIR spectra of (a) TiO2, (b) PPF, (c) TiO2-PPF nanocomposite, and 
(d) crosslinked bone cement composite.  
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Figure 2.9. Binding modes of RCOO- with TiO2 surface (R= H or CH3). 
(a) chelating bidentate (b) monodentate, and (c) bridging bidentate.[34] 
X-ray photoelectron spectroscopy (XPS) was further employed for characterization of the 
synthesized PPF (2), MA-PPF (3), and non-crosslinked TiO2-PPF (4) nanocomposites. 
The high resolution XPS scan of C 1s region for both PPF and MA-PPF (Figure 2.10a-b) 
represent similar patterns as expected for the chemistries involved. In both spectra, three 
major carbon peaks are observed with binding energies of 285 eV, 286.5, and 289.0 eV, 
which correspond to aliphatic carbon (C–C, C-H), alcohol and ether functionality (C–OH, 
C–O–C), and ester and carboxylic acid type functionality (O–C=O), respectively [6] with 
relatively equal peak intensities for the peaks at 286.5 eV and 289.0 eV. Some of the 
intensity associated with the aliphatic carbon are attributed to adventitious carbon on the 
surface of the samples. In addition, the core level spectrum of O 1s for both PPF and 
MA-PPF, shown in Figure 2.10c-d, are resolved into two peaks at binding energies of 
532 eV and 533.5 eV, which are attributed to O-C=O* and O*-C=O, respectively (* 
denotes the O of interest).[6] 
In the recorded survey spectrum for the non-crosslinked TiO2-PPF nanocomposite, the 
expected peaks for O, C, and Ti were detected (Figure 2.10e). In the high resolution XPS 
scan of the C 1s region (Figure 2.10f), the three major peaks observed for PPF and MA-
PPF are still evident. In addition, a new peak appeared at 288.2 eV, which is assigned to 
the C atom of the carbonyl group from the successful covalent interaction of carboxylate 
to TiO2.[37, 38] In order to verify the coordination of MA-PPF to the surface of TiO2 
nanofibers, a C 1s spectrum of the mechanically mixed TiO2-PPF nanocomposite sample 
prepared by mechanical mixing of PPF (1g) with nano-TiO2 (0.10 g) was measured 
(Figure 2.10g). As expected, no peak shifting or extra peaks were seen in the C 1s 
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spectrum, indicating no chemisorption of PPF to the surface of nano-TiO2. In the high 
resolution O 1s spectrum of non-crosslinked TiO2-PPF-nanocomposite (Figure 2.10h), a 
new peak appeared at 529.3 eV, which is related to the lattice oxygen atoms in TiO2 (Ti-
O bonds).[39] Furthermore, the core level spectrum of Ti 2p for the non-crosslinked 
TiO2-PPF-nanocomposite (Figure 2.10i) could be resolved into two spin-orbit pairs of 
2p3/2 and 2p1/2 with binding energies of 458.3 eV and 464 eV, respectively, attributable 
to Ti
4+
 implying that the chemical state of titanium remains as Ti
4+
.[39, 40] Therefore, 
this XPS data confirms the successful coordination of MA-PPF to the surface of TiO2 
nanofibers without changing the state of nano-TiO2. 
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Figure 2.10. High resolution XPS record of C 1s region of (a) PPF and (b) MA-PPF, 
high resolution XPS record of O 1s region of (c) PPF and (d) MA-PPF, (e) XPS full-scan 
spectrum of the TiO2-PPF nanocomposite, high resolution XPS scan of the C 1s region of 
(f) the TiO2-PPF nanocomposite and (g) the mechanically mixed TiO2-PPF 
nanocomposite, high resolution XPS scan of the O 1s region of (h) the TiO2-PPF 
nanocomposite, and high resolution XPS scan of the Ti 2p region of  (i) the TiO2-PPF 
nanocomposite.  
Thermogravimetric analysis (TGA) was also employed in the measurement of PPF 
attached to the surface of nano-TiO2 in the synthesized TiO2-PPF nanocomposites. The 
TGA characteristics of the nanocomposites are shown by the thermal weight loss and 
derivative of weight loss (DTG) of the composites with temperature. Figure 2.11 
compares the calcined TiO2, non-crosslinked PPF (2) and crosslinked PPF, non-
crosslinked TiO2-PPF (4) nanocomposites, and crosslinked TiO2-PPF (5) bone cement 
composites. A typical TGA result of TiO2-PPF nanocomposite shows two obvious 
regions when the temperature increased: the first region started from 30 °C and ended at 
200 °C with a relatively small slope (due to evaporation of the entrapped water, solvent, 
or free carboxyl groups); while the second region started at 200 °C and ended at 400 °C 
with a large slope indicating more weight loss, which is attributed to the random internal 
scission of the PPF chains chemically attached to the TiO2 nanoparticles. The sample of 
TiO2-PPF nanocomposite displayed a weight loss of 74% compared to the calcined TiO2 
with the weight loss of 3%. PPF functionalization allowed a relatively high number of 
polymer chains to be attached on the surface of TiO2 nanofibers, resulting in an increased 
weight loss for the TiO2-PPF nanocomposites.  
In addition, the effect of functionalization of the PPF on the nanocomposites can be 
observed by an enhanced thermal stability of the synthesized bone cement composite 
compared to the unmodified PPF. As shown in Figure 2.12, the onset degradation 
temperature Td for non-crosslinked PPF, crosslinked PPF, TiO2-PPF nanocomposites, and 
bone cement composite is 332 ºC, 345 ºC, 336 ºC, and 355 ºC, respectively, with bone 
cement composite representing the highest thermal dissociation temperature. This thermal 
stability enhancement is attributed to the strong interfacial adhesion between the nano-
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TiO2 and PPF matrix, which results from the excellent chemical interaction of nano-TiO2 
and functionalized polymer chains, with this strong adhesion providing a barrier effect to 
the polymer molecules evaporated during the thermal degradation of the nanocomposites. 
 
Figure 2.11. TGA curves of: (a) TiO2, (b) PPF, (c) crosslinked PPF, (d) TiO2-PPF 
nanocomposite (synthesized using 1 g of MA-PPF and 0.0250 g of TiO2) and (e) 
crosslinked bone cement composite (made of 1 g of TiO2-PPF synthesized using 0.0250 g 
of TiO2). 
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Figure 2.12. Derivative thermogravimetric (DTG) curves of: (a) PPF, (b) crosslinked 
PPF, (c) (d) TiO2-PPF nanocomposite (synthesized using 1 g of MA-PPF and 0.0250 g of 
TiO2) and (e) crosslinked bone cement composite (made of 1 g of TiO2-PPF synthesized 
using 0.0250 g of TiO2). 
2.3.3 Mechanical properties of crosslinked PPF and bone cement 
composites  
The Young’s modulus and tensile strength were measured for the crosslinked PPF and 
bone cement composites with varying nanowire-TiO2 concentrations, and mechanically 
mixed bone cement composites. The incorporation of nano-TiO2 reinforced the 
mechanical properties of the PPF, as shown in Table 2.3. The Young’s modulus and 
ultimate tensile strength of crosslinked composites increased with the initial relatively 
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low concentrations of TiO2, peaked for bone cement composite-1 and bone cement 
composite-2, and then plateaued or decreased at higher loading concentrations. There was 
a 2.5-fold increase in the Young’s modulus for the bone cement composite-1 compared to 
the pure polymer. Moreover, the tensile strength, similar to the Young’s modulus, 
decreased with loading of nano-TiO2 over 0.5-1% in the starting composition. It is clear 
from Table 2.3 that bone cement composite-1 (Sample 2) possesses the highest value of 
Young’s modulus and ultimate tensile strength amongst the different composites tested. 
This high value of Young’s modulus and tensile strength is attributed to the strong 
interfacial bonding of the functionalized PPF with nano-TiO2 fibers as shown by Figure 
2.13, which facilitates the transfer of interfacial stress from the filler to the matrix. It can 
be seen that the unfilled polymer exhibited a smooth plain surface (Figure 2.13a), while 
the bone cement composite-1 showed a rough surface with the nano-TiO2 fibers 
delaminated from the PPF matrix (Figure 2.13b). Figure 2.13b also reveals that the 
individual nano-TiO2 fibers were dispersed homogeneously throughout the bone cement 
composite-1, with strong adhesion to the matrix when reacted to the PPF after being 
functionalized. The dispersion of individual nanofibers in a polymer matrix may prevent 
slippage between TiO2 nanowires while enhancing the transfer of applied load to the 
nano-TiO2, which further enhances the mechanical reinforcement. This synthesis 
methodology provided better compatibility with nano-TiO2 while establishing chemical 
bonding through the carboxylic group, resulting in strong interfacial adhesion between 
the fibers and the matrix as the partially broken or pulled out fibers on their surface is 
shown by the arrows in Figure 2.13b. In addition to the strong adhesion with the matrix, 
these partially pulled out fibers are also shown to bridge the cracks in the matrix (Figure 
2.13c). However, at higher loading concentration (bone cement composite-2), the 
measured mechanical properties of these nanocomposites began to decline. This is 
attributed to the nano-TiO2 fibers agglomerating at higher concentrations within the 
polymer matrix, i.e., 10 wt% (Figure 2.13d). The formed agglomerates are considered to 
be responsible for accelerating crack propagation through local stress concentrators 
(voids). 
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Table 2.3. Mechanical Properties of the crosslinked PPF and the synthesized bone 
cement composites. 
*Sample **TiO2 (g) 
for 1 g of 
MA-PPF 
***TiO2 
(g) for 1 g 
of PPF 
 
Young’s 
modulus 
(MPa) 
Tensile 
strength 
(MPa) 
 
Flexural 
modulus 
(MPa) 
Flexural 
strength 
(MPa) 
1 0 - 228 ± 42 10.6 ± 2.1 
 
365 ± 66 
 
18.8 ± 2.6 
 
2 0.005  
- 
578 ± 37 
 
22.6 ± 2.9 1084 ± 115 42.5 ± 6.1 
3 0.0125 - 512 ± 26 22.3 ± 3.3 815 ± 83 35.9 ± 0.5 
4 0.0250 - 378 ± 65 15.8 ± 0.9 983 ± 34 28.2 ± 6.8 
5 - 0.05 318 ± 40 
 
14.7 ± 1.4 
 
583 ± 58 
 
20.6 ± 8.7 
 
Note: the average values and deviations were calculated from 5 sets of repeating 
experiments.* The sample number corresponds to the entry number in Table 2.2. ** The 
TiO2 concentration corresponds to the amount of nanowires/fibers used for the formation 
of TiO2-PPF nanocomposites, presented in detail in Table 2.1. *** The TiO2 
concentration corresponds to the actual TiO2 concentration in the TiO2-PPF 
nanocomposite-1 obtained by TGA analysis represented in Table 2.1. 
In addition, flexural modulus and flexural strength values of the bone cement composite 
reflect its resistance to flexural loading which is a combination of tension and 
compression forces. Similarly, dramatic reinforcements in the flexural properties (FS and 
FM) were achieved with bone cement composites, as evident in Table 2.3. This 
extraordinary mechanical reinforcement provided by bone cement composites exceeded 
the enhancements observed with the mechanically mixed bone cement composite 
(Sample 5), indicating the importance of mechanical coupling between the nanowire and 
the functionalized PPF matrix. Bone cement composite-1 formulation exhibited a roughly 
3-fold increase in flexural modulus and a greater than 2-fold increase in flexural strength 
compared to blank polymer. Loadings beyond 0.5 wt% nano-TiO2 in the starting material 
led to a decrease in the flexural properties of these bone cement composites, due in part 
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to aggregation of nanowires (Figure 2.13d). 
Due to the complexity of bone cement preparation chemistry including the type of 
polymers, nanofillers, and crosslinking agents, as well as the loading concentration, it is 
difficult to compare their mechanical properties. Previously Khaled et al. prepared bone 
cement materials by incorporating TiO2-SrO nanotubes into PMMA, achieving a flexural 
modulus of 2220 ± 100 MPa and a flexural strength 69.98 ± 1.40 MPa.[41] The highest 
flexural modulus and flexural strength measured in the present study are 1084 ± 115 MPa 
and 42.5 ± 6.1 MPa, respectively. These values are comparable with those obtained by 
utilizing high molecular weight PMMA (207 kDa),[41] although much lower molecular 
weight of PPF (2.2 kDa) was employed in this study. Studies employing functionalized 
single-walled carbon nanotubes in PPF showed flexural modulus of 769 ± 114 MPa and a 
flexural strength of 42.8 ± 3.7 MPa,[16] although the crosslinker, poly(propylene 
fumarate)-diacrylate (PPF-DA), used in their work may also be contributing to the 
reported improved mechanical properties. Considering previously reported flexural 
modulus of human trabecular bone, our results show that TiO2-PPF nanocomposites have 
sufficient mechanical strength for bone tissue engineering applications.[17]  
It should be noted that nano-titania is an established biocompatible material.[28, 41] The 
maleic anhydride-functionalized PPF having two small functional groups at each end of a 
biocompatible polymer (PPF) chain should also be biocompatible. Hence, the prepared 
TiO2-PPF bone cement materials are expected to be biocompatible; however, a future 
study will be needed to further explore the biocompatibility of functionalized-PPF and 
TiO2-PPF bone cement composites. From the above discussion it can be deduced that 
TiO2 nanofibers can act as an excellent reinforcing agent for an experimental 
functionalized PPF matrix in order to produce a new generation of bone cements. 
Chemical bonding between the filler and the polymer helps the resulting bone cement 
composites exhibit significantly enhanced mechanical properties. In addition, a study of 
degradation behavior of the prepared bone cement composites is planned as the next 
stage for this work.  
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Figure 2.13. SEM images of the fracture planes of (a) crosslinked unmodified PPF, (b) 
bone cement composite-1, (c) crack bridging within the bone cement composite-1, and 
(d) bone cement composite-2. 
(the arrows show TiO2 nanofibers are covered by polymer and aligned perpendicularly to 
the fracture surface). 
2.4 Conclusions 
Poly(propylene fumarate) (PPF) was synthesized and then functionalized with maleic 
anhydride. Successful synthesis and functionalization of PPF was confirmed by 
1
H and 
13
C NMR and XPS. The functionalized PPF was grafted to the surface of TiO2 nano-
fibers synthesized using a sol-gel reaction in supercritical CO2. Bone cement composites 
were obtained by polymerization of the PPF-grafted nano-TiO2 and a crosslinker N-
vinylpyrrolidone. The polymerization was confirmed by FTIR while TGA results 
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revealed improved thermal stability of the crosslinked bone cement composites. 
Mechanical testing demonstrated much enhanced tensile and flexural properties of the 
bone cement composites after the incorporation of TiO2 nano-fiber into the polymer 
matrix, suggesting potential application in bone cementation.  
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Chapter 3  
 
 
3 Delivery of an angiogenic mediator for bone 
regeneration in a radiopaque Sr-doped 
TiO2/poly(propylene fumarate) based bone cement 
 
Abstract 
Recently developed TiO2-poly(propylene fumarate) nanocomposites for bone 
cementation showed significantly enhanced mechanical properties. However, bone 
formation is an angiogenesis-dependent process, and the need for enhanced 
neovascularization in necrotic bone is especially important for bone regeneration. 
Moreover, it is very important to monitor healing and loosening processes to differentiate 
between bone, bone cement, and osteolysis after surgery. In the present study, a novel 
bone cement composite was developed by incorporation of an agniogenic modulator, 
ginsenoside Rg1, and a radiopaque component, Sr-doped TiO2 nanofiber, into 
poly(propylene fumarate) (PPF), a biodegradable polymer. Sr-doped TiO2 nanofibers 
were synthesized using the green solvent, supercritical carbon dioxide and characterized 
by SEM, EDX, and XPS, showing a new phase, SrTiO3, in the crystalline matrix of 
anatase. The strong interfacial adhesion between PPF and nanofibers was examined by 
SEM, FTIR, XPS, thermal analyses, and mechanical testing. The radiopacity, drug 
release, and angiogenesis behavior of the formed bone cement composites were tested 
and compared with control samples, demonstrating superior radiopacity and excellent 
release of ginsenoside Rg1 in vitro, as well as a dose-dependent increase in the branching 
point numbers, suitable for the development of next generation bone cement materials. 
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3.1 Introduction 
Osteonecrosis is a disease with a wide ranging etiology and poorly understood 
pathogenesis, most common in grownups between the ages of 20 and 50 years.[1] There 
are many risk factors, including trauma,[2] obesity,[3] gout,[2] alcoholism,[4] exposure 
to corticosteroids,[5] and radiation damage[6] which can cause the temporary or 
permanent loss of blood supply to bone.[7] Certain diseases such as sickle-cell 
anaemia,[8] Gaucher disease,[9] and altered lipid metabolism[10] are also associated with 
the development of this condition. Reduced blood flow to bone causes bone cell death, 
termed osteonecrosis, which mainly occurs in the weight-bearing parts of the body, and 
therefore with the stress of weight-bearing the necrotic segment of bone is likely to 
collapse leading to painful degenerative arthritis.[7, 11] 
Cement fixation is a recently introduced method in treating osteonecrosis of the femoral 
head.[7, 12] Bone cementation involves the injection of fluid material, which instantly 
hardens in the defect, and provides mechanical support to prevent collapse. Bone cements 
make the treatment of irregular defects easier. They are also easy to use for clinical 
practice, providing immediate symptomatic relief and faster recovery for the patient, 
while allowing improvement in mobility.[13]  
Bioactive bone cements possessing easy injectability, good biocompatibility, high 
radiopacity, and mechanical efficiency are required for cement fixation.[14, 15] Only a 
few bone cement formulations, acrylic cements based on polymethylmethacrylate 
(PMMA) and calcium phosphate cements, are specifically designed for use in these 
procedures, and even these formulations are not considered as ideal injectable bone 
cements. There are several disadvantages associated with commercial formulations of 
both bone cements families including an exothermic reaction during the curing process, 
release of cytotoxic methylmethacrylate monomer, high rigidity, nonbiodegradability, 
nonbioactivity, and poor adhesion to bone surfaces for acrylic cements based on 
PMMA[16, 17] and early resorption, poor mechanical properties, and poor handling for 
calcium phosphate cements.[18]  
Recently, poly(propylene fumarate) (PPF) has attracted considerable interest as a 
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promising degradable, injectable, and non-toxic material for cement augmentation of 
necrotic bone.[19] However, PPF does not provide for bone growth,[20, 21] and 
development of endothelial cell-based microvascularization and microcirculation is 
undoubtedly critical for the structure preservation and bone regeneration, because bone 
formation is an angiogenesis-dependent process.[22, 23] Angiogenesis is defined as the 
process of new blood vessel formation from pre-existing vessels from the surrounding 
tissues.[24] The vasculature provides enhanced mass transport requirements for the 
tissue, and delivers circulating stem cells participating in bone formation. It also 
facilitates cross-talk between endothelial cells and pre-osteoblasts to direct their 
differentiation. [25, 26] 
A variety of growth factors that direct angiogenesis including vascular endothelial growth 
factor (VEGF) have been identified.[26, 27] Also, among numerous pro-angiogenic 
mediators, ginsenoside Rg1 has been shown to be a highly stable pro-angiogenic 
compound by upregulating in vitro proliferation, migration, chemo-invasion, and tube 
formation in human umbilical vein endothelial cells (HUVECs).[28] Rg1 stimulates 
angiogenesis through enhancing the production of nitric oxide (NO) and vascular 
endothelial growth factor (VEGF).[29, 30] So, we hypothesized that a synthetic system 
based on PPF capable of delivering an angiogenic agent in a localized and sustained 
manner would direct simultaneous regeneration of bone and vascular tissue. Chang et al. 
reported the formation of ginsenoside-Rg1 incorporated PPF-tetracalcium phosphate 
(TTCP)/dicalcium phosphate (DCPA) orthopedic composite formulation.[12] However, 
the limition of Chang's study is that the proposed bone cements did not possess high X-
ray contrast along with extremely low Young’s modulus. Alike to conventional polymers, 
radiopacity of PPF is expected to be similar to soft tissue, since both are primarily 
composed of hydrogen, oxygen, nitrogen, and carbon yielding poorly resolved 
images.[31] Therefore, it is impossible to directly monitor new bone formation and 
determine the boundaries of bone cement having a pure PPF matrix during the surgery by 
ordinary X-ray imaging techniques, since the image resolution is limited. [32] 
Radiopacity is a desirable property in bone cements allowing post-operative assessment 
using X-radiography.[33] It is important that the orthopaedic surgeon can easily monitor 
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healing and loosening processes to differentiate between bone, bone cement, and 
osteolysis after surgery.[32] Therefore, to use PPF bone cement as a bone substitute, it is 
necessary to add X-ray contrast agents, such as zirconium dioxide or barium sulphate, to 
improve radiopacity and visual control.[34] Only once did Kim et al. introduce PPF 
biopolymer containing 30 Wt% barium sulfate as a radiopaque PPF cement suitable for 
kyphoplasty.[16] However, a major drawback associated with the presence of barium 
sulphate or zirconium dioxide is poor dispersion of these radiopacifiers into the polymer 
resin, which can affect both crack initiation and crack propagation in the hardened 
cement, as the radiopacifier agglomerates act as sites of high stress concentration leading 
to degradation of physical and mechanical properties.[14, 35] Later Wu et al. examined a 
newly developed bone filler, a-TCP/HAp, with PPF, and sought to quantify the 
radiopacity by CT scanning.[18] However, CT scanning costs more and takes more time 
than a regular X-ray. In addition, patients are exposed to higher doses of radiation 
compared to X-ray since a CT scan takes a much greater number of X-ray images.[36] In 
this work, biocompatible and radiopaque Sr
2+ 
component (SrTiO3) is incorporated into 
the titania nanorods/fibers using a sol-gel reaction in supercritical CO2 as a green solvent. 
Then, a bioactive bone cement is prepared by incorporating Sr-doped titania 
nanorods/fibers into a cement formulation based on PPF. There are very few studies 
regarding the Sr
2+
-modification of TiO2 nanostructures. Bhattacharyya et al. immobilized 
strontium in the crystalline matrix of rutile titania using a co-precipitation method 
presenting some structural changes with the formation of new phases, SrTiO3+Sr2TiO4 
and SrTiO3.[37] Khaled et al. incorporated strontium oxide (SrO), into the n-TiO2 tube 
in-situ during the synthesis of the tubes through the alkaline hydrothermal technique.[33] 
Also, Kumaresan et al. synthesized Sr
2+
-doped TiO2 nanoplates by sol-gel method.[38] 
However, this is the first study, to our knowledge, to synthesize Sr-doped TiO2 
nanorods/fibers in scCO2. There are several favorable characteristics that make CO2 an 
attractive solvent for the synthesis and processing of high-quality materials, as previously 
described.[39, 40]  
TiO2 itself is an oxidized metal and a highly radiopaque material.[41] Moreover, TiO2 
nanorods/fibers have a high aspect ratio and high surface area to volume ratio, and their 
incorporation into cement formulation may lead to significantly enhanced mechanical 
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properties.[42, 43] Besides, TiO2 has shown excellent in vitro apatite-forming ability and 
in vivo osteoconductivity.[41, 44] On the other hand, strontium is currently included as a 
radiopacifier in some commercially available dental cement brands improving their anti-
bacterial effectiveness.[35] Therefore, the Sr-doped TiO2 nanoparticles synthesized in 
this study are expected to provide reasonably higher radiopacity and also mechanical 
characteristics to the PPF matrix. In addition, to avoid the problem of phase separation 
and agglomeration of nanofillers in the polymer matrix and improve the compatibility 
between PPF and nanofillers, the polyester matrix was functionalized using maleic 
anhydride through the alcoholytic ring opening reaction, which produces carboxyl groups 
at each end point of the polymer for coordination onto the Sr
2+
-doped n-TiO2.[42] The 
hypothesis of this study is that Sr
2+
-doped TiO2 rods/fibers added to the functionalized 
PPF matrix will significantly enhance its mechanical properties and radiopacity as well as 
the angiogenesis characteristics provided by ginsenoside Rg1. 
 
3.2 Experimental details  
3.2.1 Materials 
Titanium isopropoxide (TIP, 99.999%), glacial acetic acid (>99.7%), zirconium (IV) 
propoxide solution 70 wt. % in 1-propanol (ZPO), barium sulfate (BaSO4, 99%), 
strontium nitrate (Sr(NO3)2, ≥99.0%) were received from Sigma-Aldrich Canada. A stock 
solution of Sr(NO3)2 in water was prepared by dissolving strontium nitrate (6.6 g) in 10 
mL of double distilled water, which was generated from Milli-Q water purification 
system (18.2  Ω·cm resistivity, Barnstead EasyPureII, Thermo Scientific, USA). 
Diethyl fumarate (98%), propylene glycol (1,2-Propanediol) (≥99.5%), zinc chloride 
anhydrous (ZnCl2, ≥99.995%), hydroquinone (99%), maleic anhydride (95%), 4-
dimethylaminopyridine (DMAP), hydrochloric acid (37%), anhydrous magnesium sulfate 
(≥99.0%), diethyl ether anhydrous (≥99.0%), anhydrous methylene chloride (DCM, 
≥99.8%), anhydrous tetrahydrofuran (THF, ≥99.9%), benzoyl peroxide (BPO), N-
dimethyl-p-toluidine (DMT), and 0.1 mol/L phosphate-buffered saline solution (PBS, pH 
7.4)  were purchased from Sigma-Aldrich Canada and used as received. Calcium nitrate 
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tetrahydrate (Ca(NO3)2.4H2O), diammonium hydrogen phosphate ((NH4)2HPO4), 
cetyltrimethylammonium bromide (CTAB), polyethylene glycol (PEG 600), ammonium 
hydroxide (NH4OH, 30%), and anhydrous ethanol (EtOH) were also obtained from 
Sigma-Aldrich, Canada and used with no further purification. Instrument grade carbon 
dioxide (99.99%) was obtained from BOC Canada. Ginsenoside Rg1 was donated by Dr. 
Edmund Lui, Department of Physiology and Pharmacology, the University of Western 
Ontario, London, Canada. Human umbilical vein cell lines (EA.hy926) were provided by 
Dr. Jeff Dixon, Department of Physiology and Pharmacology, the University of Western 
Ontario, London, Canada. Growth factor-reduced Matrigel was purchased from VWR. 
Cell culture medium and reagents were purchased from Gibco laboratories (USA). 
3.2.2 Characterization 
Scanning electron microscopy (SEM) images were collected using a Leo(Zeiss) 1540XB 
SEM. Imaging was performed at either low voltage (1 kV) for morphology or at 10 kV 
for backscatter imaging. Samples were prepared by applying the powder directly to a 
carbon adhesive tape, and coated with 5 nm of osmium metal in a Filgen OPC80T. The 
bulk composition was analyzed using energy-dispersive Quartz XOne x-ray spectroscopy 
(EDX) attached to a Hitachi S-4500 field emission scanning electron microscopy to 
investigate the dispersion of Sr
2+
 in the n-TiO2. EDX analysis was performed by taking 
spectra at three different sites in the sample. For studying the fracture surface, samples 
were broken by submersing in liquid nitrogen in a stainless steel mortar and broken with 
a stainless steel pestle.  
To identify the functional chemical groups in the synthesized polymer and coordination 
of carboxylate groups to Sr-doped n-TiO2 in the Sr
2+
-TiO2/PPF nanocomposites, 
attenuated total reflection-Fourier transform infrared (ATR-FTIR) spectra were measured 
using a Nicolet 6700 FTIR spectrometer (Thermo Scientific) equipped with a smart iTR 
(diamond ATR). The spectra were recorded in the range of 600-4000 cm
-1
 with a 
resolution of 4 cm
-1
 over 32 scans. Structural analysis of the Sr-doped TiO2 particles was 
performed using an x-ray powder diffractometer (Rigaku Miniflex XRD, TX, USA), 
fitted with a rotating sample holder, a scintillation counter detector and a divergent beam 
utili ing a CuKα source of x-rays (λ=1.5418A°). X-ray photoelectron spectroscopy 
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(XPS) analyses were carried out with a Kratos AXIS Ultra spectrometer using a 
monochromatic Al K(α) source (15mA, 14kV). Samples were placed on a carbon-based 
double-sided adhesive tape for analysis. The Kratos charge neutralizer system was used 
on all specimens. Survey scan analyses were carried out with an analysis area of 300 µm 
× 700 µm and a pass energy of 160 eV. High resolution analyses were carried out with an 
analysis area of 300 µm × 700 µm and a pass energy of 20 eV. Spectra were charge 
corrected to the main line of the carbon 1s spectrum set to 284.8 eV. Spectra were 
analyzed using CasaXPS software (version 2.3.14).  
Thermogravimetric analysis (TGA) was performed using a TA Q500 TGA at a heating 
rate of 10 ºC/min under an inert (nitrogen) atmosphere.  
Mechanical tensile properties were measured using an Instron 5943 universal testing 
machine (Instron, Canton, MA) equipped with a 500 N (tension) load cell. Tensile testing 
was conducted in accordance with ASTM D638-91a. Dogbone specimens with overall 
length of 60 mm and width of grip section of 10 mm were used for tensile testing. Stress-
strain relationship was obtained from the load and displacement data. Young’s modulus 
was determined by calculating the slope of the linear portion of the stress-strain curve, 
and tensile strength was defined as the maximum applied stress prior to failure. For each 
group, 5 independent specimens (n=5) were tested in tension at a cross-head speed of 10 
mm/min. Flexural strength and flexural modulus of the nanocomposites were determined 
in accordance with ASTM D790M-92 using a dynamic mechanical analyzer, DMA Q800 
(TA instruments). Flexural testing samples, rectangular bar specimens (n=5) (50 mm  25 
mm  2 mm), were placed on a three-point bending apparatus with two supports spanning 
40 mm from each other and loaded at the cross-head speed of 10 mm/min to the center of 
each specimen until failure. In an approach similar to that of tensile testing, flexural 
modulus was calculated as the slope of the initial linear region of the stress-strain curve, 
while flexural fracture strength was determined as the maximum applied stress prior to 
failure. 
The radiopacity of the bone cement composites reinforced n-TiO2 nanotubes/nanofibers, 
ZrO2-modified TiO2 nanofibers, Sr-doped TiO2 nanofibers, and hydroxyapatite nanorods, 
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as well as the control (crosslinked unfilled PPF and specimen containing BaSO4 as 
radiopacifier) was determined in terms of equivalent aluminum thickness according to a 
technique introduced by Amirouche et al.[45] using rectangular specimens (n = 5) (30 
mm  3 mm  2 mm) with a dental X-ray source (accelerating voltage: 40 kVp, intensity: 
0.1 mAs, source-to-film distance: 80 cm, and exposure time: 1 ms). To measure 
radiopacity, specimens were placed on a medical X-ray film along with a high-purity 
aluminum (Al) step-wedge of varying thickness from 0.5 to 5.0 mm with increments of 
0.5 mm. To minimize back-scatter, the X-ray film was positioned on a sheet of lead, and 
a standard dental X-ray source was positioned perpendicularly to the radiographic film. 
Following standard techniques, the films were developed in an automatic X-ray 
processor. Then, a transmission densitometer was employed to measure the optical 
density of each material image on the film. Five readings were taken for each image of 
each material as well as for each step of the Al step-wedge, and the average of these five 
readings was calculated. The optical density data obtained from the Al step-wedge 
images were used to construct a calibration curve of optical density of aluminum as 
function of its thickness. Finally, the radiopacity of bone cement specimens was 
expressed in terms of the equivalent thickness of aluminum (mm Al) per unit thickness of 
material, deducted in reference to the calibration curve of the radiographic optical density 
of the Al step-wedge. 
For the drug release assay, bone cement composite samples (30 mm  3 mm  2 mm) of 
optimal formulation were loaded with the angiogenic agent, ginsenoside Rg1, and 
immersed in 10 mL of pH 7.4 phosphate-buffered saline (PBS) in a small vial and 
incubated at 37 °C. At specific time points, 2 ml of the extract was collected and replaced 
with 2 ml fresh PBS. The collected supernatant was stored at -20 °C. After all the 
samples were collected, the absorption at 189 nm wavelength was measured using a UV-
Vis spectrophotometer (Shimadzu UV-Vis 3600) to determine the amount of ginsenoside 
Rg1 within the bone cement composites. Cumulative release of ginsenoside Rg1 profiles 
were acquired with the volume loss correction and plotted against time. All the 
experiments were repeated in triplicate for each time interval. Collected extracts were 
also used for following bioassay studies. 
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In order to measure angiogenic activity of ginsenoside Rg1 before incorporation into and 
after release from the bone cement composites, tube formation bioassays were performed 
using the EA.hy926 cell line derived from the fusion of human umbilical vein endothelial 
cells (HUVEC) with the A549 human pulmonary adenocarcinoma cell line. EA.hy926 
cell line was used to show the ability to attach, migrate, and form tubular structures after 
seeding on a Matrigel substrate. EA.hy926 cell lines were cultured in Dulbecco’s 
modified Eagle medium (DMEM) supplemented with ECGS (20 mg/ml), 10% fetal 
buvine serum (FBS), 1% antibiotic, and 1 ml (5X) per 50 ml of medium Hat media 
supplement. The cells were grown at 37 °C in humidiﬁed air with 5% CO2 incubator. 
When the cell cultures were 80-90% confluent, cells were harvested following trypsin 
treatment and released cells were resuspended to the cell density required for tube 
formation assay. To examine the angiogenic activity of ginsenoside Rg1 in vitro, tube 
formation bioassay was performed on 96-well tissue culture plates coated with 10 mL of 
growth factor-reduced Matrigel per well. An amount of 4.5×10
4
 cells/well of EA.hy926 
cell line was seeded on the Matrigel-coated plate loaded with medium and various 
concentrations of ginsenoside Rg1 before incorporation into the bone cement composites 
and after release from the bone cement formulations. After incubation for eighteen hours, 
images from a total of ﬁve microscopic ﬁelds per well were captured by an inverted 
microscope (Nikon TMS, Japan) using a 40x objective. The angiogenic effect was 
estimated by counting the branch points of the formed tubes, and the average numbers of 
branch points were calculated. Each experiment is repeated at least three times, with each 
experiment yielding essentially identical results. Data were expressed as mean ± standard 
deviation (SD).  
All the mechanical property measurements and bioassay experiments were conducted in 
quintuplicate and triplicate, respectively, and were measured with statistical analyses 
accomplished using GraphPad prism 4.0a Software (GraphPad Software Inc., USA). The 
data were expressed as mean ± SD.  
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3.2.3 Preparation of materials 
3.2.3.1 Synthesis of Sr-doped TiO2 nanotubes/fibers via sol-gel reaction 
in scCO2  
The schematic diagram of the experimental setup and details of the synthesis procedure 
can be found in Sui’s work.[46] To synthesize the Sr-doped TiO2 in scCO2, a 10 mL 
stainless steel view cell was connected to a syringe pump for pumping CO2. In a typical 
experiment, titanium isopropoxide (1 g) was quickly placed in the view cell, followed by 
addition of an aqueous Sr(NO3)2 (5 wt% of the TIP concentration, 0.05 g or 20 wt% of 
the TIP concentration, 0.2 g), acetic acid (6 g), and CO2 to the desired pressure and 
temperature. A magnetic stirrer was used for mixing the reaction mixture. It was found 
that the mixture of strontium nitrate/water, titanium isopropoxide, and acetic acid was 
miscible with CO2 at 60 °C and 6000 psig pressure. Stirring was stopped after 24 h, and 
6-7 days of aging were required for complete reaction. After aging, the formed gel was 
washed continuously using 80 ml of CO2 at a rate of approximately 0.5 mL/min, followed 
by controlled venting at 0.5 mL/min to prevent collapse of the solid network. The as-
prepared powder was calcined at 450 °C in air for 2 h using a heating rate of 10 °C/min, 
and the cooling rate to room temperature was 0.5 °C/min. The calcined powder was kept 
in a vacuum oven at 80 °C to remove moisture.  
3.2.3.2 Synthesis of other radiopacifiers: TiO2 nanotubes/nanofibers, 
ZrO2-modified TiO2 nanofibers, and hydroxyapatite nanorods   
For comparative radiopacity measurements, nano-structured TiO2, ZrO2-modified TiO2, 
and hydroxyapatite were also synthesized. TiO2 nanoparticles were prepared using the 
method described in Salarian et al.[42] Briefly, titanium isopropoxide (1 g) was quickly 
placed in a 10-mL view cell, followed by adding acetic acid (4 g). CO2 was then added to 
the view cell up to 6000 psig pressure while increasing the temperature to 60 °C. After 
stirring for 24 h and four days of aging, the formed gel was washed continuously using 
80 mL of CO2, followed by controlled venting. The as-prepared powder was calcined at 
450 °C in air for 2 h and kept in a vacuum oven at 80 °C.  
ZrO2-modified TiO2 nanoparticles were synthesized and loaded within the bone cement 
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composite. To synthesize ZrO2-modified TiO2, in a typical experiment, TIP (1 g) was 
quickly placed in the view cell, followed by addition of acetic acid (6 g), ZPO (0.5 g) and 
CO2 up to the desired temperature (60 °C) and pressure (6000 psi), and a magnetic stirrer 
system was used for mixing the reaction mixture. The aging, washing, and calcination 
were conducted following the reported procedure for the synthesis of Sr-doped TiO2 
nanoparticels.  
In addition, nanorods of hydroxyapatite were prepared following the experimental 
procedure introduced in Salarian et al.[47] Briefly, 0.03 mole of (NH4)2HPO4 and 0.021 
mole of CTAB were dissolved completely in 125 ml of deionized water, and stirred with 
a magnetic stirrer for 30 min. Then, the pH value was adjusted to 4.5 by adding pure 
acetic acid. Next, 0.05 mole of Ca(NO3)2.4H2O was dissolved in 175 ml of deionized 
water, and PEG 600 (20 wt%) was added to the solution under constant stirring for 30 
min. After that, the mixed solution of Ca(NO3)2.4H2O and PEG 600 was added to the 
latter dropwise under continuous magnetic stirring in air, and the pH value of reaction 
solution was adjusted to 11 using ammonia. The final milky suspension was transferred 
to a stainless steel autoclave; sealed tightly, and hydrothermally treated in an oven at 120 
°C for 22 h. The precipitates were separated from the suspension by centrifuging, washed 
three times with ethanol and three times with deionized water, and freeze-dried to yield 
white powder. 
3.2.3.3 Synthesis and functionalization of PPF 
PPF was synthesized using a two-step transesterification method[48] and functionalized 
using a recently introduced method by Salarian et al.[42] Figure 3.1 displays the synthetic 
scheme for the preparation and funtionalization of PPF and the synthesis of Sr
2+
-
TiO2/PPF nanocomposite and bone cement composite. In a typical experiment, diethyl 
fumarate and propylene glycol were reacted in an inert atmosphere. Additionally, ZnCl2 
and hydroquinone were added as a catalyst and a crosslinking inhibitor, respectively. The 
first step of the reaction occurred with a gradual increase in temperature from 110 to 150 
ºC resulting in the production of bis(hydroxypropyl) fumarate intermediate and ethanol, 
which was collected as a distillate. This step was terminated when ~ 90% of the 
theoretical yield of ethanol was collected. The second step of the reaction, 
83 
 
transesterification of the bis(hydroxypropyl) fumarate intermediate, was conducted under 
reduced pressure (<1 mm Hg) with a gradual increase in temperature from 100 to 150 ºC 
producing propylene glycol as a byproduct. The reaction proceeded until the desired 
molecular weight of PPF was obtained. The polymer product was then purified by several 
acid washes with 1 N HCl, two washes with distilled water, and two washes with brine. 
After drying with magnesium sulfate, the polymer was concentrated by rotoevaporation 
and then precipitated in ethyl ether. The ethyl ether was decanted and the purified 
polymer was vacuum dried to remove any residual solvent. 
In order to functionalize PPF chain with maleic anhydride, PPF was dissolved in 
anhydrous dichloromethane, and DMAP was added to the solution under argon, followed 
by reacting with maleic anhydride with constant stirring for 24 h at room temperature. 
The product was then washed with 1 N HCl solution and distilled water. Magnesium 
sulfate was used to absorbed water. Finally, the solvents were removed from the product 
by rotary evaporation and reduced pressure to afford maleic anhydride-functionalized 
PPF. The obtained MA-PPF was well characterized in Salarian et al.[42] 
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Figure 3.1. Synthetic scheme for the preparation and functionalization of PPF and the 
synthesis of Sr
2+
-TiO2/PPF nanocomposite and bone cement composite.  
Reagents and conditions: (a) propylene glycol, ZnCl2, hydroquinone; (b) ZnCl2, 
hydroquinone; (c) maleic anhydride, DMAP, DCM; (d) Sr-doped TiO2, THF; (e) N-VP, 
BPO, DMT, w/wo ginsenoside Rg1. 
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3.2.3.4 Synthesis of Sr2+-TiO2/PPF nanocomposites   
To prepare Sr
2+
-TiO2/PPF nanocomposites, 0.5, 1, 1.5, or 2 wt% of the synthesized Sr-
doped TiO2 nanofibers (0.005, 0.01, 0.015, or 0.02 g) were dispersed in 20 mL of THF 
with the aid of ultrasonic agitation for 1 h, followed by reacting with the above 
synthesized MA-PPF (1 g) at 70 °C under argon with constant stirring for 24 h. After 
filtering off the solvent and the unreacted MA-PPF, the product was further purified by 
dispersion in THF, centrifugation, and removal of the supernatant. This purification 
process was repeated several times until the supernatant became clear. Finally, the 
resulting solid product was dried at 55 ºC under vacuum overnight. The composition of 
the synthesized nanocomposites and the Sr-doped TiO2 concentration in each 
nanocomposite formulation reviewed by TGA analysis are presented in Table 3.1. 
Table 3.1. Formulation of the Sr
2+
-TiO2/PPF nanocomposites. 
MA-PPF 
(g)  Sr-doped TiO2 (g) 
*Content of Sr-doped TiO2 in 
the synthesized nanocomposite Sample Name 
1 g 0.005 g (synthesized from 
20 wt% Sr(NO3)2) 
 
5 wt% Sr
2+
-TiO2/PPF 
nanocomposite-1 
1 g 0.01 g (synthesized from 20 
wt% Sr(NO3)2) 
9 wt% Sr
2+-TiO2/PPF 
nanocomposite-2 
1 g 0.015 g (synthesized from 
20 wt% Sr(NO3)2) 
14 wt% Sr
2+-TiO2/PPF 
nanocomposite-3 
1 g 0.02 g (synthesized from 20 
wt% Sr(NO3)2) 
18 wt% Sr
2+-TiO2/PPF 
nanocomposite-4 
 
1 g 0.01 g (synthesized from 5 
wt% Sr(NO3)2) 
9 wt% Sr
2+-TiO2/PPF 
nanocomposite-5 
 Note: *the weight percentage of nano-Sr-doped TiO2 in each Sr
2+
-TiO2/PPF 
nanocomposite is obtained from the TGA analysis. 
3.2.3.5 Synthesis of bone cement composites    
For preparation of bone cement composites, Sr
2+
-TiO2/PPF nanocomposite (1 g) was 
86 
 
mixed with N-VP (0.4 g) for 2 h. The initiator, BPO, was dissolved in 250 μL of N-VP. 
Then, 50 μL of BPO solution was added into Sr2+-TiO2/PPF nanocomposite solution and 
mixed thoroughly into a paste formation. Afterwards, 40 μL of accelerator solution (20 
μL of D T in 980 μL of dichloromethane) was added with rapid mixing to accelerate the 
cross-linking reaction. The resulting paste was placed in a Teflon mold, then loaded in an 
oven at 60 °C for 1 h to facilitate crosslinking. After that, the mold was cooled down to 
room temperature, and the cross-linked samples were removed from the molds, and used 
for mechanical testing and radiopacity measurement analyses.  
For comparative mechanical testing, mechanically mixed bone cement composites were 
prepared by mechanical mixing of the PPF and Sr-doped TiO2 nanoparticles. Briefly, 1 g 
of PPF was mixed with 0.4 g of N-VP followed by adding 0.05 g and 0.09 g of Sr-doped 
TiO2 nanoparticles (corresponding to the Sr-doped TiO2 concentration in the Sr
2+
-
TiO2/PPF nanocomposite-1 and Sr
2+
-TiO2/PPF nanocomposite-2, respectively, reviewed 
by TGA analysis represented in Table 3.1). Then, BPO and DMT were added and mixed 
thoroughly following the explained procedure for the preparation of bone cement 
composites. The obtained pastes were molded and samples were used for mechanical 
tensile and flexural testing and radiopacity measurements. The compositions of the 
prepared mechanically mixed bone cement composites are also listed in Table 3.2.  
For comparative radiopacity measurement studies, several PPF bone cement systems 
containing different  radiopaciers/ additives including TiO2 nanotubes/nanofibers, ZrO2-
modified TiO2 nanofibers, hydroxyapatite nanorods, and BaSO4 particles were prepared. 
Specimens of the bone cement were prepared by mixing of the PPF solution in N-VP (1 g 
of PPF dissolved in 0.4 g of N-VP) and TiO2 nanoparticles (0.09 g), ZrO2-modified TiO2 
nanofibers (0.09 g), hydroxyapatite nanoparticles (0.09 g), or  BaSO4 particles (0.09 g) 
(corresponding to the Sr-doped TiO2 concentration in the Sr
2+
-TiO2/PPF nanocomposite-
2, reviewed by TGA analysis represented in Table 3.1), respectively. Then, the BPO 
solution and DMT were added and mixed thoroughly to prepare bone cement composites. 
In addition, for the drug release and tube formation assays, bone cement composites of 
optimal formulations were loaded with the angiogenic agent, ginsenoside Rg1. In a 
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typical procedure, Sr
2+
-TiO2/PPF nanocomposite-2 (1 g) was mixed with N-VP (0.4 g). 
Next, the ginsenoside Rg1 (0.01, 0.05, and 0.1 g) was added to give a final concentration 
of 1, 5, and 10 wt% of the PPF, followed by the addition of BPO (50 μL of BPO 
solution). After that, 40 μL of D T solution was used to initiate the crosslinking 
reaction. Three different angiogenic bone cement combinations were prepared using the 
following ratios: 0.01 g of ginsenoside Rg1 to 1 g of Sr
2+
-TiO2/PPF nanocomposite, 0.05 
g of ginsenoside Rg1 to 1 g of Sr
2+
-TiO2/PPF nanocomposite, and 0.1 g of ginsenoside 
Rg1 to 1 g of Sr
2+
-TiO2/PPF nanocomposite. The composition of the prepared bone 
cement composites are listed in Table 3.2. 
Table 3.2. The different compositions for the bone cement composites in each system. 
Entry 
No. Sr
2+
-TiO2/PPF PPF Additive  
Ginsenoside 
Rg1 
Formed 
Product 
1  1g   Crosslinked 
PPF 
2  1 g Sr-doped TiO2 
(0.05 g) 
 Mechanically 
mixed bone 
cement-1 
3  1 g Sr-doped TiO2 
(0.09 g) 
 Mechanically 
mixed bone 
cement-2 
4 1 g of Sr
2+
-TiO2/PPF 
nanocomposite-1 
   Bone cement 
composite-1 
5 1 g of Sr
2+
-TiO2/PPF 
nanocomposite-2 
   Bone cement 
composite-2 
6 1 g of Sr
2+
-TiO2/PPF 
nanocomposite-3 
   Bone cement 
composite-3 
7 1 g of Sr
2+
-TiO2/PPF 
nanocomposite-4 
   Bone cement 
composite-4 
8 1 g of Sr
2+
-TiO2/PPF 
nanocomposite-5 
   Bone cement 
composite-5 
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9  1 g TiO2 (0.09 g)  TiO2-loaded 
bone cement 
10  1 g ZrO2-modified 
TiO2 (0.09 g) 
 ZrO2-TiO2-
loaded bone 
cement 
11  1 g hydroxyapatite 
(0.09 g) 
 HAp-loaded 
bone cement 
12  1g BaSO4 (0.09 g)  BaSO4-
loaded bone 
cement 
13 1 g of Sr
2+
-TiO2/PPF 
nanocomposite-2 
  0.01 g Rg1-loaded 
bone cement 
composite-1 
14 1 g of Sr
2+
-TiO2/PPF 
nanocomposite-2 
  0.05 g Rg1-loaded 
bone cement 
composite-2 
15 1 g of Sr
2+
-TiO2/PPF 
nanocomposite-2 
  0.1 g Rg1-loaded 
bone cement 
composite-3 
Note: Additionally, 0.4 g of N-VP, 50 μL of BPO solution, and 40 μL of D T solution 
were added in the preparation of these materials.  
 
3.3 Results and Discussion 
3.3.1 X-ray diffraction analysis of Sr-doped TiO2 nanoparticles 
synthesized in supercritical CO2   
XRD analysis was used to investigate the effect of the dopant composition on the phase 
structure. Typical XRD patterns of the TiO2, ZrO2-modified TiO2, and Sr-doped TiO2 
particles synthesized in scCO2 are illustrated in Figure 3.2. In the XRD pattern of the 
TiO2 particles (Figure 3.2a) all diffraction peaks in the range of 20
o
 < 2θ < 80o 
correspond to the 101, 004, 100, 200, 105, 211, 204, 116, 220, and 215 reflections of 
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anatase crystal structure of TiO2.[49] The as-prepared materials were amorphous, while 
after calcination at 450 °C the material reorganized itself, and the anatase particles began 
to grow, resulting in the crystalline material. The XRD pattern of ZrO2-modified TiO2 
powder (Figure 3.2c) indicates that the ZrO2-TiO2 nanofibers consist of anatase crystals, 
with no rutile phase. A new peak appeared at 2 = 30.4°, which is assigned to zirconium 
titanium oxide (ZrTiO4).[50] In the XRD pattern of Sr-doped TiO2 nanoparticles shown 
in Figure 3.2b, all peaks correspond to anatase phase, which indicates that the as-prepared 
materials transferred from the amorphous to anatase phase during heat treatment. In 
addition, there was no distinct SrO peak indicating no phase separation,[51] and that the 
SrO is well-integrated into the anatase crystal structure for both investigated 
compositions. It is also believed that it is difficult for the Sr
2+
 ion to enter the TiO2 lattice, 
as its ionic radius is too high (1.12 Å) compared to Ti
4+
 (0.605 Å).[38] Therefore, it is 
very difficult to predict whether Sr
2+
 exists as Sr-O on the surface of TiO2 or as SrTiO3 
from the XRD pattern owing to the low dopant concentration. 
 
 
Figure 3.2. Powder XRD spectra of (a) TiO2, (b) Sr-doped TiO2 synthesized using 20 
wt% of Sr(NO3)2, and (c) ZrO2-modified TiO2 nanofibers. 
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3.3.2 Scanning electron microscopy (SEM) and energy-dispersive X-
ray spectroscopy (EDX) analyses of Sr-doped TiO2 
nanoparticles synthesized in supercritical CO2  
The morphology and size of the calcined Sr-doped TiO2 synthesized in scCO2 with two 
different dopant concentrations were characterized by SEM analysis. The presence of 
Sr
2+
 in the TiO2 matrix results in the formation of rod-like and fiber-like structures 
regardless of the dopant concentrations. However, a higher amount of Sr
2+
 precursor (20 
wt% of Sr(NO3)2 solution) increased the mean particle size to 60-100 nm in diameter, as 
can be seen in Figure 3.3a. Using a lower concentration of the same precursor (5 wt% of 
Sr(NO3)2 solution), nanoparticles with typical diameters of about 30-60 nm and an 
increased aspect ratio of about 40-50 (Figure 3.3b) were formed. EDX elemental analysis 
was also performed to investigate the bulk atomic composition of the elements in the 
synthesized Sr-doped TiO2 particles. EDX spectra of the two samples are presented in 
Figure 3.3c & d. Carbon, oxygen, strontium, and titanium are evident in both cases, with 
the elemental compositions of the two Sr-doped TiO2 samples along with the standard 
deviation being provided in Table 3.3. It has been revealed that the amount of strontium 
was less when the smaller amount of dopant was used. In addition, the atomic 
composition of strontium is less than the atomic composition of Sr in the starting 
precursor mixture; for example, Sr atomic% of 3.0 ± 0.1 was observed for the 20 wt% Sr-
doped TiO2. This indicates that not all Sr(NO3)2 (Sr
2+
) was integrated into the product, 
and this free Sr
2+
 not integrated into the nanofibers are believed to be washed away 
during the washing steps using CO2. The carbon in these samples arose from the reaction 
under scCO2, unreacted acetic acid, and washing with scCO2. 
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Figure 3.3. SEM images of (a) the 5 wt% Sr-doped TiO2 and (b) the 20 wt% Sr-doped 
TiO2 and EDX Spectra of (c) the 5 wt% Sr-doped TiO2 and (d) the 20 wt% Sr-doped 
TiO2. 
Table 3.3. Elemental composition of Sr-doped TiO2 nanofibers (n = 3, mean ± SD). 
 Atomic % 
Ti O Sr C 
5 wt% Sr-doped TiO2 18.6 ± 1.2 57.6 ± 1.7 1.6 ± 0.1 22.2 ± 0.1 
20 wt% Sr-doped TiO2 15.2 ± 2.3 59.5 ± 1.3 3.0 ± 0.1 22.3 ± 0.1 
 
3.3.3 X-ray photoelectron spectroscopy (XPS) measurement of Sr-
doped TiO2 and Sr
2+
-TiO2/PPF nanocomposites 
nanocomposites 
X-ray photoelectron spectroscopy (XPS) was used to elucidate both the TiO2 structure 
92 
 
and the chemical state of the Sr
2+
-doped TiO2 particles. In the recorded survey spectrum 
for the Sr-doped TiO2 (prepared from 20 wt% of Sr(NO3)2 solution), the expected peaks 
for O, C, Ti, and Sr were detected (Figure 3.4a). The high resolution XPS scan of the Ti 
2p region of Sr-doped TiO2 shows two peaks (Figure 3.4c), the Ti 2p3/2 peak at 458.6 and 
the Ti 2p1/2 peak at 464.3 eV binding energy, which are attributed to Ti in the 4+ 
state.[52] The O 1s XPS spectrum has two peaks (Figure 3.4b), with the first at 529.8 eV 
assigned to the lattice oxygen atoms TiO2 (Ti-O bonds), and the second at 531.0 eV being 
due to surface hydroxyl and defective oxide sites.[52] Besides, in the core level spectrum 
of Sr 3d, the Sr 3d5/2 peak shows a binding energy of 133.5 eV, which can be assigned to 
SrTiO3  (Figure 3.4d).[53] 
In the high resolution XPS scan of the C 1s region of non-crosslinked Sr
2+
-TiO2/PPF 
nanocomposite (Figure 3.4e), the three major carbon peaks are observed with binding 
energies of 284.8, 286.3, and 288.9 eV, which correspond to aliphatic carbon (C–C, C-
H), alcohol and ether functionality (C–OH, C–O–C), and ester and carboxylic acid type 
functionality (O–C=O), respectively.[54] In addition, a peak appearing at 287.8 eV is 
assigned to the C atom of the carbonyl group from the successful covalent interaction of 
carboxylate to Sr-doped TiO2.[42, 55, 56] The high resolution O 1s spectrum of non-
crosslinked Sr
2+
-TiO2/PPF nanocomposite (Figure 3.4f), shows three different peaks at 
binding energies of 529.4, 531.9, and 533.3 eV, attributable to the lattice oxygen atoms in 
TiO2 (Ti-O bonds),[52] O–C=O*, and O*–C=O, respectively (* denotes the O of 
interest).[54] Furthermore, the core level spectrum of Ti 2p for the non-crosslinked Sr
2+
-
TiO2/PPF nanocomposite (Figure 3.4g) could be resolved into two spin-orbit pairs of 
2p3/2 and 2p1/2 with binding energies of 458.1 and 463.8 eV, respectively, attributable 
to Ti
4+
 implying that the chemical state of titanium remains as Ti
4+
 that the chemical state 
of titanium remains as Ti(IV)(TiO2), and does not change to Ti(II) and Ti(III) species.[42, 
57] In addition, in the high resolution XPS scan of the Sr 3d region (Figure 3.4h), the two 
peaks at binding energies of 133.1 and 135 eV are evident, which were observed for the 
Sr-doped TiO2 nanoparticles. Therefore, the XPS results confirm the successful 
coordination of MA-PPF to the surface of Sr-doped TiO2 nanofibers without changing the 
oxidation state of nano Sr
2+
-doped TiO2, which indicates that any other Ti(II) and Ti(III) 
oxides, TiO  and Ti2O3, were not formed.  
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Figure 3.4. (a) XPS full-scan spectrum of the Sr-doped TiO2 nanoparticles, high 
resolution XPS record of O 1s region (b), high resolution XPS scan of the Ti 2p region 
(c), and high resolution XPS scan of the Sr 3d region (d) of the Sr-doped TiO2 
nanoparticles and high resolution XPS record of the C 1s region (e), high resolution XPS 
record of the O 1s region (f), high resolution XPS scan of the Ti 2p region (g), and high 
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resolution XPS scan of the Sr 3d region (h) of the Sr
2+
-TiO2/PPF nanocomposite-3. 
3.3.4 Fourier transform infrared (FTIR) spectroscopy of Sr2+-
TiO2/PPF nanocomposites  
The FTIR spectra of TiO2 nanoparticles, Sr-doped TiO2 nanoparticles, PPF, non-
crosslinked Sr
2+
-TiO2/PPF composite, and crosslinked bone cement composite-1 were 
measured and compared. There was no significant difference between the spectra of TiO2 
nanoparticles and Sr-doped TiO2 nanoparticles in the wavenumber range of 600-4000 cm
-
1
 (data not shown). This is because  SrO2 vibrations occur only below 350 cm
-1
.[38] The 
FTIR spectra of PPF, non-crosslinked Sr
2+
-TiO2/PPF composites, and cross-linked Sr
2+
-
TiO2/PPF bone cement composites are compared in Figure 3.5. PPF exhibits several 
major characteristic peaks at 1713, 1645, 1251, and 1148 cm
-1
 (Figure 3.5a), attributed to 
the C=O stretching, C=C stretching, asymmetric C-O-C stretching, and symmetric C-O-C 
stretching bands, respectively. These characteristic peaks are evident in the FTIR 
spectrum of non-crosslinked Sr
2+
-TiO2/PPF composites (Figure 3.5b), indicating the 
well-preserved C=C groups during the functionalization of Sr
2+
-TiO2 using MA-PPF. In 
addition, the FTIR spectrum of the non-crosslinked Sr
2+
-TiO2/PPF composites exhibits 
new peaks at 1568, 1379, and 1173 cm
-1
. These peaks are 
 
assigned to the bridging or 
chelating bidentate coordination between titanium atoms and the carboxyl groups. The 
band separation (Δυ=395 cm-1) between 1568 and 1173 cm-1 falls into the monodentate 
range (350-500 cm
-1) while another band separation (Δυ=189 cm-1) between 1568 and 
1379 cm
-1
 might be indicative of a structure of bridging bidentate (150-180 cm
-1
).[58] 
These bands confirmed the coordination of the PPF-g-MA (functionalized PPF) with Sr-
doped TiO2. These coordination peaks appear in the FTIR spectrum of cross-linked Sr
2+
-
TiO2/PPF bone cement composites (Figure 3.5c), suggesting the well-preseved 
coordination bonds during the crosslink reaction. The disappearance of the peak at 1645 
cm
-1
 in Figure 3.5c confirmed the cross-link reaction where the C=C double bonds were 
consumed.  
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Figure 3.5. ATR-FTIR spectra of (a) PPF, (b) Sr
2+
-TiO2/PPF nanocomposite-3, and (c) 
crosslinked bone cement composite-3. 
3.3.5 TGA     
In order to determine PPF attachment to the surface of Sr-doped TiO2 nanofibers and 
investigate the effect of PPF functionalization on the thermal stability of the proposed 
Sr
2+
-TiO2/PPF nanocomposites, thermogravimetric analysis (TGA) was performed on the 
non-crosslinked PPF, crosslinked PPF, non-crosslinked Sr
2+
-TiO2/PPF nanocomposites, 
and crosslinked Sr
2+
-TiO2/PPF bone cement composites. The sample of Sr
2+
-TiO2/PPF 
nanocomposite-3 displayed a weight loss of 80% compared to the calcined Sr-doped TiO2 
nanofibers with a weight loss of 3%. Therefore, it can be concluded that PPF 
functionalization allowes a relatively high number of polymer chains to be attached to the 
surface of Sr-doped TiO2 nanofibers, resulting in an increased weight loss for the Sr
2+
-
TiO2/PPF nanocomposite-3. A typical DTG curve of the unfilled PPF and Sr
2+
-TiO2/PPF 
nanocomposite appears to have two degradation steps (Figure 3.6B), amongst which the 
main peak (at 330-360 °C) is attributed to the scission of the polymer chains attached to 
the Sr-doped TiO2 nanoparticles. For the Sr
2+
-TiO2/PPF nanocomposite-3, this peak is 
shifted to a higher temperature by 7 ºC, which is attributed to the polymer chains being 
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chemically attached to the nanofibers. The higher thermal dissociation temperature 
revealed from the TGA results of the nanocomposites is attributed to the excellent 
chemical interaction of nano-Sr-doped TiO2 and functionalized polymer chains, 
providing a barrier effect to the polymer molecules evaporated during the thermal 
degradation of the nanocomposites. 
 
  
Figure 3.6.
 
 (A) TGA curves of: (a) TiO2, (b) PPF, (c) crosslinked PPF, (d) Sr
2+
-
TiO2/PPF nanocomposite-3 (synthesized using 1 g of MA-PPF and 0.015 g of Sr-doped 
TiO2), and (e) crosslinked bone cement composite-3 (made of 1 g of Sr
2+
-TiO2/PPF 
synthesized using 0.015 g of Sr-doped TiO2). (B) Derivative thermogravimetric (DTG) 
curves of: (a) PPF, (b) crosslinked PPF, (c) Sr
2+
-TiO2/PPF nanocomposite-3 (synthesized 
using 1 g of MA-PPF and 0.015 g of Sr-doped TiO2), and (d) crosslinked bone cement 
composite-3 (made of 1 g of Sr
2+
-TiO2/PPF synthesized using 0.015 g of Sr-doped TiO2). 
 
3.3.6 Mechanical testing (tensile and flexural strength and modulus)     
Figure 3.7 summarizes the results of the tensile and flexural moduli and strengths of the 
bone cement composites tested in this work. Bone cement composites prepared using Sr-
doped TiO2 nanoparticles showed no significant difference in flexural modulus and 
strength compared to composites prepared using TiO2 nanofibers. The flexural modulus 
of crosslinked PPF alone is 365 ± 66 MPa. With a loading of 0.5 wt % in the starting 
A B 
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composition, bone cement composites-1 exhibited a flexural modulus of 1062 ± 90 MPa, 
representing a roughly 3-fold increase compared to crosslinked PPF. The flexural 
modulus increased to a maximum (1176 ± 152 MPa) and then slowly decreased with 
increased Sr-doped TiO2 nanoparticles loading. Flexural strength of the reinforced bone 
cement composites exhibits similar behavior as in the case of Flexural modulus with bone 
cement composite-2 exhibiting a nearly 2.5-fold increase in the flexural strength (Figure 
3.7d). Similar to the flexural modulus, a significant decrease in flexural strength was also 
observed between the 0.5 and 2 wt % loadings. Flexural moduli and strengths of 
reinforced bone cement composites are mainly influenced by the transfer of applied load 
from matrix to filler.[33] The effectiveness of load transfer is controlled by a number of 
factors such as distribution and orientation of fillers within the matrix and most 
importantly interfacial shear strength between the fillers and matrix. In the case of one 
dimensional nano-fillers (Sr-doped TiO2 nanofibers), the load is transferred from the 
matrix to the filler via interfacial shear stresses between the two phases.[59] 
Functionalization of PPF establishes an enhanced chemical bonding between the Sr-
doped TiO2 nanofibers and matrix, which ensures stronger interfacial shear strength 
between the fillers and matrix, allowing flexural stress to be more effectively transferred 
from the matrix to the filler and vice versa.[60] Therefore, bone cement composites 
significantly exceeded the enhancements observed for the mechanically mixed 
composites at the same loading concentration. In addition, bone cement composites-3 
loaded with 14 wt% Sr-doped TiO2 nanofibers, demonstrated lower flexural properties, 
which is partly due to the agglomeration of nanofibers as shown by arrows in Figure 8e. 
The Young’s modulus of crosslinked PPF is 228 ± 46 MPa. The Young’s modulus values 
of crosslinked composites increased with the initial low concentrations of Sr-doped TiO2 
nanofibers, peaked for bone cement composite-2 and bone cement composite-3, and then 
decreased at higher loading concentrations. Tensile strength showed little variation 
between different cement formulations; however, a noticeable trend was observed with 
respect to loading concentration (Figure 3.7b). The tensile strength starts decreasing with 
increased loading of Sr-doped TiO2 nanofibers over 1 wt% in the starting composition, 
which is also attributed to the observed agglomeration of nanofibers in the cement matrix. 
The SEM micrographs of the fracture surfaces of the unfilled PPF and the bone cement 
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composite-2 loaded with 9 wt% Sr-doped TiO2 nanofibers are shown in Figure 3.8. The 
plain crosslinked PPF exhibits a smooth plain surface (Figure 3.8a), while the bone 
cement composite-2 shows a rough surface (Figure 3.8b) with a certain amount of Sr-
doped TiO2 nanofibers “pull out” occurring within the fractured plane of the composite 
(Figure 3.8d). These partially pulled out nanofibers can take part in bridging the crack 
during propagation.[61] In addition to the strong interfacial adhesion between the fibers 
and the matrix resulting from the chemical bonding through the carboxylic group, Sr-
doped TiO2 fibers are dispersed homogeneously throughout the bone cement composite-2 
(Figure 3.8c), when reacted to the PPF after being functionalized.  
 
Figure 3.7.
 
Mechanical properties of cross-linked bone cement composites as a function 
of the Sr-doped TiO2 nanofibers concentration. 
(a) Young's modulus, (b) tensile strength, (c) flexural modulus, and (d) flexural strength. 
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Figure 3.8.
 
SEM images of the fracture planes of: (a) crosslinked unmodified PPF, (b-d) 
bone cement composite-2, and (e) bone cement composite-3 (the arrows show Sr-doped 
TiO2 nanofibers are agglomerating at higher concentrations within the polymer matrix). 
It has been believed that drug-loaded cement is mechanically less strong than plain 
cement.[62] However, our results show that plain bone cement displays a slightly better 
flexural and tensile strength than those of the ginsenoside Rg1-loaded bone cement. For 
example, Rg1-loaded bone cement-3 exhibited a Young's modulus and tensile strength of 
545.2 ± 86 MPa and 21.3 ± 1.6 MPa and flexural modulus and strength of 1014 ± 105 
MPa and 41.5 ± 5.4 MPa, respectively.  
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3.3.7 Radiopacity     
The radiopacity values in Al equivalent of 1mm specimen thickness for crosslinked 
unfilled PPF and bone cement composites loaded with 9 wt% n-TiO2 nanofibers, ZrO2-
modified TiO2 nanofibers, Sr-doped TiO2 nanofibers, hydroxyapatite nanorods, as well as 
BaSO4 particles (corresponding to the Sr-doped TiO2 concentration in the Sr
2+
-TiO2/PPF 
nanocomposite-2 reviewed by TGA analysis represented in Table 3.1) are presented in 
Table 3.4. As shown in this Table, crosslinked PPF loaded with 9 wt% BaSO4 exhibits a 
radiopacity of 0.36 mm Al, which is the highest value of radiopacity among different 
formulations examined in this study, while hydroxyapatite-loaded bone cement 
composite exhibits the lowest value of radiopacity, 0.15 mm Al. Moreover, bone cement 
composite containing 9 wt% n-TiO2 fibers exhibiting a low level of radiopacity (0.20 mm 
Al), which is not significantly different from the unfilled PPF. The bone cement 
composite-2 exhibited a slightly higher level of radiopacity (0.32 mm Al) compared to 
the composite loaded with ZrO2-modified nanofibers at the same amount of loading 
exhibiting a radiopacity of 0.29 mm Al. The bone cement composite-2 increased the 
radiopacity of PPF matrix to approximately 88% of the radiopacity shown by the 
specimen containing 9 wt% BaSO4, and is deemed sufficient. Besides, it is possible to 
integrate more Sr
2+
 into the TiO2 nanofibers by adjusting the synthesis conditions.  
In addition, as shown in Table 3.4, the radiopacity of bone cement composite-2 
formulation does not decrease significantly when loaded with 0.1 g of ginsenoside Rg1. 
Table 3.4. Radiopacity values (mm Al) of bone cement composites of equivalent Al 
thickness (means ± SD). 
Sample Radiopacity (mmA1) 
Crosslinked PPF 0.18 ± 0.01 
Bone cement composite-1 0.30 ± 0.02 
Bone cement composite-2 0.32 ± 0.03 
Bone cement composite-3 0.32 ± 0.02 
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Bone cement composite-4 0.35 ± 0.04 
Bone cement composite-5 0.29 ± 0.03 
TiO2-loaded bone cement 0.20 ± 0.01 
ZrO2-TiO2-loaded bone cement 0.29 ± 0.01 
HAp-loaded bone cement 0.15 ± 0.01 
BaSO4-loaded bone cement 0.36 ± 0.03 
Rg1-loaded bone cement composite-3 0.30 ± 0.12 
3.3.8 Angiogenesis effect/tube formation of HUVEC cell line 
Figure 3.9 displays the tube formation of EA.hy926 cell line seeded in a growth factor-
reduced Matrigel-coated 96-well plate untreated or treated with ginsenoside Rg1 at 
different concentrations before and after incorporation into the bone cement composite 
formulations. As shown in Figure 3.9a, after seeding for twelve to eighteen hours, the 
EA.hy926 cell line aligned and formed tube-like structures on Matrigel. In the presence 
of Rg1, the cells formed relatively complete, condensed, and narrow tube-like structures 
indicating the proangiogenesis activity of ginsenoside Rg1, as shown in Figure 3.9b-g. 
This stimulation occurs in a dose-dependent manner within the dose range of 1-32 μg/ml 
Rg1 extract. Therefore, it is concluded that above a concentration of 1 μg/ml, Rg1 
significantly stimulated the EA.hy926 cell line to proliferate. It was also found that the 
tube formation was considerably augmented in the presence of 8 µg/ml Rg1 (Figure 3.9e), 
as cells tend to aggregate to form a denser structure by stimulation of Rg1 leading to 
higher area coverage per photographed field.  
Tube formation stimulation activity of ginsenoside Rg1 did not change significantly 
before and after release from the delivery carrier indicating that the prepared bone cement 
composites did not significantly affect the angiogenic activity of Rg1. The extract liquid 
in 2 mL of medium from the second day to the third day and from the ninetienth to 
twentieth day of release was collected. The concentration of Rg1 in the collected medium 
was measured using UV-Vis spectrophotometry. It was found that the Rg1 released from 
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composites were above the functional concentration in our selected time intervals, 1 
μg/ml, for the second day to the third day and the ninetieth to twentieth day, as the release 
amount in PBS and lasted for twenty five days (Figure 3.9). These concentrations in 
collected medium were diluted to different concentrations of 1-32 µg/ml. As illustrated in 
Figure 3.10i-n, ginsenoside Rg1 released from the bone cements exhibits similar potency 
towards the formation of networks of honeycomb-like or tube-like structures in the 
EA.hy926 cell line in a dose-dependent manner. These results indicate that similar to 
Chang's study cells treated with ginsenoside were incorporated into the developing 
network to a greater extent;[12] however, we were able to show the dose-dependent 
increase in the Rg1-induced angiogenic tube formation of HUVESc cell line.  
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Figure 3.9. Tube formation of HUVECs cell line cultured in different 
extract-contained media from bone cements. 
Effect of 18 h incubation with ginsenoside Rg1 (before incorporation into bone cement) 
on tube formation of EA.hy926 cell line: Control (a), cells treated with 1 µg/ml (b), 2 
µg/ml (c), 4 µg/ml (d), 8 µg/ml (e), 16 µg/ml (f), and 32 µg/ml ginsenoside Rg1 (g), Rg1-
induced angiogenic tube formation of EA.hy926 cell line cultured in media contained 
extract released from Rg1-loaded bone cement composite-2 for the second day to the third 
day of release at 1 µg/ml (i), 2 µg/ml (j), 4 µg/ml (k), 8 µg/ml (l), 16 µg/ml (m), and 32 
µg/ml (n) ginsenoside Rg1 concentration compared to blank (h), a dose-dependent 
increase in the branching points up to 32 μg/ml ginsenoside Rg1 released from Rg1-loaded 
bone cement composite-2 for the second day to the third day (o), and for the ninetieth to 
twentieth day (p) of release. 
3.3.9 In vitro drug release behavior of Rg1  
Bone cement composites should have the ability to deliver angiogenic agents such as 
ginsenoside Rg1 as examined in this work. The optimal bone cement formulation, which 
was found to be Sr
2+
-modified TiO2/PPF bone cement-2 for providing better mechanical 
and radiopacity properties, was examined for drug release. As shown in Figure 3.10, the 
three groups of drug-loaded bone cements have nearly identical release profiles; after a 
high initial release of ginsenoside Rg1, a reduced yet constant, sustained release was 
observed. In the first 5 days, 46.5% of the Rg1 was released promptly from Rg1-loaded 
bone cement composite-3, which can be attributed to either dissolution of the adsorbed 
particles or diffusion of ginsenoside Rg1 particles close to the surface of the bone 
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cement.[62, 63] The burst phase, lasting approximately 5 days, ranged from 29.5% to 
59.3% for Rg1-loaded bone cement composite-1 and Rg1-loaded bone cement composite-
2, respectively. After day 5, the profiles showed a decrease in the amount of Rg1 released 
over time to the day 40. Typically, the release rate is decreased with time due to a 
decreased driving force, as the Rg1 is depleted from the surface matrix. During this phase, 
the release depends on various other chemical and physical processes, such as polymer 
chain cleavage, diffusion of the drug (Rg1) and of polymer degradation products out of 
the bone cement, and the breakdown of the polymeric structure.[64] After 40 days, the 
release varied between 63% and 86.5% for Rg1-loaded bone cement composite-1 and 
Rg1-loaded bone cement composite-3, respectively. Additionally, the amount of 
ginsenoside Rg1 released from Rg1-loaded bone cement composite-3 was higher than that 
from the Rg1-loaded bone cement composite-1 and Rg1-loaded bone cement composite-2 
over the 40-day period, which is in agreement with the report by chang et al. presenting a 
higher amount of ginsenoside Rg1 released in vitro from the bone cement composite 
containing higher Rg1 content.[12] 
The Rg1 release from bone cement formulations examined here is rather slow, as the PPF 
matrix is hydrophobic and thus impervious to Rg1 diffusion. In addition, Sr
2+
-TiO2/PPF 
based bone cement composites are crosslinked due to the interfacial covalent bonding. 
Consequently, the ginsenoside Rg1 needs to diffuse entirely through the tightly 
crosslinked PPF matrix, leading to a slow release.[65] The tube formation bioassays 
showed that the optimal concentration for ginsenoside Rg1 to stimulate cell lines to 
proliferate is 8 µg/ml. In our system, the Rg1 released from bone cement composites were 
above this functional concentration and last for almost twenty five days (Figure 3.10).  
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Figure 3.10. The cumulative amount of released ginsenoside Rg1 from Rg1-loaded bone 
cement composite-1, Rg1-loaded bone cement composite-2, and Rg1-loaded bone cement 
composite-3. 
In addition, Sr is a natural bone-seeking trace element that accumulates in the skeleton, 
since strontium is chemically closely related to calcium (both Sr and Ca are in the same 
group in the periodic table), and it is incorporated into bone at the same rate as 
calcium.[66] It is believed that Sr stimulates the proliferation and growth of bone cells as 
a result of its chemical similarity to calcium.[33] Moreover, Sr stimulates bone formation 
and reduces bone resorption, leading to increased bone mass in osteopenic subjects.[66] 
Therefore, Sr
2+
 incorporated bone cement formulation can be potentially useful for the 
treatment of osteonecrosis in humans. These factors may exert an important role in 
biocompatibility of bone cements containing n-Sr-doped TiO2 nanoparticles. Therefore, a 
study of biocompatibility behavior of these bone cement nanocomposites is 
recommended for future work. From the above discussion it can be deduced that TiO2 
nanofibers can act as an effective reinforcing agent for an experimental functionalized 
PPF matrix in order to produce a new generation of bone cements when modified with 
Sr
2+
. Chemical bonding between the filler and the polymer helps the resulting 
nanocomposites retain the enhanced mechanical properties of the unmodified counterpart, 
while the incorporation of ginsenoside Rg1 did not alter other important physical 
properties of the bone cement such as radiopacity and mechanical characteristics.  
106 
 
 
3.4 Conclusions 
This study shows a novel pathway to develop an alternative radiopacifier for PPF-based 
bone cement, which also can act as a reinforcing agent. Radiopaque Sr
2+ 
component 
(SrTiO3) was successfully incorporated into the titania nanorods/fibers using a sol-gel 
reaction in supercritical CO2. In order to enhance the reinforcing effect, the polyester was 
functionalized with maleic anhydride (MA) using a ring opening reaction. Sr-doped TiO2 
particles showed strong chemical interaction with the functionalized polymer, as 
confirmed by X-ray photoelectron spectroscopy (XPS) and micrographic analyses of the 
nanocomposites. The prepared bone cement nanocomposites provided higher thermal 
stability than mechanically mixed bone cement nanocomposites, confirmed by 
thermogravimetric analysis (TGA) as well as higher mechanical properties. The 
ginsenoside Rg1 release analysis revealed that the bone cement composites loaded with 
higher Rg1 content released relatively higher Rg1 into the surrounding environment in 
vitro. The tube formation stimulation of released Rg1 was statistically significant as Rg1 
both before and incorporation into the cement composition. In addition. mechanical 
testing of Rg1-loaded bone cement showed that the incorporation of ginsenoside Rg1 did 
not adversely affect the mechanical properties. 
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Chapter 4  
4 Encapsulation of ginsenoside Rg1 within PPF 
Microspheres using Microfluidic Technique 
 
Abstract 
This study sought to encapsulate the pro-angiogenic mediator, ginsenoside Rg1, into 
biodegradable poly(propylene fumarate) (PPF) microspheres to induce bone formation. 
We examine the fabrication of ginsenoside Rg1-loaded PPF microspheres using both an 
emulsion method and a microfluidic device. These PPF microspheres were engineered 
with defined sizes, ranging from 3 µm to 52 µm and standard deviations less than 10% 
depending on the system flow rate. The morphology and size of the Rg1-loaded PPF 
microspheres were characterized using SEM while FTIR was used to verify the formation 
of Rg1-loaded PPF microspheres and the chemical stability of Rg1 in the microspheres. 
X-ray diffraction (XRD) revealed that ginsenoside Rg1 was uniformly distributed in the 
polymer matrix. Using synchrotron X-ray absorption spectroscopy, the interactions 
between the ginsenoside Rg1 and PPF were studied on an atom-by-atom basis, showing 
how the ginsenoside Rg1 could be loaded into the PPF microspheres. Release profiles 
were studied and quantified by UV-Vis spectrophotometry. The results showed that the 
microfluidic approach gave good physical properties (spherical and discrete) and high 
encapsulation efficiency of Rg1-loaded PPF microspheres, 95.35 ± 0.82%. Kinetic 
analysis showed that the release of Rg1 from PPF microspheres fabricated using the 
microfluidic method was slower than that from conventional method of the same average 
size giving a significantly smaller initial burst, is attributed to the uniform distribution of 
Rg1 inside the particles generated using the microfluidic method. Moreover, on 
investigating the angiogenesis behavior of the PPF-based Rg1 delivery systems, the 
released ginsenoside Rg1 maintained its angiogenic effect in vitro. The obtained results 
suggest that the PPF microspheres developed in this study are promising to serve as 
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vehicles for long-term controlled drug delivery leading to therapeutic angiogenesis in 
bone tissue engineering strategies. 
4.1 Introduction 
Biodegradable polymers are attractive as scaffold materials for bone tissue engineering 
applications. Polymer scaffolds must possess a number of specific properties in order to 
be successful, such as biocompatibility, biodegradability, highly porous and well-
interconnected structure sufficient for cellular infiltration, appropriate surface chemistry, 
and mechanical properties similar to the surrounding host tissue.[1, 2] The scaffold must 
also support cellular migration and proliferation to allow for the infiltration of osteoblasts 
and the formation of bone.[3, 4] 
One promising material for treating bone defects and non-unions caused by disease  
trauma, or abnormal development is poly(propylene fumarate) (PPF) (Figure 4.1). PPF is 
of interest as an injectable material for making preformed scaffolds for bone tissue 
engineering applications.[5, 6] It is an unsaturated linear polyester that can be cross-
linked through its carbon-carbon double bonds and can be degraded by simple hydrolysis 
of the ester bonds into nontoxic products.[7, 8] An advantage of PPF over many other 
biodegradable synthetic polymers is that it can be utilized as an injectable system, 
allowing for direct application into a defect site and cross-linking in situ.[9, 10]  
In addition, development of endothelial cell-based microvascularization and 
microcirculation is of critical importance for bone regeneration.[11] Angiogenesis is the 
formation of capillaries as outgrowths from preexisting vasculature; it is a complex 
multi-step process comprising activation, chemotactic invasion and migration, 
morphological alteration, proliferation, and capillary tube formation of endothelial cells 
from preexisting blood vessels. [11, 12] The influence of angiogenesis on osteogenesis 
has been previously shown. Particularly, the vasculature provides for mass transport 
requirements of the tissue, and delivers circulating stem cells participating in bone 
formation. It also facilitates cross-talk between endothelial cells and pre-osteoblasts to 
direct their differentiation.[13]  
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Among the angiogenic regulators, vascular endothelial growth factor (VEGF) and nitric 
oxide (NO) are the critical angiogenic stimulators that work closely with one another in 
the modulation of angiogenesis. Also, among other angiogenic mediators and growth 
factors, ginsenoside Rg1 (Figure 4.1) has been shown to be a highly stable pro-angiogenic 
compound which stimulates angiogenesis through enhancing the production of NO and 
up-regulating the VEGF expression.[14, 15] Interestingly, ginsenoside Rg1-induced 
angiogenesis was found to be comparable to or even better than bFGF-induced 
angiogenesis in vivo. So, we hypothesized that a synthetic system based on PPF capable 
of delivering an angiogenic agent, ginsenoside Rg1, in a localized and sustained manner 
would direct simultaneous regeneration of bone and vascular tissue.  
To incorporate the pro-angiogenic mediator, ginsenoside Rg1, into the scaffolds, it can be 
encapsulated in biodegradable microspheres.[16-18] These polymeric microspheres can 
be used as a local delivery vehicle capable of preserving the injectability of the PPF 
composite. [18] Controlled local delivery potentially optimizes local therapeutic 
responses, which reduces the incidents of peak-related side effects and systemic toxic 
effects.[19] Furthermore, these microspheres protect the pro-angiogenic mediator during 
the crosslinking reaction of the PPF, thereby preserving the bioactivity of the ginsenoside 
Rg1. They also offer more variables for the attenuation of the release kinetics of the 
mediator from the scaffold adding the advantage of controlled release over a prolonged 
period of time; therefore, there is no requirement for multiple doses during prolonged 
therapy.[19] Besides, the microspheres have the potential capacity to covalently bind to 
the PPF scaffold through carbon-carbon double bonds along the PPF backbone, thus 
achieving better immobilization of the microspheres and improving the mechanical 
properties of the microsphere/scaffold composite.[18, 20] Kempen et al. developed PPF 
microspheres encapsulating the model drug Texas red dextran (TRD) and demonstrated 
the effects of various processing parameters on the release kinetics of the model drug 
from these microspheres prepared using a double emulsion-solvent extraction 
technique.[20] However, monodispersity of PPF microspheres and its effect on 
controlling the drug release kinetics, reproducibility, and bioavailability was not 
investigated in their study. 
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Recently, the microfluidic method has attracted considerable attention owing to the 
flexibility to generate microdroplets with controlled morphology and size.[21, 22] 
Conventional techniques such as double emulsion creates microspheres with broad size 
distributions due to inhomogeneous forces involved, which results in an unpredictable 
degradation rate and kinetics of drug release, limiting their clinical application.[23] The  
microfluidic approach has been shown to produce microspheres with high-drug loading 
and encapsulation efficiency, and sustained release behavior due to outstanding 
monodispersity.[23, 24] To the best of our knowledge, no previous study has addressed 
the fabrication of PPF microspheres via the microfluidics method and fundamental 
differences between the drug delivery behavior of PPF microparticles produced via 
traditional method to generate emulsions and those prepared via microfluidics. In 
addition, very little is known about the interaction between the Rg1 molecules and the 
PPF-based carriers. For the first time this paper reports the use of C K-edge XANES 
spectroscopy, which is a type on syncotron radiation, to identify how ginsenoside Rg1 
molecules interact with PPF microspheres. The success of the procedure showed a high 
Rg1 carrying ability of PPF microspheres and excellent sustained release behaviors could 
lead to new biomedical applications. The hypothesis underlying this study is that delivery 
of ginsenoside Rg1, pro-angiogenic mediator, from PPF microspheres can sufficiently 
enhance angiogenesis to enable bone regeneration in osseous defects. Hence, we 
addressed the following questions: (1) How does alteration in the PPF microparticle 
preparation in terms of spherical shape, narrow size distribution, and high encapsulation 
efficiency, influence the kinetics of drug release? (2) How is the mechanism and kinetics 
of ginsenoside Rg1 released from monodisperse PPF microspheres?, and (3) How does 
the pro-angiogenic mediator, ginsenoside Rg1, maintain its angiogenic effect before 
encapsulation into the PPF microspheres and after release from the microparticles?  
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Figure 4.1. Chemical structure of (a) ginsenoside Rg1 and (b) PPF 
4.2 Experimental details 
4.2.1 Materials 
Polymer synthesis: Diethyl fumarate (98%), propylene glycol (1,2-Propanediol) 
(≥99.5%), zinc chloride anhydrous (ZnCl2, ≥99.995%), hydroquinone (99%), 
hydrochloric acid (37%), anhydrous magnesium sulfate (99.0%), anhydrous diethyl ether 
(≥99.0%), diethyl ether anhydrous (≥99.0%), methylene chloride anhydrous (DCM, 
≥99.8%) were purchased from Sigma-Aldrich Canada and used as received.  
Microsphere preparation, microfluidic chip fabrication, in vitro release study, and 
bioassays: Ginsenoside Rg1 was donated by Dr. Edmund Lui, Department of Physiology 
and Pharmacology, the University of Western Ontario, London, Canada. Poly(vinyl 
alcohol) (PVA) (87–89% hydrolyzed, Mw=13,000–23,000), methylene chloride 
anhydrous (DCM, ≥99.8%), HPLC grade methanol (≥99.9%), and 0.1 mol/L phosphate-
buffered saline solution (PBS, pH 7.4) were purchased from Sigma-Aldrich, and used as 
received. Poly(dimethylsiloxane) (PDMS; Sylgard 184) was obtained from Dow Corning 
(Midland, USA). Double distilled water used throughout the experiments was generated 
from a Milli-Q water purification system (18.2 Ω·cm resistivity, Barnstead EasyPureII, 
a) 
(B
) 
b) 
PPF 
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Thermo Scientific, USA). Glass syringes (1000 series, Hamilton Co., NV) and syringe 
pumps (KD scientific pump, Inc. Legato 2200, 1100) were used for sending liquids into 
microchannels. Human umbilical vein cell lines (EA.hy926) were provided by Dr. Jeff 
Dixon, Department of Physiology and Pharmacology, the University of Western Ontario, 
London, Canada.  Growth factor-reduced Matrigel was purchased from VWR. Cell 
culture medium and reagents were purchased from Gibco laboratories [25]. 
4.2.2 Characterization of PPF microspheres encapsulating 
ginsenoside Rg1 
The surface morphology of microspheres was analyzed using scanning electron 
microscopy (SEM) (model: Hitachi S-4500). Samples for SEM imaging were prepared by 
applying the powder directly to a carbon adhesive tape. Samples were sputter-coated for 
1 min with gold to reduce charging problems. The particle size distribution was 
characterized by measuring the particle diameter in the SEM images using version 1.37 
Image J software, which is a Java based image processing program developed at the 
National Institute of Health for analyzing images. The Image J software calculated the 
mean diameters and standard deviations of the microspheres. FTIR-ATR (Nicolet 6700, 
Thermo Scientific) was used to investigate the chemical structure of the PPF, Rg1, and 
Rg1-loaded PPF microspheres. The spectra were recorded in the range of 500-4000 cm
-1
 
with a resolution of 4 cm
-1
 over 32 scans. To evaluate the crystallinity of Rg1 after 
encapsulation, XRD data for Rg1, placebo PPF microspheres, and Rg1-loaded PPF 
microspheres were obtained using an Inel CPS Powder Diffractometer. The instrument 
was equipped with a Cu-X-ray radiation Tube, an Inel XRG3000 generator, and an Inel 
CPS 120 detector. The CPS is a curved detector and performed the simultaneous 
collection of X-rays diffracted by the samples over 120 °2θ. Powder samples were 
ground to a uniform composition and placed on a flat aluminum sample holder. To 
investigate the interaction between the Rg1 and PPF, C K-edge X-ray absorption near 
edge structures (XANES) of the Rg1 molecules, PPF microspheres and Rg1-loaded PPF 
microspheres were measured at the high-resolution spherical grating monochromator 
(SGM) beamline at the Canadian Light Source (CLS), the University of Saskatchewan. 
The samples were mounted on indium foils with an angle of 20° facing toward the photon 
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beam. XANES spectra were recorded in partial fluorescence yield (PFY) that was 
measured by detecting the X-ray fluorescence photons emitted from the element of 
interest (e.g.: carbon). All XANES spectra were normalized to the incident photon flux 
(I0), which was measured using a silicon wafer as the photodiode. 
4.2.3 Preparation of materials 
4.2.3.1 Synthesis of poly(propylene fumarate) (PPF) 
PPF was synthesized using a two-step transesterification method explained in Salarian et 
al.[26] In a typical experiment, diethyl fumarate (31.56 g, 183 mmol) and propylene 
glycol (41.38 g, 549 mmol) were reacted in an inert atmosphere. Additionally, ZnCl2 
(0.250 g, 1.83 mmol) and hydroquinone (0.0403 g, 0.366 mmol) were added as a catalyst 
and a crosslinking inhibitor, respectively. The first step of the reaction occurred with a 
gradual increase in temperature from 110 to 150 ºC in an increment of 10 ºC every 15 
min resulting in the production of bis(hydroxypropyl) fumarate intermediate and ethanol, 
which was collected as a distillate. This step was terminated when ~ 90% of the 
theoretical yield of ethanol was collected. The second step of the reaction, 
transesterification of the bis(hydroxypropyl) fumarate intermediate to produce PPF, was 
conducted under reduced pressure (<1 mm Hg) with a gradual increase in temperature 
from 100 to 150 ºC in an increment of 10 ºC every 30 min producing propylene glycol as 
a byproduct. The reaction proceeded until the desired molecular weight of PPF was 
obtained. The polymer product was then dissolved in methylene chloride followed by 
several acid washes with a 5% v/v solution of 1 N HCl to remove the ZnCl2 catalyst, two 
washes with distilled water, and two washes with brine. Sodium sulfate was then used to 
dry the organic polymer phase. After drying with magnesium sulfate, the polymer was 
concentrated by rotoevaporation and then precipitated in ethyl ether to remove the 
hydroquinone inhibitor. The ethyl ether was decanted and the purified polymer was 
vacuum dried to remove any residual solvent. 
4.2.3.2 Preparation of PPF microspheres encapsulating ginsenoside Rg1 
using W/O/W double emulsion method 
A water-in-oil-in-water (W/O/W) double emulsion-solvent extraction technique, which 
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includes encapsulation of water-soluble therapeutic agents for targetable drug 
delivery,[16] was employed to prepare PPF microspheres encapsulating ginsenoside Rg1, 
as illustrated in Figure 4.2. Briefly, 100 mg of PPF was dissolved in 10 mL of 
dichloromethane, and 10 mg of Rg1 was dissolved in 5 mL of solution 
[V(methanol):V(double distilled water) = 4:6]. The ginsenoside Rg1 solution was added 
to the PPF solution to create the first emulsion W/O. After stirring for 2h using a 
magnetic stirring bar at 1200 rpm, the entire mixture was re-emulsified in 20 mL of an 
aqueous PVA solution (4% w/v) to create the W/O/W double emulsion. After stirring for 
0.5h using a magnetic stirrer bar at 400 rpm, the emulsion was poured into a beaker 
containing 40 mL of an aqueous PVA solution (0.5% w/v) and stirred for 2h. This 
solution was then added to double-distilled water and stirred for another 3h, at room 
temperature. Finally, the emulsion was ultrasonically agitated for 10 min at 30 °C. After 
removing DMC by evaporation, the formed microspheres were centrifuged at 5000 rpm 
for 5 min, followed by washing with distilled water twice to remove PVA and freeze-
drying to remove water. The Rg1-loaded microspheres were stored at −20°C. 
 
 
Figure 4.2. Schematic of the double emulsion method. 
4.2.3.3 Fabrication of microfluidic device 
Microfluidic chips with typical channel dimensions of 100 µm in depth and 200 µm in 
width were fabricated using conventional soft lithography techniques in collaboration 
with Dr. Jun Yang, Mechanical and Material Engineering Department, Western 
University, Canada.[27] The microfluidic chip was molded by a mixture of PDMS 
elastomer base/curing agent in 10:1 ratio from SU-8 mold, and bonded to a flat PDMS 
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substrate under plasma treatment for 35 seconds in a PX-250 plasma chamber (March 
Instruments, Concord, MA), and then immediately placed in contact to bond the surfaces 
irreversibly. The devices were then bonded using a homemade UV-ozone generator. 
Since there is a favorable wettability between the disperse phase and the inner surface of 
the device, surface treatment is applied to the channels to make the PDMS surface 
hydrophilic.[23] The plasma-treated chip was immediately filled with a 4% PVA aqueous 
solution (continuous phase) and then placed at room temperature for 30 min. Then, the 
channels were emptied by a vacuum pump and the PDMS chip was placed in a 60 °C 
oven for 2h to dry and immobilize the PVA. The above procedure was repeated, resulting 
in a two layer coating. Finally, the coating was thermally immobilized in an oven at 100 
°C for 20 min, and then the chip was allowed to cool to room temperature inside the 
oven.[28]  
4.2.3.4 Preparation of PPF microspheres encapsulating ginsenoside Rg1 
using droplet microfluidic method 
The schematic drawing of the microfluidic device is shown in Figure 4.3. The disperse 
phase was prepared by emulsifying the ginsenoside Rg1 solution (2 mg/ml or 10 mg of 
Rg1 in 5 ml of solution of methanol/double distilled water (2:3 v/v)) in PPF organic 
solvent solution (10 mg/ml or 100 mg of PPF in 10 ml of DCM), that flowed into inlet 1. 
The continuous phase, an aqueous solution of PVA (4% w/v), flowed into inlet 2. Both 
liquid phases were loaded into glass syringes, and digitally controlled syringe pumps 
delivered to the microfluidic device using Teflon tubing (1.6 mm OD, 0.6 mm ID). 
Following the previous studies in our group, the flow rate of the continuous phase ranged 
between 0.05-0.2 ml/min while the flow rate of the dispersed phase was constant and held 
at 0.01 ml/min.[28] The outlet of the device was a Teflon tubing submerged into a 10 ml 
beaker containing 0.5% PVA aqueous solution to collect the monodisperse droplets. 
Next, the solvent within the droplets was removed by evaporation at room temperature, 
and hardened microparticles were then centrifuged (5000 rpm, 5 min), washed twice with 
distilled water to remove excess PVA, freeze-dried, and stored at -20 ºC.  
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Figure 4.3. Schematic of the microfluidic system. 
(1) disperse phase inlet (ginsenoside Rg1 solution emulsified in PPF in DCM solution), 
(2) continuous phase inlet (4% w/v PVA aqueous solution), and (3) outlet. 
 
4.2.4 Determination of encapsulation efficiency (EE) of Rg1-loaded 
PPF microspheres 
Encapsulation efficiency (EE) for Rg1-loaded PPF microspheres prepared using the 
conventional double emulsion and microfluidic methods was determined by dissolving 
dried Rg1-loaded microspheres in NaOH solution. Specifically, 5mg microspheres were 
dissolved in 1 ml of a 1N NaOH solution.[20] The Rg1 concentration was determined by 
absorption at the λmax value of 189 nm in a UV-Vis spectrophotometer (Shimadzu UV-
Vis 3600). A calibration curve was constructed from Rg1 solutions with known 
concentrations. Encapsulation efficiency of Rg1 in the PPF microspheres was determined 
by normalizing the amount of Rg1 actually entrapped to the starting amount,[18] the ratio 
between the actual Rg1 content of the microspheres and the amount initially added to 
them.[29] Each experiment was carried out in triplicate. The EE of drug was defined as: 
100
esmicrospher  the toaddedinitially  Rg of weight 
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4.2.5 In vitro release of ginsenoside Rg1 
For the release study, 5 mg of Rg1-loaded PPF microspheres was dispersed into 10 mL of 
pH 7.4 phosphate-buffered saline (PBS) in a small centrifuge tube. The tubes were sealed 
and placed in a shaking water bath with a rotation rate of 100 rpm at 37 °C. At specific 
time intervals, the tubes were centrifuged at 2500 rpm for 5 min, and 2 ml of the 
supernatant was collected and replaced by fresh PBS. The supernatant was stored at -20 
°C. After all the samples were collected, the absorption at 189 nm wavelength was 
measured using a UV-Vis spectrophotometer (Shimadzu UV-Vis 3600) to determine the 
amount of released Rg1. Cumulative release of Rg1 profiles were acquired with the 
volume loss correction and plotted against time. All the experiments were repeated in 
triplicate for each time interval. Collected extracts were also used for the following 
bioassay studies. 
4.2.6 Angiogenic activity of ginsenoside Rg1 before encapsulation 
into and after release from the PPF microspheres 
Tube formation bioassays were performed using the EA.hy926 cell line derived from the 
fusion of human umbilical vein endothelial cells (HUVEC) with the A549 human 
pulmonary adenocarcinoma cell line. The HUVEC cell line has been shown to attach, 
migrate, and form tubular structure after seeding on a Matrigel substrate.[30, 31] Cell 
lines were cultured in Dulbecco’s modified Eagle medium (D E ) supplemented with 
ECGS (20 mg/ml), 10% fetal buvine serum (FBS), 1% antibiotic, and 1 ml (5X) per 50 
ml of medium Hat media supplement. The cells were grown at 37 °C in humidiﬁed air 
with 5% CO2 incubator. When the cell cultures were 80%-90% confluent, cells were 
harvested following trypsin treatment, and the released cells were resuspended to the cell 
density required for tube formation assay. To examine the angiogenic activity of 
ginsenoside Rg1 in vitro, 4.5×10
4
 cells/well of EA.hy926 cell line were seeded in a 
growth factor-reduced Matrigel-coated 96-well tissue culture plate loaded with medium. 
Various concentrations of ginsenoside Rg1 were examined before encapsulation into the 
PPF microspheres and after release from the microparticles. After incubation for eighteen 
hours, images from a total of ﬁve microscopic ﬁelds per well were captured by an 
inverted microscope (Nikon TMS, Japan) using a 40x objective. Tube formations were 
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analyzed by Motic Image Plus 2.0 software (Motic Instruments Inc., Richmond, Canada). 
The angiogenic effect was estimated by counting the branch points of the formed tubes, 
and then the average numbers of branch points were calculated. Each experiment was 
repeated at least three times, with each experiment yielding essentially identical results. 
4.3 Results and Discussion 
4.3.1 Surface morphology and particle size analysis of the Rg1-
loaded PPF microspheres 
SEM images of the PPF microspheres encapsulating ginsenoside Rg1 prepared using both 
a conventional solvent evaporation/extraction method based on the W/O/W double 
emulsion method and a microfluidic approach are displayed in Figure 4.4. The size 
distribution of the microspheres were analyzed using Image J software and are displayed 
in Figure 4.5. The results show that polydisperse microspheres with an average size of 
13.5 µm in diameter and a standard deviation of 11.11 µm were obtained using the 
conventional double emulsion method. SEM and Image J size distribution images of 
these microspheres highlight that these particles have a broad size distribution of 2-45 
µm, evident in Figure 4.4a, b. Figure 4.4c, d represent SEM images of PPF microcapsules 
prepared using the droplet microfluidic method when the flow rate for continuous phase 
and disperse phase were set at 0.1 and 0.01 ml/min, respectively. These observations 
demonstrate that by using the microfluidic device, spherical and discrete microspheres 
with an average diameter of 52 µm and a standard deviation of 7 µm are formed. In 
addition, the microfluidic approach gave much more uniform microspheres (50-65 µm) 
compared to the conventional double emulsion method. The size of these microspheres 
renders them suitable for mixing the prefabricated components in a syringe and 
fabrication of microsphere/scaffold composites, as microsphere with the diameter ranged 
from 1 to 110 are considered to be ideal for effortless injection of the composite through 
a small needle (14-gauge needle) indicating very good handling properties.[18] The size 
of the particles could be regulated by changing the flow rates of the two continuous and 
disperse phases. When the flow rates of 0.2 and 0.01 ml/min were chosen for the 
continuous phase and disperse phase, respectively, microparticles with an average 
diameters of about 3 µm and standard deviation of 1.78 µm revealing the narrower size 
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distribution of 1-10 µm are fabricated using the same microfluidic device. Lowering the 
flow rate of the continuous phase to the 0.05 ml/min, the system could not produce any 
droplets and microspheres. Our experimental results illustrate that the size of the 
microparticles obtained using the microfluidic method are tunable by changing the flow 
rate; however, only a narrow experimental window enabled microsphere formation. 
 
Figure 4.4. SEM images of Rg1-loaded PPF microspheres from (a, b) double emulsion 
method and (c, d) microfluidic method where the continuous phase flow rate and disperse 
phase flow rate was 0.1 and 0.01 ml/min, respectively, and (e, f) microfluidic method 
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where the continuous phase flow rate and disperse phase flow rate was 0.2 and 0.01 
ml/min, respectively. 
 
Figure 4.5. Image J number of size distributions for Rg1-loaded PPF microspheres. 
prepared using (a) a double emulsion method, (b) microfluidic method where the 
continuous phase flow rate and disperse phase flow rate was 0.1 and 0.01 ml/min, 
respectively, and (c) microfluidic method where the continuous phase flow rate and 
disperse phase flow rate was 0.2 and 0.01 ml/min, respectively. 
4.3.2 Encapsulation efficiency of Rg1 in the PPF microspheres 
The encapsulation efficiencies of the ginsenoside Rg1 in the PPF microspheres fabricated 
using the conventional double emulsion method and microfluidic technique was 
determined as explained in section 4.2.4. EE of Rg1 in PPF microspheres fabricated using 
the microfluidics was quite satisfactory in the range of 73.48 ± 2.31% and 95.35 ± 0.82%, 
exhibiting a 29.76% increase with increasing the average size of the microspheres. Rg1-
loaded PPF microspheres prepared by the conventional method had a lower EE (78.48 ± 
1.64%). In explanation, the entrapment efficiency is affected by the volume of the 
internal aqueous phase containing ginsenoside Rg1, vortex speed, internal PVA phase, 
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and polymer viscosity.[19] However, it seems that the higher entrapment efficiency 
achieved for the PPF microspheres obtained from the microfluidic approach compared to 
that from the double emulsion method is due to the more uniform structure. In addition, 
the mechanism of polymer precipitation is different for Rg1 encapsulation within the PPF 
microparticles produced using the microfluidic and double emulsion methods. Fast 
polymer precipitation on the surface of the dispersed phase can prevent drug loss into the 
continuous phase and increase the encapsulation efficiency, as less drug diffuses into the 
continuous phase.[32] The encapsulation efficiency of PPF microspheres prepared using 
the microfluidics method increases with size since a lower ratio of disperse phase flow 
rate to continuous phase flow rate was used for the production of larger monodisperse 
particles, which may result in the fast solidification of microspheres and subsequently 
higher encapsulation efficiency.[28] Thus, the microsphere size shows a direct effect on 
the drug release, bioavailability, and the encapsulation efficiency.[23] Encapsulation 
efficiency is an important factor in drug delivery, especially for valuable and expensive 
bioactive compounds.[24] The microfluidic method, when the flow rate for the 
continuous phase and disperse phase were 0.1 and 0.01 ml/min, respectively generated 
monodisperse Rg1-loaded PPF microspheres with the narrow size distribution (Figure 
4.5b). The encapsulation efficiency of 95.35 ± 0.82% was selected for further analyses as 
explained in more detail below. 
4.3.3 Fourier transform infrared (FTIR) spectroscopy of Rg1, PPF, 
and Rg1-loaded PPF microspheres 
To investigate the presence and chemical stability of PPF in the ginsenoside Rg1-loaded 
PPF microspheres, the FTIR spectra of Rg1, pure PPF, and Rg1-loaded PPF microspheres 
were measured and are compared in Figure 4.6. In the FTIR spectrum of Rg1 (Figure 
4.6a), three major peaks appear at 3332, 1643, and 1011 cm
-1
, attributable to O-H, C=C, 
and C-O stretching bands, respectively. The FTIR spectrum of PPF (Figure 4.6b) exhibits 
several major characteristic peaks at 1713, 1645, 1250, and 1147 cm
-1
, attributed to the 
C=O stretching, C=C stretching, asymmetric C-O-C stretching, and symmetric C-O-C 
stretching bands, respectively.[8, 25] After ginsenoside Rg1 was loaded into the PPF, all 
the PPF peaks are observed in the spectrum of Rg1-loaded PPF microspheres (Figure 
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4.6c), confirming the structural stability of PPF during the formation of microspheres. 
The peaks of ginsenoside Rg1 are not evident in the spectrum of Rg1-loaded PPF 
microspheres, except a weak broad peak at 3332 cm
-1
, which is attributed to excellent Rg1 
dispersion in the PPF matrix and the resulting low concentration of ginsenoside Rg1 on 
the PPF microsphere surface. 
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Figure 4.6. FTIR spectra of (a) ginsenoside Rg1, (b) PPF, and (c) Rg1-loaded PPF 
microspheres prepared using microfluidic method. 
4.3.4 X-ray diffraction analysis of Rg1, placebo PPF microspheres, 
and Rg1-loaded PPF microspheres 
XRD was used to study the physical state of the encapsulated Rg1 in the PPF 
microspheres. As evident in the XRD pattern of Rg1-loaded PPF microspheres fabricated 
using the microfluidic technique (Figure 4.7d), the crystalline peak at 2θ = 5° indicates 
the semicrystalline nature of Rg1 disappeared after encapsulation within the PPF 
microspheres, which confirms the amorphous state of Rg1 in the PPF microspheres.[28] 
This also indicates that Rg1 is distributed uniformly in the polymer matrix, confirming the 
FTIR results. Therefore, XRD analysis of the microspheres confirmed that ginsenoside 
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Rg1 is dispersed molecularly into the PPF matrix, and that no crystals are present in the 
Rg1-loaded matrices.[33] 
 
Figure 4.7. XRD patterns of (a) background, (b) placebo PPF microspheres prepared 
using  microfluidic method, (c) ginsenoside Rg1, and (d) Rg1-loaded PPF microspheres 
prepared using microfluidic method. 
4.3.5 XANES spectroscopy of Rg1, PPF, and Rg1-loaded PPF 
microspheres 
XANES spectroscopy provides additional information about the structure and bonding 
associated with the absorbing atoms and their immediate surroundings.[34] Thus, we can 
probe the interaction between the drug carriers and drug molecules by tracking the 
changes of the electronic structures (XANES spectra) of the drug carriers before and after 
drug loading.[35] Figure 4.8a displays the C K-edge XANES spectra of the PPF 
microspheres with/without Rg1 prepared using the microfluidic technique as well as pure 
Rg1 for comparison. The spectrum of the pure PPF microspheres (green curve) is 
characterized by features at 285.6 (“a”), 290.1 (“d”), and 294.5 (“e”) eV. Feature “a” and 
“e” are attributed to the C=C π* and σ* transitions, while feature “d” is assigned to the 
C=O π* transition.[36, 37] The spectrum of the pure Rg1 (blue curve) is a bit more 
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complicated showing features at 286.9 (“b”), 289.1 (“c”), 290.1 (“d”), and 294.5 (“e”) 
eV. Feature “b” is proposed to come from the C-O-C bond or C-OH π* transition.[38] 
Feature “d” is attributed to the C-H* resonance, while the shoulder “c” at lower energy is 
assigned to the C-H
*
 resonance of the carbon not bonded to oxygen.[36] Feature “e” 
corresponds to the C-C σ* and C-O σ* resonances.[36] Comparing the XANES spectra of 
the PPF microspheres with/without Rg1 molecules showed that in the spectrum of the 
Rg1-loaded PPF microspheres (red curve), i) the intensity of feature “a” drops off by 
about 25% compared to that of pure PPF microspheres, ii) feature “a” becomes 
broadened, and iii) a weak shoulder shows up at the lower energy side of feature “d”. The 
broadening of feature “a” and presence of shoulder “c” in the spectrum of the Rg1-loaded 
PPF microspheres are due to the contribution from Rg1 molecules (feature “b” and “c”), 
which indicates that Rg1 molecules were successfully loaded into the PPF microspheres. 
The decrease of the intensity of feature “a” relative to the total edge jump could be due 
to: i) Rg1 molecules contributed to the total edge jump and ii) the decrease of the number 
of carbon-carbon double bonds in the PPF polymer chain after Rg1 loading. If the Rg1 
molecules were physically loaded or sealed in the PPF microspheres without chemical 
interaction between each other, the Rg1 and PPF both contributed to the total edge jump 
at the C K-edge, and the weight ratio between Rg1 and PPF would be about 1:3 that 
resulted in the dropping of the “a” intensity by 25%. Figure 4.8b shows the linear 
combination fitting result of the Rg1-loaded PPF microspheres (the weight ratio of Rg1 
and PPF is 1:3). The fitting spectrum (black curve) matches well with the experimental 
one (red curve) except the intensities of feature “a” and “b”. As shown in the inset of 
Figure 4.8b, the intensity of feature “a” in the fitting curve is a bit stronger than that in 
the experimental one, while feature “b” is weaker, which might be due to chemical 
interaction between the Rg1 molecules and PPF microspheres. Here we proposed that 
during the Rg1 loading process, some of the carbon-carbon double bonds in the PPF 
broke to form carbon-carbon single bonds, which interacted with the Rg1 molecules via 
C-O-C and C-C bonds. After the Rg1 loading, the decrease of the carbon-carbon double 
bonds in the PPF and the presence of the C-O-C bond between the Rg1 and PPF lead to 
the dropping of feature “a” and the rising of feature “b”, respectively. 
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Figure 4.8. (a) C K-edge XANES spectra of pure PPF microspheres, ginsenoside Rg1, 
and Rg1-loaded PPF microspheres prepared using microfluidic method. (b) Linear fitting 
of the Rg1-loaded PPF microspheres prepared using microfluidic method. Inset shows the 
π* resonance. 
4.3.6 Release of ginsenoside Rg1 from delivery system in vitro 
We assayed the kinetic profiles of in vitro release of ginsenoside Rg1 from monodisperse 
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microparticles fabricated using the microfluidic approach and polydisperse microparticles 
prepared using the conventional double emulsion technique, as shown in Figure 4.9. In 
general, Rg1 release behavior for all monodisperse and polydisperse PPF microspheres 
exhibited a biphasic profile: an initial burst release in the first 2 days followed by a 
decreased sustained release over a 40-day period. The release profiles show that the total 
cumulative Rg1 release from the monodisperse microspheres and conventional 
polydisperse microspheres are 48.7% and 88%, respectively. In addition, the initial burst 
release varied from 18.5% to 56.5% for microfluidic microspheres and polydisperse 
microspheres, respectively. Monodisperse microspheres prepared by the microfluidics 
device released Rg1 more slowly than from the conventional polydisperse microspheres. 
Furthermore, the monodisperse particles revealed a significantly smaller initial burst 
release than that observed for the polydisperse microspheres. It has been shown the initial 
burst release of entrapped bioactive agent is affected most by the viscosity of the polymer 
solution used for the fabrication of microspheres;[19] however, the PPF microspheres for 
both methods were fabricated using the same batch and viscosity of synthesized polymer. 
In addition, it is known that the burst release depends on the rapid water penetration into 
the polymer matrix; therefore, encapsulated molecules that are immediately accessible at 
the periphery of the microspheres and/or in the aqueous channels inside the microspheres 
are rapidly released upon contact with the release medium, PBS.[19] The smaller initial 
burst and slower release kinetics from the conventional microspheres is attributed to 
homogeneous mixing in the microfluidic device, leading to a more uniform and even 
drug distribution in the interior of the microparticles, while the conventional 
microspheres may have drug-rich domains near the surface of the microparticles most 
likely caused by the inhomogeneous forces involved.[24] The conventional double 
emulsion method produced a broad size distribution of the particles, particularly a high 
number of small particles. These will contribute to the larger initial burst release and 
faster overall kinetics observed in the conventional particles, owing to the larger surface-
area-to-volume ratio of the smaller particles.[24] In addition, the large amounts of Rg1 
absorbed at the surface of the microparticles escape easily into PBS solution also 
resulting in the larger observed initial burst and faster release kinetics.[23] Using the 
microfluidics approach, PPF scaffolds could be rendered angiogenic by incorporation of 
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Rg1-loaded PPF microspheres. It is expected that microsphere incorporation into PPF 
scaffolds may result in a negligible burst release and a more sustained in vitro release 
over a prolonged period of time. 
 
Figure 4.9. Release profiles of ginsenoside Rg1 from monodisperse PPF microspheres. 
prepared with microfluidic device and polydisperse PPF microspheres prepared using the 
conventional double emulsion technique. 
4.3.7 Angiogenesis effect/tube formation of HUVEC cell line 
Figure 4.10 displays the tube formation of EA.hy926 cell line seeded in a growth factor-
reduced Matrigel-coated 96-well plate. This bioassay shows the tube formation in both 
the absence and presence of ginsenoside Rg1 at different concentrations before loading 
and after release from the PPF microspheres prepared using the microfluidic device. 
After seeding for twelve to eighteen hours in the absence of angiogenic factor, HUVECs 
cell line formed incomplete and narrow tube-like structures (control sample); however, in 
the presence of Rg1 within the dose range of 1-32 μg/ml, elongated and robust capillary-
like networks are observed to form, which were organized by a greater number of cells 
compared with the control indicating the proangiogenesis activity of ginsenoside Rg1, as 
shown in Figure 4.10b-g. Based on the obtained results, the functional concentration of 
Rg1 was found to be 1 μg/ml, while the optimal concentration is 8 µg/ml, as seen in 
Figure 4.10o demonstrating that 8 µg/ml of Rg1 stimulated tube formation by 2-fold over 
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the control. To study the angiogenesis behavior of ginsenoside Rg1 after release from the 
PPF microspheres, the extract liquid in 2 mL of medium from the 19th day to 20th day of 
release was collected. The concentration of Rg1 was measured using UV-Vis 
spectrophotometry, and diluted to different concentrations of 1-32 µg/ml. It was found 
that tube formation stimulation activity of ginsenoside Rg1 did not change significantly 
after release from the delivery carriers. This indicates that the examined PPF microsphere 
delivery systems did not significantly affect the angiogenic activity of Rg1. Similarly, 
ginsenoside Rg1 released from the PPF microspheres exhibits similar potency towards the 
formation of networks of honeycomb-like or tube-like structures in the EA.hy926 cell 
line in a dose-dependent manner, as illustrated in Figure 4.10i-n. These results 
demonstrate that Rg1-induced tube formation is related to the dosage. Hence, Rg1 
incorporation into PPF microspheres may result in a gradual in vitro release from the PPF 
composites maintaining local in vivo concentrations at angiogenic levels for sufficient 
time. Therefore, further optimization of the Rg1 pharmacokinetics is required to obtain a 
release profile that coincides better with the normal rate of tube and bone formation.[39] 
In addition, it should be noted that HUVECs' ability to form a network of tubular 
structures across the surface of a Matrigel substratum is a complex phenomenon which 
combines elements of attachment, migration, organization, and differentiation. The 
complex organizational behavior of  HUVECs on Matrigel models the type of 
coordinated activities that are relevant to angiogenesis by endothelial cells. Although the 
in vitro Matrigel model does not represent true angiogenesis, it suggests that Rg1 is 
important for many of the activities that are required for vessel formation.[40]  
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Figure 4.10. Tube formation of HUVECs cell line cultured in different 
extract-contained media from PPF microspheres. 
Effect of ginsenoside Rg1 (before incorporation into PPF microspheres) on tube 
formation of EA.hy926 cell line: control (a), 1 µg/ml (b), 2 µg/ml (c), 4 µg/ml (d), 8 
µg/ml (e), 16 µg/ml (f), and 32 µg/ml ginsenoside Rg1 (g), Rg1-induced angiogenic tube 
formation of EA.hy926 cell line cultured in media contained extract released from Rg1 
loaded-PPF microspheres for the ninetieth to twentieth day of release at 1 µg/ml (i), 2 
µg/ml (j), 4 µg/ml (k), 8 µg/ml (l), 16 µg/ml (m), and 32 µg/ml (n) ginsenoside Rg1 
concentration compared to blank (h), and (p) a dose-dependent increase in the branching 
points up to 32 μg/ml ginsenoside Rg1 released from Rg1-loaded PPF microspheres for 
the 19th day to 20th day of release. 
4.4 Conclusions 
In this study, ginsenoside Rg1 was encapsulated in PPF microspheres comparing a 
microfluidic and conventional double emulsion method, with the microfluidic method 
generating microspheres of more uniform size. SEM, FTIR, and XRD analyses were 
employed to examine the morphology, chemical stability, and physical state of Rg1 in the 
microspheres. We also reported the C K-edge XANES study of the PPF microspheres 
loaded with/without ginsenoside Rg1. XANES results confirmed that Rg1 was 
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successfully loaded in the PPF microspheres and the weight ratio between Rg1 and PPF is 
about 1:3. It is proposed that chemical interaction between the Rg1 and PPF took 
place via C-O-C and C-C bonds during the Rg1 loading process. The monodisperse PPF 
microspheres prepared using the microfluidic method (50-65 μm) exhibited a slower 
release rate and a smaller burst effect compared to the polydisperse microspheres 
produced using the double emulsion method (2-45 μm). Furthermore, the ginsenoside 
Rg1 released from delivery systems showed tube formation stimulation effect on human 
umbilical vein cell lines as Rg1 before loading into the PPF microparticles, which reveales 
that the microsphere preparation method does not affect the bioactivity of ginsenoside 
Rg1 in vitro. Monodisperse Rg1-loaded PPF microspheres could be incorporated to the 
scaffold formulations to generate Rg1-releasing scaffolds serving as a synthetic 
extracellular matrix that would enhance bone regeneration through improved 
vascularization. 
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Chapter 5  
 
5 Hydroxapatite-TiO2-based Nanocomposites 
Synthesized in Supercritical CO2 for Bone Tissue 
Engineering: Physical and Mechanical Properties 
 
Abstract 
Calcium phosphate-based nanocomposites offer a unique solution towards producing 
scaffolds for orthopedic and dental implants. However, despite attractive bioactivity and 
biocompatibility, hydroxyapatite (HAp) has been limited in heavy load-bearing 
applications due to its intrinsic low mechanical strength. In order to improve the 
mechanical properties of HAp, in this work HAp nonaplates were grown from the surface 
of one-dimensional titania nanorod structures by combining a co-precipitation and sol-gel 
methodology using supercritical fluid processing with carbon dioxide (scCO2). The effect 
of metal alkoxide concentration (1.1-1.5 mol/L), reaction temperature (60-80 °C), and 
pressure (6000-8000 psi) on the morphology, crystallinity, and surface area of the 
resulting nanostructured composites was examined using scanning electron microscopy, 
transmission electron microscopy, X-ray diffraction (XRD) analysis, and Brunauer-
Emmet-Teller method. Chemical composition of the products was characterized using 
Fourier transform infrared (FTIR), X-ray photoelectron spectroscopy (XPS), and X-ray 
absorption near-edge structures (XANES) analyses. HAp nanoplates and HAp-TiO2 
nanocomposites were homogenously mixed within poly(ε-caprolactone) (PCL) to 
develop scaffolds with enhanced physical and mechanical properties for bone 
regeneration.  echanical behavior analysis demonstrated that Young’s and flexural 
modulus of PCL/HAp-TiO2 composites were substantially higher than PCL/HAp 
composites. Therefore, this new synthesis methodology in scCO2 holds promise for bone 
tissue engineering with improved mechanical properties.  
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5.1 Introduction 
Hydroxyapatite (Ca10(PO4)6(OH)2, HAp) nanoparticles have attracted great interest, as 
their chemical and crystallographic structure is similar to the mineral phase of human 
hard tissues, bone and teeth.[1] HAp has shown excellent biocompatibility, bioactivity, 
and high osteo-conductivity. Thus, it has been extensively used in dental and medical 
applications such as reconstructive and prosthetic materials for bone and teeth.[1-3] 
However, the principal limitation in the clinical use of pure HAp as a load bearing 
implant is its intrinsic brittleness and poor mechanical properties in the presence of body 
fluids and under local loading.[4, 5] Generally, the size and morphology of the HAp 
particles have a direct influence on its ability to reinforce materials.[6] Mechanical 
properties of these HAp-based materials can potentially be improved by dispersing into 
them one dimensional nanostructures including nanorods, nanofibers, or nanotubes.[7, 8] 
It was previously shown that the morphology and size of HAp particles could be 
controlled by the presence of cetyltrimethylammonium bromide (CTAB) and 
polyethylene glycol (PEG) under hydrothermal conditions.[9, 10] Nevertheless, it is very 
challenging to prepare HAp nanogeometries, as  HAp nanoparticles tend to 
agglomerate.[5]  
On the other hand, immobilization of a biocompatible metal/metal oxide, such as Al2O3, 
ZrO2, SiO2, and TiO2 on the surface of the hydroxyapatite will enhance the mechanical 
properties of HAp along with enhancing cellular responses and biocompatibility.[11, 12] 
Among these HAp-based composites, HAp-TiO2 composites have attracted considerable 
attention due to the combined advantages of both materials. Namely TiO2 is capable of 
enhancing osteoblast adhesion[13] and inducing cell growth[14] by forming a chemical 
bond with the living tissue as well as the bioactivity of the HAp.  
These composite materials are suggested to demonstrate improved mechanical and 
physical properties compared to pure HAp ceramics. Therefore, HAp-TiO2 composite 
materials have recently been indicated for load-bearing biomedical applications.[15, 16] 
In addition, HAp-TiO2 composites are able to decompose both bacteria and organic 
materials, hence being beneficial in antibacterial applications.[17]  
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HAp-TiO2 composites have been prepared by different methods such as sol-gel,[18, 19] 
hydrothermal,[20] combined gravity/hydrothermal processing,[5] electrospinning 
method,[16] microwave-assisted co-precipitation process,[11, 21] and so on. However, 
obtaining a crystalline powder in most of these methods requires costly heat treatments at 
high temperatures or for long reaction periods. Besides, they are not environmentally 
friendly, and suffer scale-up problems.[11] Consequently, a more efficient synthetic 
methodology has been explored to prepare HAp-TiO2 composites. Previously, direct sol-
gel reactions in scCO2 have attracted much attention for synthesizing oxide nanomaterials 
of unique morphologies.[22, 23] Recently, the Charpentier group introduced a one-step 
sol-gel method to prepare TiO2 nanofibers and ZrO2-modified TiO2 nanotubes where 
scCO2 was used as the functional solvent for both self-assembly and as the drying 
agent.[24, 25] This method provides several advantages to tailoring the nanomorphology 
by "tuning" the  supercritical fluids temperature and/or pressure.[24, 26] Moreover, any 
unreacted starting materials can be safely removed from the synthesized products by 
supercritical fluid extraction (SFE) during the cleaning process, maintaining the porous 
nanostructure of the product while providing clean products suitable for biomedical 
applications.[25, 26]  
The aim of this study was to develop a new synthetic procedure for the synthesis of HAp-
TiO2 nanocomposites by combining co-precipitation and sol-gel method in scCO2. The 
nanosized HAp-TiO2 particles are examined as a reinforcing phase in polycaprolactone 
(PCL) matrix. PCL is a biocompatible and bioresorbable polyester used in numerous 
medical and drug delivery applications.[27, 28] The degradation kinetics and preservation 
of the mechanical properties make PCL an excellent candidate as a temporary joint 
spacer in total joint prostheses.[29] It was found that Young’s and flexural modulus of 
PCL/HAp-TiO2 composites are significantly higher than PCL/HAp composites confirmed 
by uniaxial tensile and flexural testings. In addition, X-ray absorption near-edge 
structures (XANES) spectroscopy that probes the local structure and bonding of the 
absorbing atoms by monitoring the absorption coefficient above the absorption edge 
using tunable X-rays from a synchrotron light source and provides information on 
oxidation states, coordination, and symmetry of the system was applied to study the 
composition of the HAp-TiO2 nanoparticles, showing that the weight ratio between 
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anatase TiO2 and HAp is about 1:1.6. These nanosized PCL/HAp-TiO2 composites are 
encouraging for the preparation of scaffolds for next generation bone tissue engineering 
applications. 
 
5.2 Experimental details 
5.2.1 Materials 
Calcium nitrate tetrahydrate (Ca(NO3)2.4H2O), diammonium hydrogen phosphate 
((NH4)2HPO4), cetyltrimethylammonium bromide (CTAB), and polyethylene glycol PEG 
400 were obtained from Sigma-Aldrich, Canada. All chemicals were of analytical grade 
or higher and used as received. Titanium isopropoxide (TIP, 99.999%) trace metals basis, 
glacial acetic acid (>99.7%), ammonium hydroxide (NH4OH, 30%), dichloromethane 
(DCM, 99.5%), anhydrous ethanol (EtOH), and polycaprolactone (PCL) (MW 80,000 
g/mol) were purchased from Sigma-Aldrich, Canada and used as received. 
5.2.2 Characterization 
The morphologies of the samples were examined using scanning electron microscopy 
(SEM, Hitachi S-4500) and transmission electron microscopy (TEM, JEOL 2010F) with 
a 200 keV Schottky field emission microscope (TEM/STEM). For SEM imaging, 
samples were prepared by applying the powder directly to a carbon adhesive tape. 
Samples were then coated with an ultrathin layer of gold to reduce charging problems. 
For TEM analysis, the powdered samples were dispersed in methanol by sonication for 1 
min, and then placed on a copper grid covered with holey carbon film, and dried by 
normal evaporation. The bulk composition and elemental analysis of the HAp-TiO2 
powders was analyzed using energy-dispersive Quartz XOne x-ray spectroscopy (EDX) 
attached to a Hitachi S-4500 field emission SEM on three fields of view (n=3). Structural 
analysis of the powders was performed using an Inel Powder Diffractometer. The 
instrument was equipped with a Cu-X-ray radiation Tube, an Inel XRG3000 generator 
and an Inel CPS 120 detector. The diffraction pattern data was processed with the IMAD 
146 
 
program and the MATCH Software, which was used for phase identification from 
powder diffraction data. ICDD PDF4+ database was used to search for reference patterns.  
The thermogravimetric analysis (TGA) was carried out to study the thermal 
decomposition behavior of the HAp and HAp-TiO2 nanocomposites. TGA analysis of the 
synthesized nanostructures was performed using a thermogravimetric analyzer, TA 
Instrument (TA-Q500), at a heating rate of 10 °C/min from room temperature to 1200 °C 
under flowing air. X-ray photoelectron spectroscopy (XPS) analyses were carried out 
with a Kratos Axis Ultra spectrometer using a monochromatic Al Kα source (15mA, 
14kV). Samples were mounted on a non-conductive double-sided adhesive tape. The 
Kratos charge neutralizer system was used on all specimens. Survey scan analyses were 
carried out with an analysis area of 300 x 700 microns and a pass energy of 160 eV. 
Spectra have been charge corrected to the main line of the carbon 1s spectrum set to 
284.8 eV. Spectra were analyzed using CasaXPS software (version 2.3.14).  
Synchrotron measurements were carried out at the high-resolution spherical grating 
monochromator (SGM) beamline at the Canadian Light Source (CLS), the University of 
Saskatchewan. The samples were mounted on conventional carbon tapes with an angle of 
20° facing toward the photon beam. XANES spectra were recorded in total electron yield 
(TEY) that was detected with the specimen current. All XANES spectra were normalized 
to the incident photon flux collected on a refreshed Au grid.  
The FTIR spectra of the samples were collected using a Bruker IFS 55 FTIR instrument 
with an attached MCT detector. Specimens were prepared by mixing 4 wt % of each 
sample with potassium bromide (KBr) and then pressing into a pellet. The spectra were 
recorded within the range of 400-4000 cm
-1
 with a resolution of 4 cm
-1
 over 32 scans. 
The specific surface areas and the average pores size of the powders were determined via 
Brunauer-Emmet-Teller method and Barret-Joyner-Halenda (BJH) analysis of BET 
isotherms using Tristar II 3020 (Micromeritics Instrument Corporation). All the samples 
were degassed at 150 °C for 12 h.  
Mechanical properties of PCL/HAp-TiO2 and PCL/HAp composites were determined 
using an Instron 5943 universal testing machine (Instron, Canton, MA) equipped with a 
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500 N (tension) load cell. For tensile testing, dogbone specimens with overall length of 
60 mm and width of grip section of 10 mm were prepared by slicing the PCL/HAp and 
PCL/HAp-TiO2 films and adding to a stainless steel mold. The mold was heated at 100 
°C for 30 min and heat-pressed at 100 °C and 670 N for 2 min. Prepared specimens were 
soaked in deionized water at 37 °C for 24 h prior to testing. Stress-strain relationships 
were obtained from the load and displacement data. The Young’s modulus was 
determined by calculating the slope of the linear portion of the stress-strain curve, and the 
tensile strength was defined as the maximum stress achieved. For each group, 5 
independent specimens (n=5) were tested in tension at a crosshead speed of 10 mm/min. 
Flexural strength and flexural modulus of the nanocomposites were determined in 
accordance with ASTM D790M-92 using a dynamic mechanical analyzer, DMA Q800 
(TA instruments). Flexural testing samples, rectangular bar specimens (n=5) (50 mm  25 
mm  2 mm), were prepared using the stainless steel mold heat-pressed following the 
same procedure as tensile testing specimens. Prepared specimens were soaked in 
deionized water at 37 °C for 24 h prior to testing, and placed on a three-point bending 
apparatus with two supports spanning 40 mm from each other and loaded at the cross-
head speed of 10 mm/min to the center of each specimen until failure. In an approach 
similar to that of tensile testing, flexural modulus was calculated as the slope of the initial 
linear region of the stress-strain curve, while flexural fracture strength was determined as 
the maximum applied stress prior to failure. 
 
5.2.3 Preparation of materials 
5.2.3.1 Preparation of HAp nanoparticles using a combined co-
precipitation and sol-gel method 
The reactant molar ratio of Ca
2+
/PO4
3-
 was kept at 1.67 (stoichiometric ratio of HAp). 
The general procedure is as follows: first, (NH4)2HPO4 (1.078 g, 0.008 mol) and CTAB 
(2.083 g, 0.0056 mole) were dissolved in 33.3 ml of deionized water. The solution was 
stirred for 30 min with a magnetic stirrer, then the pH value was adjusted to 4.5 by 
adding pure acetic acid. After this, Ca(NO3)2.4H2O (3.228 g, 0.0135 mol) was dissolved 
in 46.67 ml of deionized water and 6.67 ml of PEG 400 was simultaneously added to the 
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solution under constant stirring for 20 min. Then, the mixed solution of Ca(NO3)2·4H2O 
and PEG 400 was added to the latter dropwise under continuous magnetic stirring in air. 
The pH of the solution was then adjusted to 9 using ammonia. The final milky-white 
suspension was rigorously stirred at room temperature for 6 h. The resulting white 
precipitates were separated from the suspension by centrifuging, washed 3X with ethanol 
to remove the residual CTAB and PEG 400 and denoted as the HAp precursor (Figure 
5.1). To synthesize the HAp nanoplates in scCO2, HAp precursor (3 g) was dispersed in 
ethanol at the ratio of 1:1 by weight while vigorously stirring, and placed in a 10 mL 
stainless steel view cell reactor, followed by the addition of CO2 using a high pressure 
syringe pump (Isco 260D). The schematic diagram of the experimental setup can be 
found in Sui et al.[23] The temperature and pressure in the view cell were controlled to a 
range from 60 to 80 °C and 6000 psi as the optimized experimental conditions. The 
precursor was stirred for one day using a magnetic stirrer with TFE stir bar. Stirring was 
stopped after 24 h, while 4-5 days of aging were required for complete reaction. After 
aging, the formed gel was washed continuously using CO2 at a rate of approximately 0.5 
mL/min, followed by controlled venting at 0.5 mL/min to prevent collapse of the solid 
network. The as-prepared powder was kept in a vacuum oven at 80 °C to remove 
moisture. 
 
 
 
Ca(NO3)2.4 H2O (NH4)2HPO4PEG 400 CTAB Water Water 
Mixing pH adjustment to 4.5 
using acetic acid
Mixing
Adding calcium solution to 
phosphate solution (dropwise)
pH adjustment to 9 using ammonia 
Aging for 6 h, centrifuging, washing 
3 times with anhydrous ethanol
HAp-Precursor
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Figure 5.1. Schematic representation of the preparation of HAp precursor. 
5.2.3.2 Preparation of HAp-TiO2 nanocomposites using a combined co-
precipitation and sol-gel method  
In a typical experiment, the HAp precursor (1.5 g), prepared following the explained 
procedure in section 3.3.1 was dispersed in ethanol (1.5 g) and placed in a 10 mL high 
pressure view cell followed by quick addition of titanium isopropoxide (1 g) and acetic 
acid (4 g) and heated/pressurized with CO2 to the desired temperature and pressure. A 
magnetic stirrer with TFE stir bar was used for mixing the reaction mixture. The mixture 
of HAp precursor, titanium isopropoxide, and acetic acid was dispersed in supercritical 
CO2 at the studied temperature 80 °C and pressure range from 6000 to 8000 psi. The 
reaction was kept under continuous stirring for 24 h, and 5-6 days of aging were required 
for complete reaction, as shown in Figure 5.2. After aging, the formed gel was washed 
with CO2 followed by controlled venting at 0.5 mL/min. After CO2 extraction and 
venting, the resulting powders were subjected to further drying and calcination at 500 °C 
in air for 2 h using a heating rate of 10 °C/min and a cooling rate of 0.5 °C/min to room 
temperature.   
For comparison of XANES study, TiO2 nanoparticles were synthesized following the 
procedure presented in Salarian et al.,[30] and calcined at 450 °C and 750 °C. 
 
Figure 5.2. Schematic representation of sol-gel process for producing HAp-TiO2 
composites. 
Titanium 
isopropoxide
Acetic 
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Supercritical 
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TiO2-Sol
Mixing
HAp
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5.2.3.3 Preparation of HAp-TiO2 nanocomposites using hydrothermal 
technique 
Similar to the synthesis of HAp precursor, (NH4)2HPO4 (1.213 g, 0.009 mol) and CTAB 
(2.343 g, 0.0063 mol) were dissolved in 37.5 ml of deionized water, and the solution was 
stirred for 30 min with a magnetic stirrer followed by adjusting the pH value to 4.5 using 
acetic acid. After that, Ca(NO3)2·4H2O (3.632 g, 0.0152 mol) was dissolved in 52.5 ml of 
deionized water and 7.5 ml of PEG 400 was simultaneously added to the solution while 
stirring for 20 min. Then, the Ca(NO3)2·4H2O+PEG 400 solution was added to the 
(NH4)2HPO4+CTAB solution dropwise with constant stirring. Simultaneously, TIP (1 g) 
was mixed with acetic acid (6 g), and added dropwise to the reaction media (phosphate 
solution). Ammonia was used to adjust the solution pH to 11. The final suspension was 
transferred to a 125 ml stainless steel autoclave; then hydrothermally treated at 200 °C for 
24 h. After reaction, any precipitates were separated from the suspension by 
centrifugation at 5000 rpm for 10 min, washed 3X with ethanol, then freeze-dried to yield 
the product (white powder). 
5.2.3.4 Preparation of PCL/HAp-TiO2 and PCL/HAp composite  
In order to produce PCL/HAp composites, HAp powders synthesized in scCO2 were 
added to dichloromethane (DCM) and then stirred for 15 min, followed by sonication for 
5 min. PCL was then added to the HAp/DCM suspension to produce a PCL/HAp slurry 
containing the following ratios PCL:HAp (w/w): 90:10, 80:20, and 70:30. The PCL/HAp 
slurry was cast in a glass dish, and the solvent evaporated in a fume hood. Finally, the 
resulting PCL/HAp films were heat-pressed at 100 °C and 670 N for 2 min. PCL/HAp-
TiO2 specimens were prepared following the same procedure using HAp-TiO2 powders 
synthesized by combined co-precipitation and sol-gel method and hydrothermal 
treatment. 
5.3 Results and Discussion 
5.3.1 SEM and TEM characterization of the as-synthesized HAp and 
calcined HAp-TiO2 composites powders  
The experimental conditions and characterization results for the as-synthesized HAp and 
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calcined HAp-TiO2 composites powders are provided in Table 5.1.  
Table 5.1. Synthesis conditions of HAp and HAp-TiO2 nanostructures in scCO2 and 
characterization results (morphology and BET surface area). 
 Temperature 
[°C] 
Pressure 
[psi] 
C0 (TIP) 
[mol l
-1
] 
(AcOH/TIP) 
weight ratio 
BET 
[m
2
 g
-1
] 
Morphology 
TiO2 60 6000 1.1 4 111 Nanofiber-
Nanotube 
HAp-1 60 6000 - - 60 Nanoplate 
HAp-2 80 6000 - - 72 Nanoplate 
HAp-TiO2-
1 
80 6000 1.1 4 100 Nanoplate-
Thick sheet 
type structure 
HAp-TiO2-
2 
80 6000 1.5 4 170 Nanoplate on 
the surface of 
Nanorods 
HAp-TiO2-
3 
80 8000 1.5 4 108 
 
Nanoplate-
Nanorods 
HAp-TiO2-
h 
Hydrothermal treatment at 200 °C for 24 hours 98 Oblong-shaped 
 
SEM micrographs of the synthesized materials (Figure 5.3(a-f)) and TEM images of 
HAp-TiO2-2 and HAp-TiO2-h nanocomposite (Figure 5.3g&h) show that the HAp and 
the HAp-TiO2 composites powders were composed of various nanostructures. SEM 
image of the TiO2 nanoparticles calcined at 450 °C are shown in Figure 5.3a indicating 
the formation of tube-like and fiber-like structure. More detailed information on the 
experimental procedure of these TiO2 nanoparticles are presented in Salarian et al.[30] 
Figure 5.3b&c show the plate-like particles of samples HAp-1 (150-250 nm in width) and 
HAp-2 (40-100 nm in width), synthesized in ScCO2 using a system pressure of 6000 psi 
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at 60 °C and at 80 °C, respectively. In general, we found slight changes in the 
morphology and dimensions of the particulates when adjusting the reaction temperature 
from 60 to 80 °C, although the higher studied reaction temperature (80 °C) gave 
nanoplates with smaller dimensions and higher surface areas. SEM analysis of the 
composite samples revealed that the initial concentration of TIP had a significant 
influence on the morphology of the synthesized nanocomposites. Typically, at 80 °C and 
6000 psi with initial concentration of 1.1 mol l
-1
  TIP (HAp-TiO2-1), HAp nanoplates 
with 50-200 nm width and TiO2 particles having a thick sheet-type structure with 200 nm 
width and 1-2 μm length were obtained (Figure 5.3d). At higher TIP concentration (1.5 
mol/l), HAp nanoplates were formed on the surface of well-separated TiO2 nanorods with 
a diameter of about 50-300 nm and lengths from 1 to 4 μm, as seen in the SE  and TE  
images of HAp-TiO2-2 given in Figure 3.3 e&g. The effect of the reaction pressure on the 
morphology of the nanocomposites was studied by varying the pressure from 6000 to 
8000 psi, while keeping the temperature at 80 °C and the initial TIP concentration of 1.5 
mol l
-1
. SEM analysis of the HAp-TiO2-3 (prepared at 8000 psi) revealed that the scCO2 
pressure did not have a significant effect on the morphology of the synthesized 
particulates (data not shown here). On the other hand, using the hydrothermal technique 
resulted in the formation of oblong-shaped particles, as shown in Figure 5.3f&h. 
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Figure 5.3. SEM images of the (a) TiO2 nanotubes calcined at 450 °C, (b) as-prepared 
HAp-1 nanoplates, (c) as-prepared HAp-2 nanoplates, (d) HAp-TiO2-1 nanocomposites 
calcined at 500 °C, (e) HAp-TiO2-2 nanocomposites calcined at 500 °C, and (f) HAp-
TiO2-h nanocomposites and TEM images of (g) HAp-TiO2-2 nanocomposites calcined at 
500 °C and (h) HAp-TiO2-h nanocomposites. Arrows in Figure 5.3c indicate the voids 
between aggregates of plate-like HAp secondary particles. 
5.3.2 EDS analysis of HAp and HAp-TiO2 nanocomposites  
To provide additional information on elemental analysis for the synthesized HAp-TiO2 
nanocomposites, energy-dispersive spectroscopy (EDS) was used to map Ca, P, Ti, and 
O. EDS is a widely utilized tool for bulk elemental analysis of samples where the X-rays 
are generated in a region about 2 µm in depth. Figure 5.4 and Figure 5.5 clearly 
demonstrate the presence of Ca, P, Ti, and O in the nanocomposites. From the EDS 
elemental mapping of HAp-TiO2-2 nanocomposites (Figure 5.4), the rod like morphology 
shows the presence of Ti, the major elemental component of TiO2, in the composites 
(Figure 5.4c). It can also be seen that Ca (Figure 5.4e) and P (Figure 5.4d), found 
exclusively in HAp, are uniformly distributed on the surface of the TiO2 rods. This 
further confirms that the nanoplates are HAp grown on the surface of TiO2 rods.  
 
Figure 5.4. EDS elemental mapping of HAp-TiO2-2 nanocomposites: (a) selected area on 
the sample, (b) O mapping, (c) Ti mapping, (d) P mapping, and (e) Ca mapping. 
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EDX elemental mapping of HAp-TiO2-h nanocomposites demonstrates a relatively 
homogeneous distribution of Ti (Figure 5.5c), P (Figure 5.5d), and Ca (Figure 5.5e) 
throughout the composite material. Thus, it can also be concluded that the oblong-shaped 
particles of TiO2 and HAp are uniformly and homogeneously distributed within the 
synthesized nanocomposites.  
 
Figure 5.5. EDS elemental mapping of HAp-TiO2-h nanocomposites: (a) selected area on 
the sample, (b) O mapping, (c) Ti mapping, (d) P mapping, and (e) Ca mapping. 
The EDX spectra for HAp-2 and HAp-TiO2-2 are shown in Figure 5.6. The investigation 
confirms the existence of Ca, P, O, and C elements for HAp-2 (Figure 5.6a) and Ca, P, O, 
Ti, and C elements in the synthesized HAp-TiO2-2 nanocomposites (Figure 5.6b). 
Calcium to phosphorus (Ca/P) atomic ratio of HAp-1 and HAp-2 powders (Table 5.2) 
indicates a predominately stoichiometric HAp crystal (Ca/P≈1.67). In addition, there was 
no significant difference among the Ca/P ratios of the HAp-TiO2 nanocomposites 
synthesized at different conditions (reaction temperature, reaction pressure, and initial 
concentration of TIP) and HAp-TiO2-h nanocomposites, exhibiting a lowered Ca/P 
atomic ratio, likely reflecting higher PO4
3-
 content. 
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Figure 5.6. EDX spectra of the (a) HAp-2 and (b) HAp-TiO2-2 nanocomposites. 
 
Table 5.2. Ca/P atomic ratio of HAp powders and HAp-TiO2 nanocomposites. 
 Atomic % 
Ca P Ca/P Ti 
HAp-1 21.9 ± 1.2 13.45 ± 1.7 1.63 ± 0.06 - 
HAp-2 24.7 ± 2.3 14.97 ± 1.3 1.65 ± 0.06 - 
HAp-TiO2-1 27.36 ± 1.8 17.2 ± 1.6 1.59 ± 0.04 5.8 ± 1.2 
HAp-TiO2-2 27.6 ± 1.9 17.81 ± 1.3 1.53 ± 0.02 7.8 ± 1.1 
HAp-TiO2-3 25.08 ± 2.2 16.5 ± 1.8 1.52 ± 0.05 5.9 ± 0.08 
HAp-TiO2-h 21.85 ± 1.4 14.64 ± 0.9 1.49 ± 0.02 4.88 ± 0.06 
 
5.3.3 XRD analysis of HAp and HAp-TiO2 nanocomposites 
Figure 5.7 shows the XRD patterns for the HAp-2 and HAp-TiO2-2 and HAp-TiO2-h 
nanocomposites in the 2θ range of 10-70°. In the XRD pattern of HAp-2 (Figure 5.7a), all 
the diffraction peaks correspond to hexagonal HAp according to JCPDS: 09-432.[5] No 
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impurities are observed in the pattern, indicating pure HAp. In Figure 5.7b&c (for HAp-
TiO2 nanocomposites), the XRD patterns show all the diffraction peaks for HAp, along 
with new intensive peaks at 2θ ≈ 25.2°, 37.7°, 53.8°, and 55° (shown by filled triangles) 
which are the prominent characteristic peaks of anatase TiO2 assigned to the diffraction 
of (101), (004), (105), and (211) planes of TiO2 anatase phase, respectively, confirming 
the incorporation of titania into the HAp matrix. This perfectly coincides with the anatase 
TiO2 JCPDS card data (file No: 21-1272). Meanwhile, the peak at 47.9° is consistent with 
(213) Bragg reflection of HAp and (200) plane of TiO2 anatase.[5, 21, 31] From the XRD 
patterns, it can be concluded that the unique HAp-TiO2 nanocomposites maintain HAp 
crystal phase without phase transformation. Under the examined experimental conditions, 
the HAp precursor is stable, with TIP precursors grown to form anatase TiO2 rod-like 
crystals. For the composite samples it can also be observed that the intensity of the TiO2 
peaks increases with the increase of the TiO2 content, while the intensity of the HAp 
peaks decreases, as distinguishable in the XRD pattern of HAp-TiO2-2 nanocomposites 
shown in Figure 4b compared to the HAp-TiO2-h nanocomposite (Figure 5.7c). 
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Figure 5.7. XRD patterns of the (a) HAp-2, (b) HAp-TiO2-2, and (c) HAp-TiO2-h 
nanocomposites. In Figure 5.7b&c, filled triangles are representing the prominent 
characteristic peaks of anatase TiO2. 
5.3.4 FTIR spectroscopy of HAp and HAp-TiO2 nanocomposites 
The synthesized HAp and HAp-TiO2 nanocomposites were also analyzed by means of 
FTIR. The FTIR spectra of HAp-2 nanoplates and HAp-TiO2-2 and HAp-TiO2-h 
nanocomposites are displayed in Figure 5.8. Several characteristic peaks of HAp are 
present in all the three spectra at 3570, 1095, 1034, 962, 633, 602, and 565 cm
-1
. The 
peaks at 3570 and 633 cm
-1
 are attributed to the stretching and libration bands originating 
from the OH
-
 ion, respectively while the characteristic bands of PO4
3-
 ion appear at 1095 
and 1034 (υ3), 962 (υ1), 602 and 565 cm
-1
 (υ4).[32-34] The well-preserved characteristic 
peaks of HAp in the spectra of HAp-TiO2 nanocomposites suggest no significant 
structural change or transformation of HAp during the formation of the HAp-TiO2 
nanocomposites. This is fairly difficult to attain by using other synthesis methods, 
confirming the superior temperature control provided by the proposed synthesis method 
for HAp-TiO2 nanocomposites. The broad peaks at 3429 and 1635 cm
-1
 in Figure 3.8 a 
are attributable to the O-H stretching and bending modes of the surface-absorbed water, 
respectively. These peaks became more evident in the spectra of the synthesized HAp-
TiO2 nanocomposites (Figure 5.8b&c), maybe also attributable to the structural hydroxyl 
group in the nano TiO2.[35] In comparison to the spectrum of HAp (Figure 5.8a), there is 
an extra broad peak in the region of 600-800 cm
-1
 in the spectra of HAp-TiO2 
nanocomposites (Figure 5.8b&c), with the spectrum of HAp-TiO2-2 (Figure 5.8b) being 
more evident. This broad peak may be due to the Ti-O-Ti band of TiO2 as revealed by 
XRD.[36] Hence, these FTIR results confirmed the presence of TiO2 with intact HAp in 
the synthesized HAp-TiO2 nanocomposites. 
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Figure 5.8. Fourier transform infrared (FTIR) spectroscopy of the (a) HAp-2, (b) HAp-
TiO2-2, and (c) HAp-TiO2-h nanocomposites. 
5.3.5 BET analysis of HAp and HAp-TiO2 nanocomposites 
synthesized in supercritical CO2     
The N2 adsorption-desorption isotherms of the pure HAp-2 and HAp-TiO2-2 
nanocomposites are plotted in Figure 5.9a&b, respectively. Both isotherms correspond to 
type IV isotherms (IUPAC classification) with a capillary condensation step above 0.4 
P/P0, which is typical of mesoporous structures.[37, 38] According to the IUPAC 
classification, the isotherms have a type H3 hysteresis loop with the continuous nitrogen 
uptake at very high relative pressure that is associated with aggregates of plate-like HAp 
particles giving rise to slit-shaped pores.[39] The HAp-TiO2 nanocomposites show 
significantly higher specific surface area, close to 170 m
2
/g with very homogeneous 
mesopores that are clearly distinguished from the macropores as confirmed by its N2 
physisorption isotherm (Figure 5.9b). The adsorption in the low relative pressure region 
is a consequence of adsorption in micropores. The first hysteresis loop in the P/P0 range 
of 0.4-0.6 corresponds to the small size mesopores generated from the void space 
between the HAp crystallites.[39] Moreover, it exhibits another distinguished steep 
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increase in the adsorption starting at P/P0 of 0.8. This nitrogen uptake at very high 
relative pressure corresponds to the formation of macropores that start filling only at high 
P/P0, close to 1.0. The observed macroporosity can be referred to the voids between 
agglomerate of plate-like HAp primary particles, voids between the secondary 
particles.[40] Pure HAp-2 exhibits surface area of about 72 m
2
/g, and compared with 
HAp-TiO2 nanocomposites it showed a wide distribution of the pores and larger average 
pore diameter as shown in Figure 5.9a. The capillary condensation step is much 
pronounced and shifted to higher relative pressures, 0.6-0.8, for pure HAp with respect to 
HAp-TiO2 composite, which reveals the dominance of larger mesopores.[37] The SEM 
micrographs of pure HAp, Figure 5.3c, show aggregates of porous secondary particles. 
Compared with HAp-TiO2 composite, the aggregates are larger, 0.3-0.8 μm, indicating 
the presence of larger and less homogeneous macropores. Therefore, it is suggested that 
in the case of HAp-TiO2 nanocomposite, the HAp agglomerates forming the slit like 
pores tend to diminish in population and size. Also, the volume of the intercrystallite 
HAp space is reduced, so it could be concluded that the mesopore size of HAp is altered 
upon formation of TiO2. Farhangi and Charpentier synthesized TiO2 nanowires on the 
graphene sheets in scCO2, reporting similar results.[41] 
 
Figure 5.9.
 
N2 adsorption/desorption isotherm of the (a) HAp-2 and (b) HAp-TiO2-2 
nanocomposites. 
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5.3.6 XPS measurements of HAp and HAp-TiO2 nanocomposites 
synthesized in supercritical CO2     
During the A chemical analysis of the HAp and HAp-TiO2 samples was performed using 
XPS, and the core level spectra obtained for the samples of HAp-2 and HAp-TiO2-2 are 
depicted in Figure 5.10. As illustrated in the survey scans (Figure 5.10a&e), the only 
elements detected on the surface are Ca, P, O, and C for HAp-2 and Ca, P, O, Ti, and C 
for HAp-TiO2-2 nanocomposites. The respective atomic percentages of those elements 
are given in Table 5.3. No contaminant element other than carbon was detected. The 
carbon concentration of 11.3 and 11.9% observed in HAp-2 and HAp-TiO2-2 composites, 
respectively, is typical for organic contamination levels on clean surfaces.[18] This 
contamination could be resulted from the chemisorption of CO2 molecules from the 
atmosphere and from the reaction under ScCO2, unreacted acetic acid, and washing with 
ScCO2. In the recorded spectrum for HAp-2, the high resolution XPS scan of the Ca 2p 
region (Figure 5.10b) could be resolved into two peaks for Ca 2p1/2 and Ca 2p3/2 at 
binding energies of 350.80 eV and 347.28 eV, respectively, which are related to 
hydroxyapatite. In the high resolution P 2p XPS scan of HAp (Figure 5.10c), two peaks 
for P 2p1/2 and P 2p3/2 are observed at 134.99 eV and 133.15 eV, respectively, which 
correspond to P in hydroxyapatite. Figure 5.10d shows the core level spectrum of O 1s, 
and the peaks at binding energies of 532.93 eV and 531.12 eV are attributed to the 
adsorbed water in hydroxyapatite crystal and phosphate group, respectively.[11] The 
calculated Ca/O and Ca/P ratios for the HAp-2 are 0.34 and 1.62, respectively, which are 
very close to the theoretical values of 0.38 and 1.67 for HAp. The high resolution XPS 
record of Ca 2p region of HAp-TiO2 (Figure 5.10f) shows peaks for Ca 2p1/2 and Ca 
2p3/2 at bonding energies of 350.99 eV and 347.44 eV, respectively, and that of P 2p 
represents two peaks for P 2p1/2 and P 2p3/2 at 134.12 eV and 133.28 eV, respectively 
(Figure 5.10g). These peak positions coincide well with the Ca and P in hydroxyapatite, 
as explained earlier, and only the negligible difference in binding energies of Ca 2p and P 
2p core levels indicates the formation of HAp with similar stoichiometries in both HAp-2 
and HAp-TiO2-2 nanocomposite. The O 1s XPS spectrum (Figure 5.10h) could be 
deconvoluted into three distinct peaks indicating the presence of multiple O species on 
the surface.[42] The sub-peak at binding energy of 529.59 eV is assigned to the lattice 
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oxygen atoms TiO2 (Ti-O bonds), while the sub-peak peak at 533.36 corresponds to 
adsorbed water in HAp crystal, and the other peak at 531.41 eV is due to contribution of 
OH
-
 groups on the surface, phosphate group, and/or defective oxide sites. In Figure 5.10, 
the core level spectrum of Ti 2p could be resolved into two spin-orbit pairs of 2p3/2 and 
2p1/2 with binding energies of 458.35 eV and 464.02 eV, respectively, which are 
attributed to Ti in the 4+ state.[43] Therefore, the Ti detected in TiO2-HAp 
nanocomposites is only the oxide (TiO2) derived from the TIP hydrolyzed in the 
synthesis procedure. These XPS results confirm the formation of hydroxyapatite and 
titania in the HAp-TiO2 nanocomposites, and also indicate that the HAp-TiO2 
nanocomposite is stable under the reaction conditions. The calculated Ca/O and Ca/P 
ratios for the HAp-TiO2-2 composite are 0.3 and 1.43, respectively. The obtained Ca/O 
and Ca/P ratios can be considered close to the theoretical ones, as the XPS information is 
mediated on the analyzed area constituted by TiO2 and HAp.[18] Consequently, due to 
the matrix effect, the intensity and the resolution of the Ca 2p and P 2p signals in both 
HAp-2 and HAp-TiO2-2 composite samples are lower than the ones detected for the same 
elements in stoichiometric HAp powder.  
Table 5.3. Atomic percentage of the elements detected in the HAp-2 and HAp-TiO2-2 
samples. 
 Atomic % 
Ca  P  O  C Ti 
HAp-2 19.3 11.9 57.5 11.3 - 
TiO2-HAp-2 15.2 10.6 57.9 11.9 4.5 
TiO2 HAp, OH 
6.72 51.18 
 
Compared to the theoretical value for Ca/O ratio, 0.38, the calculated Ca/O ratio for the 
HAp-TiO2-2 composite corresponds to the oxygen excess that could be attributed to the 
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presence of OH groups on the surface. It is reported that the hydroxyl groups, such as Ti-
OH, remain in the sol-gel prepared materials promoting the osteointegration process [18]. 
Therefore, from the XPS results it could be suggested that the prepared HAp-TiO2 
composites may exhibit enhanced bioactive properties. In order to confirm this 
hypothesis, a study of in vitro biocompatibility of the synthesized nanocomposites is 
planned as the next stage for this work.   
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Figure 5.10.
 
 (a) XPS survey spectrum of the HAp-2 and core level spectra of (b) Ca 2p, 
(c) P 2p, and (d) O 1s recorded from the HAp-2 and (e) XPS survey spectrum of the 
HAp-TiO2-2 and core level spectra of (f) Ca 2p, (g) P 2p, (h) O 1s, and (i) Ti 2p recorded 
from the HAp-TiO2-2. 
5.3.7 XANES spectroscopies of TiO2, HAp, and HAp-TiO2 
nanocomposites synthesized in supercritical CO2     
Figure 5.11 shows the Ti L3,2-edge XANES of the HAp-TiO2-2 nanocomposites in 
comparison with TiO2 nanoparticles synthesized in supercritical CO2 following the 
procedure presented in Salarian et al.[30] after calcination at 450 °C and 750 °C as 
standard samples. X-ray diffraction studies of the TiO2 nanoparticles showed that the as-
prepared materials transferred from the amorphous to anatase phase during heat treatment 
at 450 °C, while after calcination at 750 °C the transformation from anatase to rutile 
occurs (data not shown here). Characteristic features of TiO2 can be observed that arise 
from the transitions of Ti 2p electrons to unoccupied 3d electronic states. From the 
XANES spectra of TiO2 standard samples, the peaks in the spectra can be understood as 
due to the crystal field splitting of the d orbitals into t2g and eg under Oh symmetry 
followed by local distortion resulting in a local symmetry of D2d and D2h for anatase 
(TiO2 nanoparticles calcined at 450 °C) and rutile (TiO2 nanoparticles calcined at 750 
°C), respectively. It can be seen that the most significant difference is the intensity ratio 
of peak a and b, i.e. a is more intense than b in anatase (Figure 5.11a), but in rutile 
(Figure 5.11b) this is reversed. The lowering of the Oh symmetry to D2d and D2h leads to 
the 2p→eg transition further splitting into peak a and b at the L3-edge. The eg state is 
more sensitive to the variation in symmetry; and thus, anatase and rutile phases can be 
tracked by the relative ratio of peaks a and b.[44, 45] The spectrum of the HAp-TiO2-2 
nanocomposites (Figure 5.11c) shows well-resolved features of the anatase phase, as can 
be immediately identified by the intensity ratio between a and b. It indicates that the TiO2 
in the nanocomposites is of anatase phase, which is consistent with the XRD results. 
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Figure 5.11. Ti L3,2-edge XANES spectra of the (a) TiO2 nanoparticles calcined at 450 
°C, (b) TiO2 nanoparticles calcined at 750 °C, and (c) HAp-TiO2-2 nanocomposite. 
Figure 5.12 shows the Ca L3,2-edge XANES spectra of the HAp-TiO2-2 nanocomposites 
and HAp-2 powders. Sharp peaks at 351.4 and 354.7 eV are observed, which come from 
the transitions of 2p3/2 and 2p1/2 electrons to the empty 3d state of Ca
2+
 ion that yields this 
spin-orbit doublet. The XANES spectrum of HAp-TiO2-2 nanocomposites (Figure 5.12b) 
shows the same features to that of HAp-2 (Figure 5.12a), indicating that HAp was formed 
in the sample. Ca L3,2-edge XANES results agree with the XRD results. 
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Figure 5.12. Ca L3,2-edge XANES spectra of the (a) HAp and (b) HAp-TiO2-2 
nanocomposite powders. 
Figure 5.13(I) shows the O K-edge XANES spectra of the HAp-TiO2-2 nanocomposites 
in comparison with HAp-2, anatase, and rutile TiO2. The peaks are from the transitions of 
O 1s to 2p (for TiO2, O 2p states are hybridized with Ti 3d states). It can be seen that the 
spectrum of the HAp-TiO2-2 nanocomposites (Figure 5.13(I) b) shows the features of 
both anatase TiO2 and HAp (e.g.: peaks a and c are from anatase TiO2, and peaks b, d, 
and e are from HAp). It agrees well with the Ti L3,2-edge and Ca L3,2-edge XANES 
results, confirming that the prepared sample contains both anatase TiO2 and HAp. Since 
the edge jump of the XANES spectrum is proportional to the quantities of the sample, the 
compositional fractions of the HAp-TiO2-2 nanocomposites can be obtained by fitting a 
linear combination of the spectra of their components to that of the composites. Figure 
5.13(II) displays the linear fitting results of the HAp-TiO2-2 nanocomposites. The fitting 
curve (red dash-dotted curve) is in good agreement with the experimental data (black 
solid curve), illustrating that the weight ratio between anatase TiO2 and HAp is about 
1:1.6. This also implies that the nanocomposite is uniform in the area being probedwhich 
are essentially at the same retention times as that of the reference sample. 
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Figure 5.13. (I) O K-edge XANES spectra of the (b) HAp-TiO2-2 nanocomposites in 
comparison with (b) HAp-2, (c) TiO2 nanoparticles calcined at 450 °C, and (d) TiO2 
nanoparticles calcined at 750 °C. (II) O K-edge linear fitting of the HAp-TiO2-2  
nanocomposites. 
5.3.8 TGA of HAp and HAp-TiO2 nanocomposites 
The thermal analysis of the HAp-2 powder and HAp-TiO2-2 and HAp-TiO2-h   
nanocomposites was performed under flowing air from room temperature to 1200 °C by 
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TGA, as illustrated in Figure 5.14. The TGA curve of pure HAp is divided into four 
stages based on heating in air, as illustrated in Figure 5.14a. The first stage from room 
temperature to 240 °C corresponds to the evaporation of the physically absorbed water of 
the product. The second stage is from 240 to 440 °C, which is attributed to the 
combustion and carbonization of organic substance such as CTAB and unreacted acetic 
acid. The third stage from 440 to 550 °C is caused by the decomposition of residual 
organic materials. The forth stage took place between 550-1100 °C with a peak at 800 °C, 
which is due to the partial decomposition of HAp to low-temperature phase of tricalcium 
phosphate (β-TCP). It has been reported that HAp is likely to decompose at 800-900 °C 
in air and 950 °C in vacuum,[46, 47] and the following chemical reaction is proposed: 
Ca10(PO4)6(OH)2 = CaO + 3Ca3(PO4)2 + H2O (g)                                                     (1) 
For TiO2-HAp nanocomposites, the increase in peak area of the peak at 800 °C as 
compared to pure HAp is due to both the partial dissociation of HAp to TCP as well as 
the conversion of anatase TiO2 to the rutile phase of TiO2 crystal, as the transformation 
from anatase to rutile occurs at temperatures between 400 and 1000 °C.[12] Moreover, it 
has been reported that the reaction between HAp and TiO2 is feasible and expected to 
happen at the temperature above ~750 °C, and β-TCP and CaTiO3 are formed.[47] The 
related chemical reaction is as follows:  
Ca10(PO4)6(OH)2 + TiO2 = 3Ca3(PO4)2 + CaTiO3 + H2O (g)                                      (2) 
There is another possibility of formation of TCP through the direct dissociation of HAp, 
as it can dissociate to Ca-orthophosphate and TCP by the following reaction: 
Ca10(PO4)6(OH)2 = 2Ca3(PO4)2  + Ca4O(PO4)2 + H2O (g)                                          (3) 
And the Ca-orthophosphate formed as a result of reaction (3) subsequently reacts with 
TiO2 leading to the formation of TCP and CaTiO3.[47] The suggested reaction could be: 
Ca4O(PO4)2 + TiO2 = CaTiO3 + Ca3(PO4)2                                                                   (4) 
From the above discussion, the weight changes in this region should therefore be 
correlated with TiO2 phase transformation and TCP and CaTiO3 formation (Eq. 2, 3, and 
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4). Since TCP formation is widely reported in all the HAp-TiO2 compositions at or above 
900 °C, it is highly likely that the weight loss must be due to TCP formation by reaction 
(Eq. 2), while CaTiO3 formation does not produce recordable weight change. In any case, 
the CaTiO3 formation can be described by two possible reactions (Eq. 2, 4). So, it could 
be concluded that the presence of the titania modifies the thermal behavior with respect to 
the pure HAp.  
 
Figure 5.14. TGA spectrum of (a) HAp-2, (b) HAp-TiO2-2 nanocomposites, and (c) 
HAp-TiO2-h nanocomposites. 
5.3.9 Mechanical properties of PCL/HAp and PCL/HAp-TiO2 
composites  
The Young’s modulus and tensile strength of PCL/HAp and PCL/HAp-TiO2 composites 
comprising 0-30% (w/w) HAp and HAp-TiO2 synthesized by the combined co-
precipitation and sol-gel method and hydrothermal process were investigated. An 
exponential increase in the Young’s modulus of PCL/HAp-2 and PCL/HAp-TiO2-2 was 
observed with the increase in HAp-2 and HAp-TiO2-2 concentrations, respectively. For 
example, the 20% (w/w) HAp-TiO2-2 added composite possesses the highest Young’s 
modulus with more than a 4-fold increase from 155.2 MPa for PCL alone to 665.5 MPa. 
Therefore, it could be concluded that the growth of titania nanorods followed by HAp 
deposition on the surface of the TiO2 nanorods in supercritical CO2 highly influences the 
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mechanical properties of reinforced composites. Moreover, the ultimate tensile strength 
showed little variation between examined material groups, while a noticeable trend was 
observed with respect to loading concentration. It was shown that the tensile strength of 
PCL/HAp decreased from 9.3 for unfilled PCL to 6.47 MPa for PCL/HAp with 
increasing the amount of filler, HAp-2, to 30%. In other words, the greater HAp-2 
content results in an increase in the brittle nature of the composites. On the contrary, an 
exponential increase in the tensile strength of PCL/HAp-TiO2 composites to 11.97 and 
15.76 MPa for specimens containing 10-20% (w/w) HAp-TiO2 occurred. On the other 
hand, compared to PCL/HAp-TiO2-h composite specimen containing 20% (w/w) HAp-
TiO2-h, PCL/HAp-TiO2-2 composite clearly exhibits higher modulus and higher 
maximum tensile strength. The strengthening effects observed for PCL/HAp-TiO2-2 
composite over the PCL/HAp-TiO2-h composition were concluded to be due to the 
morphology, size and, the preferred orientation. The comparison of the mechanical 
properties of our resulting nanocomposites to the work of others is complicated by the 
different measurement techniques utilized, although compared to cortical and cancellous 
bone, the tensile strength of our PCL/HAp-TiO2-2 composites is considered to be 
sufficient enough to preserve their structure and mechanical integrity for predictable 
times, even under load-bearing conditions.  
In addition, flexural modulus and flexural strength values of composites reflect its 
resistance to flexural loading which is a combination of tension and compression forces. 
Similarly, dramatic reinforcements in the flexural properties (FS and FM) were achieved 
for PCL/HAp-TiO2-2 composites, as evident in Table 5.4. PCL/HAp-TiO2-2 composite 
formulation containing 20 wt% HAp-TiO2-2 exhibited a roughly 3-fold increase in 
flexural modulus and 2-fold increase in flexural strength compared to blank PCL. This 
extraordinary mechanical reinforcement provided by PCL/HAp-TiO2-2 composites 
exceeded the enhancements observed with PCL/HAp-2 composites, indicating the 
importance of mechanical coupling between the TiO2 nanorods and the PCL matrix.  
The SEM micrographs of the fracture surfaces of the PCL/HAp-TiO2 nanocomposite 
loaded with 20 wt% HAp-TiO2 are shown in Figure 5.15. It can be seen that the 
nanocomposite loaded with 20 wt% HAp-TiO2 exhibited a rough surface with partially 
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broken or pulled out TiO2 rod like structures on their surface, shown by the arrows in 
Figure 5.15b. This nanorod “pull out” effect may significantly increase the work of 
fracture due to interfacial friction between the TiO2 nanorods and matrix resulting from 
the high surface area of the nanorods and the strong interfacial shear strength between the 
TiO2 nanorods and PCL matrix. Moreover, it is clear from Figure 5.15b and d that there 
is a strong adhesion between the HAp-TiO2 and PCL matrix, as these partially pulled out 
TiO2 nanorods take part in bridging the crack during propagation and bridge the cracks in 
the matrix, seen in Figure 5.15c. Conversely, the unfilled PCL matrix displays a very 
smooth fracture plane with the cracks propagating without any hindrance (data not shown 
here). 
 
Figure 5.15. SEM images of the fracture surfaces of (a) PCL/HAp and (b-d) PCL/HAp-
TiO2 containing 20 wt% HAp and HAp-TiO2, respectively. Short arrows indicate 
nanorods pullout and the long arrows indicate crack bridging by the TiO2 nanorods. 
 
Table 5.4. Mechanical Properties of PCL/HAp and PCL/HAp-TiO2 composites. 
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PCL:HAp-
TiO2- 2 
(w/w) 
PCL: HAp-
TiO2- h 
(w/w) 
Young’s 
modulus 
(MPa)  
Tensile 
strength 
(MPa) 
Flexural 
modulus 
(MPa)  
Flexural 
strength 
(MPa)  
100:0 - - 155.2 ± 24.5 9.3 ± 2.9 247 ± 28.5 13.2 ± 1.6 
90:10 - - 379.6 ± 16.1 10.9 ± 2.5 551 ± 16.8 16.3 ± 0.3 
80:20 - - 352.8 ± 16.3 7.1 ± 0.9 485.8 ± 23.6 16.6 ± 2.2 
70:30 - - 238.2 ± 11.5 6.47 ± 1.4 425 ± 32.7 11.4 ± 0.6 
- 90:10 - 355.2 ± 13.2 11.97 ± 3.6 744.6 ± 25.8 18.23 ± 2.62 
- 80:20 - 665.5 ± 24.6 15.76 ± 0.9 716.3 ± 14.6 26.5 ± 0.7 
- 70:30 - 467 ± 6 11.51 ± 1.9 512 ± 24.3 17.4 ± 0.9 
- - 100:20 241.8± 25.6 6.24 ± 1.9 423.6 ± 35.4 10.8 ± 1.7 
 
5.4 Conclusions 
A novel combined co-precipitation and sol-gel method in the green solvent, supercritical 
carbon dioxide (scCO2), was successfully applied to derive an innovative HAp-titania 
bioceramic with excellent chemical and structural uniformity. PCL/HAp-TiO2 
composites with significantly improved physical and mechanical properties suitable for 
tissue engineering was designed as described above. Our results showed that the 
morphology of the HAp-TiO2 composites could be tailored by changing the initial 
concentration of TIP and the reaction temperature. The formed HAp-TiO2 
nanocomposites with a higher surface area and greater thermal stability compared to HAp 
nanoparticles are particularly attractive as reinforcing fillers for biodegradable synthetic 
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polymers. With a loading of 20% (w/w) TiO2-HAp, the obtained nanocomposites 
exhibited a tensile modulus of 665.5 MPa, which is more than a 4-fold increase compared 
to blank polymer. The presented work suggests that PCL/HAp-TiO2 nanocomposites may 
be synthesized to match the mechanical properties of bone, and thus demonstrates the 
potential for their use in orthopedic and dental implant materials. 
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Chapter 6  
 
6 Conclusions and Recommendations 
 
6.1 Conclusions 
 
The need for biodegradable polymer composite materials for bone regeneration is 
increasing due to the aging of our population as well as the increase of traumatologic 
injuries and necrosis-related bone resorption. Therefore, superior synthetic orthopaedic 
materials and techniques are required for clinical practice. In orthopaedics, the demand 
for synthetic bone cement materials can be fulfilled by using composite structures, as it is 
possible to mimic better the structures of living materials, like bone, cartilage or teeth 
using these composites. Polymer composites are combinations of two or more 
components, usually containing an inorganic phase and a polymer phase that are 
essentially insoluble in one another. Polymers have typically lower modulus and 
deformation resistance than the inorganic phase, although provide processability to the 
system. Thus, attempts are made to adjust the mechanical properties of polymeric 
materials to approximate those of bone, using a composite structure. 
 
The mechanical performance of any kind of nanocomposite reflects the interaction 
between the various phases. If there is adhesion between the two phases either chemical 
or physical, even at low strains, stress transfer can take place across the interface, which 
allows the filler to share the stress and provide a reinforcing effect. The successful 
reinforcement of poly(propylene fumarate) matrix by nanostructured titania fibers shows 
that the incorporation of one-dimensional nanomaterials is a promising technique for 
augmenting the mechanical properties of PPF-based bone cements. A novel 
functionalizing technique using the ring opening reaction of maleic anhydride was 
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applied to PPF in order to establish chemical adhesion between the nanofillers and 
organic polymer matrix. The major outcomes from these studies include:  
(1) TiO2 nanofibers up to a certain limit of loading exhibit homogenous dispersion in the 
functionalized polymeric continuous phase. 
(2) Reinforcement using TiO2 nanofibers is a promising technique only when there is a 
homogenous distribution of the nanomaterials to provide strong adhesion with the 
continuous phase. 
(3) The obtained reinforcing effect of the TiO2 nanofibers is attributed mainly to the 
strong interfacial chemical adhesion between the TiO2 nanofibers and the functionalized 
PPF matrix. 
It is very important for an orthopaedic surgeon to be able to easily monitor and evaluate 
the healing and loosening processes to differentiate between bone, bone cement, and 
osteolysis. Incorporation of TiO2 nanofibers into a cement formulation will not provide 
sufficient radiopacity to the PPF matrix at the optimum level of loading, which seems to 
be a major limitation for the potential application of the nanocomposites as bone cement 
materials. In an attempt to address this limitation, this study demonstrated a novel 
pathway to develop an alternative radiopacifier for PPF-based bone cements which also 
acts as a reinforcing agent. The modification of the titania nanotubes was performed 
through a novel sol-gel reaction in supercritical CO2. 
(1) TiO2 nanofibes were successfully modified with radiopaque Sr
2+ 
component using a 
sol-gel methodology in supercritical CO2.  
(2) This process offers several advantages over conventional sol-gel processes including: 
producing well-defined nanostructure, very good dispersion, high conversions, high 
surface areas, simple operating procedure, e.g. one-pot synthesis, mild operating 
conditions, e.g. 60 °C and 6000 psi, and environmental benignness. 
(3) Nanostructured Sr-doped TiO2 material was incorporated into the PPF-based bone 
cement formulations as reinforcing fillers presenting a homogeneous dispersion of the 
nanomaterials with strong chemical adhesion with the matrix while keeping the 
radiopacity of the cement intact. 
Blood vessels are an important component of bone formation and maintenance, and the 
bone tissue differentiation is related to the local presence of blood vessels. The local 
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release of a pro-angiogenic mediator leads to more intensive angiogenesis in the necrotic 
defect area, and thus improves osteogenesis and bone regeneration. Therefore, novel 
ginsenoside Rg1-releasing PPF microspheres were fabricated using both a conventional 
double emulsion and a microfluidic method.  
(1) The microfluidic approach produced more uniform sized microspheres (50-65 µm) 
compared to the more polydisperse microspheres prepared the W/O/W emulsion method 
(2-45 µm). 
(2) The monodisperse microspheres produced by the microfluidic method were found to 
exhibit a slower release rate and a smaller burst effect than the polydisperse microspheres 
formed by the double emulsion method. 
(3) The PPF microspheres obtained from the microfluidic approach demonstrated higher 
encapsulation efficiencies, which is a very important factor in drug delivery, especially 
for valuable and expensive bioactive compounds. 
(4) Rg1-induced tube formation is related to the dosage, and tube formation stimulation 
activity of ginsenoside Rg1 did not change significantly before and after release from the 
PPF microspheres. 
(5) Monodisperse microspheres generated by microfluidic devices are believed to 
enhance drug release kinetics, reproducibility, and bioavailability. Therefore, the 
monodisperse Rg1-loaded PPF microspheres are expected to significantly increase blood 
vessel density and vascular perfusion in necrotic defects and increased bone formation.  
In addition, immobilization of the biocompatible TiO2 on the surface of the 
hydroxyapatite will enhance the mechanical properties of HAp along with enhancing 
cellular responses and biocompatibility. A novel combined co-precipitation and sol-gel 
methodology using supercritical fluid processing with carbon dioxide (scCO2) was 
proposed to improve the mechanical properties of hydroxyapatite with HAp nonoplates 
grown from the surface of one-dimensional TiO2 nanorods. Then, a novel 
polymer/ceramic composite network of poly(ε-caprolactone) (PCL) and HAp-TiO2 with 
improved mechanical properties was developed for bone regeneration and bone tissue 
engineering applications. The rationale for the design of the nanocomposite consists of 
synthetic polymer, PCL, in combination with nanoscale synthetic HAp-TiO2 was based, 
in part, on the natural nanocomposite structure of bone tissue.  
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(1) The particle diameter and length, morphology, and BET surface area of the HAp-TiO2 
composite materials was tunable by adjusting the metal alkoxide concentration, reaction 
temperature, and pressure. 
(2) Morphologies of the HAp-TiO2 compound varied from nanoplate-thick sheet type 
structure to Nanoplate-Nanorods. 
(3) HAp-TiO2 nanocomposites were homogenously mixed within poly(ε-caprolactone) 
(PCL) to develop scaffolds with enhanced physical and mechanical properties for bone 
regeneration. 
(4) The significant increase in the Young’s and flexural modulus observed for PCL/HAp-
TiO2 composite over the PCL/HAp composition were concluded to be due to the 
morphology, size and, the preferred orientation. Due to the small diameters and large 
aspect ratios of TiO2 nanorods (large surface area), an intimate interface with the polymer 
matrix is formed, and the intrinsic properties of the HAp-TiO2 fillers contribute to an 
increase in the mechanical strength and stiffness of composites. In addition, there is a 
strong adhesion between the HAp-TiO2 and PCL matrix, and partially pulled out TiO2 
nanorods will impart the bridging of the crack during propagation and bridge the cracks 
in the PCL matrix. 
 
6.2 Recommendations 
The intended use of nanocomposite materials described in this thesis will be to provide 
temporary mechanical strength and conditions for new bone growth into a skeletal region 
deficient in trabecular bone of femoral head as well as tissue engineering which offers a 
promising alternative to conventional therapies by potentially enabling the regeneration 
of normal native tissues. 
The following recommendations will be useful in the future investigations of this study: 
i) N-Vinyl pyrrolidone (NVP) is normally used as a crosslinking reagent in PPF-
based formulations, but any unreacted NVP after in situ polymerization is of 
concern on account of its toxicity. In addition, even if titania is an established 
biocompatible material, nanomaterials are well known to exhibit completely 
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different characteristics at their nanodimensions, often being more toxic. This is 
attributed to their larger surface area, enhanced chemical reactivity, and easier 
penetration into cells. Therefore, the PPF-based polymer networks using NVP as 
a crosslinking reagent and reinforced with TiO2 nanofibers needs to be evaluated 
in terms of cell adhesion, proliferation, and cytotoxicity in a rat model system. In 
addition, the in vitro growth of osteoblast onto the reinforced cement composites 
and in vivo biocompatibility should be explored. 
ii) The synthesis part of the composite biomaterials or composite-Rg1 construct 
should degrade in a controlled fashion into nontoxic molecules that the body can 
metabolize or excrete and then allow the usual process of remodeling to optimize 
the mechanical properties of the newly formed bone. It has been reported that the 
poly(vinyl pyrrolidone) (PVP) crosslinks in the crosslinked PPF networks might 
be non-degradable. Thus, the degradation reaction of the PPF-based polymer 
networks and TiO2-PPF-based bone cement composite networks needs to be 
studied, and the degradation products should be isolated and characterized by 
instrumental analysis (
1
H and 
13
C NMR). 
iii) The sol-gel methodology using supercritical fluid processing with carbon dioxide 
(scCO2) to modify the titania nanofibers with strontium atom needs to be 
optimized in terms of concentration of strontium atom in the nanofibers. In 
addition, the effect of synthesis conditions including metal alkoxide 
concentration, reaction temperature, and pressure on the morphology, 
crystallinity, and chemical and physical state of modified nanofibers need to be 
studied by HRTEM, XPS and XRD. 
iv) Functionalization reaction of PPF with maleic anhydride (MA) needs to be 
optimized. The extent of functionalization could be adjusted by varying the pH of 
the reaction medium. 
v) An injectable, in situ polymerizable, biodegradable poly(propylene fumarate) 
(PPF) scaffold with embedded ginsenoside Rg1-delivering PPF microspheres 
should be developed for bone regeneration. Then, the performance of the 
ginsenoside Rg1-releasing scaffold is evaluated by observing in vitro cell 
differentiation of pre-osteoblast and in vivo bone formation in a rat model system 
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of irradiated osseous defects compromised in their vasculature as well as the tube 
formation of human umbilical vein endothelial cells (HUVEC) to examine the 
angiogenesis behavior of the PPF-based Rg1 delivery systems. In addition, the 
release profiles in vitro should be measured to monitor how the fabricated 
microsphere-containing scaffold could gradually releases agniogenic modulator. 
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Appendices  
Appendix A. Calibration curve of Rg1 
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